Country/Territory,Coverage (age/grade),Drug Group,Lifetime,Notes,Past Month,Past Year,Region,Source,Subregion,Year of Estimate
Ethiopia,Youth (undefined),Cannabis-type,11,Ages not specified,,,AFRICA,ARQ,Eastern Africa,1999
Kenya, (HHS) age 15 - 17,Cannabis-type,1.1,Resin,0.9,,AFRICA,Govt.,Eastern Africa,2007
Kenya,15 - 16,Cannabis-type,3.1,Herb,,,AFRICA,ARQ,Eastern Africa,2012
Kenya,15 - 16,Cannabis-type,0.8,Resin,,,AFRICA,ARQ,Eastern Africa,2012
Kenya,15 - 16,Cannabis-type,2.8,Herb,1.1,1.1,AFRICA,ARQ,Eastern Africa,2016
Madagascar,15 - 19,Cannabis-type,, ,,18.53,AFRICA,ARQ,Eastern Africa,2004
Mauritius,14 - 18,Cannabis-type,10.9, ,,2.2,AFRICA,ARQ,Eastern Africa,2004
Seychelles,11 - 16,Cannabis-type,, ,,0.31,AFRICA,ARQ,Eastern Africa,2001
Algeria,15 - 16,Cannabis-type,, ,,,AFRICA,ARQ,Northern Africa,2005
Algeria,15 - 16,Cannabis-type,0.17,Herb,0.07,0.07,AFRICA,ARQ,Northern Africa,2010
Algeria,15 - 17,Cannabis-type,5.44,Resin,2.69,3.61,AFRICA,ARQ,Northern Africa,2016
Egypt,15,Cannabis-type,18.9, ,,,AFRICA,ARQ,Northern Africa,2006
Egypt,15 - 16,Cannabis-type,,(general population survey),,1.4,AFRICA,ARQ,Northern Africa,2013
Egypt,15 - 16,Cannabis-type,,Herb (general population survey),,5.3,AFRICA,ARQ,Northern Africa,2013
Morocco,(SS) 15 - 17,Cannabis-type,6.573,Select regions (Rabat),2.9456,4.6228,AFRICA,MedSPAD,Northern Africa,2005
Morocco,(SS) 15 - 17,Cannabis-type,7.2,Resin,2.6,4.6,AFRICA,MedSPAD,Northern Africa,2009
Morocco,15-16,Cannabis-type,9.2, ,4.1,6.2,AFRICA,MedSPAD,Northern Africa,2009
Morocco,(SS) 15 - 17,Cannabis-type,5, ,3,3,AFRICA,ARQ,Northern Africa,2013
Sudan,18 - 20,Cannabis-type,3, ,,,AFRICA,ARQ,Northern Africa,2009
Namibia,15 - 16,Cannabis-type,9.3,Herb,6.2,6.4,AFRICA,Govt.,Southern and South-Eastern Africa,2015
South Africa,13 - 22,Cannabis-type,12.7,Herb,9.7,,AFRICA,ARQ,Southern and South-Eastern Africa,2008
South Africa,(SS) grades 8- 10,Cannabis-type,23.6,Western Cape Town only,8.2,12.3,AFRICA,ARQ,Southern and South-Eastern Africa,2011
Zambia,(SS) grades 7 - 10,Cannabis-type,35.3,GSHS,,,AFRICA,WHO,Southern and South-Eastern Africa,2004
Ghana,13 - 15,Cannabis-type,, ,,17.1,AFRICA,ARQ,West and Central Africa,2007
Togo,(SS) age 14 - 16,Cannabis-type,1.9, ,,1.2,AFRICA,ARQ,West and Central Africa,2009
Antigua and Barbuda,Secondary/ High School,Cannabis-type,24.9, ,8.4,13.4,AMERICAS,OAS (MEM),Caribbean,2005
Antigua and Barbuda,SS,Cannabis-type,32.58, ,17.96,23.89,AMERICAS,CICAD/ OAS,Caribbean,2013
Bahamas,15 - 16,Cannabis-type,15.6, ,,8.5,AMERICAS,Govt.,Caribbean,2008
Bahamas,SS,Cannabis-type,12.78, ,4.29,8.1,AMERICAS,CICAD/ OAS,Caribbean,2011
Barbados,"(SS) 13, 15, & 17",Cannabis-type,17.4, ,6,10.6,AMERICAS,OAS (MEM),Caribbean,2006
Barbados,SS,Cannabis-type,20.93, ,10.44,15.96,AMERICAS,CICAD/ OAS,Caribbean,2013
Dominica,"(SS) 13, 15, & 17",Cannabis-type,29.4, ,11.8,17.9,AMERICAS,OAS (MEM),Caribbean,2006
Dominica,SS,Cannabis-type,32.87, ,12.47,19.77,AMERICAS,CICAD/ OAS,Caribbean,2011
Dominican Republic,12 - 18,Cannabis-type,1.7, ,0.4,1,AMERICAS,ARQ,Caribbean,2008
Grenada,15 - 16,Cannabis-type,29.1, ,10.4,18.1,AMERICAS,Govt.,Caribbean,2005
Grenada,SS,Cannabis-type,19.74, ,6.99,12.92,AMERICAS,CICAD/ OAS,Caribbean,2013
Haiti,15 - 16,Cannabis-type,3, ,,1.7,AMERICAS,ARQ,Caribbean,2005
Haiti,SS,Cannabis-type,3.2, ,1.21,2.36,AMERICAS,CICAD/ OAS,Caribbean,2014
Jamaica,Ages 11 - 19,Cannabis-type,25.1, ,8.5,14.6,AMERICAS,OAS,Caribbean,2006
Jamaica,(SS) 15 - 17,Cannabis-type,14.3, ,,,AMERICAS,ARQ,Caribbean,2010
Jamaica,SS,Cannabis-type,21.11, ,6.29,11.93,AMERICAS,CICAD/ OAS,Caribbean,2013
Puerto Rico,(SS) Grades 9 - 12,Cannabis-type,12.5,Youth Risk Behavior Survey,6.8,,AMERICAS,Govt.,Caribbean,2005
Saint Kitts and Nevis,15 - 16,Cannabis-type,32.4, ,9.74,18.5,AMERICAS,Govt.,Caribbean,2006
Saint Kitts and Nevis,SS,Cannabis-type,24.24, ,11.61,16.07,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Lucia,"(SS) 13, 15, & 17",Cannabis-type,25.5, ,8.8,15.9,AMERICAS,OAS (MEM),Caribbean,2005
Saint Lucia,SS,Cannabis-type,28.77, ,10.71,17.22,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Vincent and the Grenadines,"(SS) 13, 15, & 17",Cannabis-type,17.76, ,5.17,11.72,AMERICAS,OAS (MEM),Caribbean,2006
Saint Vincent and the Grenadines,SS,Cannabis-type,26.7, ,14.11,19.39,AMERICAS,CICAD/ OAS,Caribbean,2013
Trinidad and Tobago,"(SS) 13, 15, & 17",Cannabis-type,11.97, ,2.75,6.55,AMERICAS,OAS (MEM),Caribbean,2006
Trinidad and Tobago,SS,Cannabis-type,16.6, ,6.23,10.7,AMERICAS,CICAD/ OAS,Caribbean,2013
Turks and Caicos Islands,11 - 20,Cannabis-type,21.4, ,,14.5,AMERICAS,ARQ,Caribbean,2002
Belize,"(SS) 13, 15, & 17",Cannabis-type,20.5, ,6.7,13.4,AMERICAS,OAS (MEM),Central America (excluding Mexico),2002
Belize,SS,Cannabis-type,24.27, ,10.64,15.84,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2013
Costa Rica,SS,Cannabis-type,9.97,Herb,3.56,6.82,AMERICAS,ARQ,Central America (excluding Mexico),2009
Costa Rica,15- 16,Cannabis-type,16.83,Herb,5.65,11.74,AMERICAS,ARQ,Central America (excluding Mexico),2012
Costa Rica,15 - 16,Cannabis-type,13.309,Herb,1.795,7.3,AMERICAS,ARQ,Central America (excluding Mexico),2015
El Salvador,13-17,Cannabis-type,5.5, ,1.8,3.5,AMERICAS,ARQ,Central America (excluding Mexico),2008
El Salvador,17 - 25,Cannabis-type,12.7, ,0.7,3.4,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,17 - 25,Cannabis-type,0.9,Resin,0,0.1,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,17 - 25,Cannabis-type,11.8,Herb,0.7,3.3,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,13 - 17,Cannabis-type,15.4, ,4,7.3,AMERICAS,ARQ,Central America (excluding Mexico),2016
Guatemala,12 - 19,Cannabis-type,2, ,,1,AMERICAS,ARQ,Central America (excluding Mexico),2004
Guatemala,11 - 22,Cannabis-type,11.31,Herb,3.08,5.69,AMERICAS,ARQ,Central America (excluding Mexico),2014
Guatemala,11 - 22,Cannabis-type,0.88,Resin,,,AMERICAS,ARQ,Central America (excluding Mexico),2014
Honduras,13 - 25,Cannabis-type,3.4,Select Regions (Central  District),,,AMERICAS,ARQ,Central America (excluding Mexico),2008
Honduras,SS,Cannabis-type,16.8,"Herb, Secondary Schools",4.4,9.6,AMERICAS,ARQ,Central America (excluding Mexico),2014
Honduras,14-17,Cannabis-type,14.7,"Herb, Secondary Schools",1.1,6.8,AMERICAS,ARQ,Central America (excluding Mexico),2015
Nicaragua,15 - 16,Cannabis-type,4.8, ,,,AMERICAS,Govt.,Central America (excluding Mexico),2003
Panama,SS,Cannabis-type,6.2, ,1.8,2.9,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2008
Panama,18-25,Cannabis-type,8.56,Herb,1.13,3.33,AMERICAS,ARQ,Central America (excluding Mexico),2013
Panama,18-25,Cannabis-type,0.64,Resin,0.04,0.21,AMERICAS,ARQ,Central America (excluding Mexico),2013
Canada,15 - 19,Cannabis-type,34.3, ,13.3,23.7,AMERICAS,ARQ,Northern America (including Mexico),2010
Greenland,"11,13,15",Cannabis-type,16.2, ,4.31,12.17,AMERICAS,HBSC,Northern America (including Mexico),2010
Mexico,12 - 17,Cannabis-type,2.4, ,0.73,1.33,AMERICAS,National Adiction Household Survey,Northern America (including Mexico),2011
Mexico,12- 17,Cannabis-type,, ,,1.2,AMERICAS,National Adiction Household Survey,Northern America (including Mexico),2008
Mexico,12 -17,Cannabis-type,, ,,0.5,AMERICAS,National Adiction Household Survey,Northern America (including Mexico),2002
Mexico,15 - 16,Cannabis-type,2.4, ,,1.3,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15 - 16,Cannabis-type,10.6,Herb only,3.9,7.6,AMERICAS,ARQ,Northern America (including Mexico),2014
Mexico,12 - 17,Cannabis-type,5.3,Herb,1.1,2.6,AMERICAS,ARQ,Northern America (including Mexico),2016
Mexico,12 - 17,Cannabis-type,0.7,Resin,,,AMERICAS,ARQ,Northern America (including Mexico),2016
United States of America, (SS) Grade 10,Cannabis-type,32.3,Herb,15.9,26.7,AMERICAS,ARQ,Northern America (including Mexico),2009
United States of America, (SS) Grade 10,Cannabis-type,33.4,Herb,16.7,27.5,AMERICAS,Govt.,Northern America (including Mexico),2010
United States of America, (SS) Grade 10,Cannabis-type,34.5,Herb,17.6,28.8,AMERICAS,ARQ,Northern America (including Mexico),2011
United States of America, (SS) Grade 10,Cannabis-type,33.8,Herb,17,28,AMERICAS,ARQ,Northern America (including Mexico),2012
United States of America, (SS) Grade 10,Cannabis-type,35.8, ,18,29.8,AMERICAS,ARQ,Northern America (including Mexico),2013
United States of America, (SS) Grade 10,Cannabis-type,33.7, ,16.6,27.3,AMERICAS,ARQ,Northern America (including Mexico),2014
United States of America,(SS) 15 - 16,Cannabis-type,31.1,Monitoring the future,14.8,25.3,AMERICAS,ARQ,Northern America (including Mexico),2015
United States of America,(SS) Grade 10,Cannabis-type,29.7, ,14,23.9,AMERICAS,ARQ,Northern America (including Mexico),2016
Argentina,13 - 17,Cannabis-type,10.9, ,,7.6,AMERICAS,ARQ,South America,2007
Argentina,15 - 16,Cannabis-type,13.2,Herb,5.7,9.5,AMERICAS,ARQ,South America,2009
Argentina,15 - 16,Cannabis-type,14.7,Herb,6.5,11.1,AMERICAS,ARQ,South America,2011
Argentina,15 - 16,Cannabis-type,18.3,Herb,8.8,13.6,AMERICAS,ARQ,South America,2014
Bolivia (Plurinational State of),13 - 18,Cannabis-type,6.2, ,1.9,3.6,AMERICAS,ARQ,South America,2008
Bolivia (Plurinational State of),12 - 17,Cannabis-type,1.1,Herb,0.34,0.71,AMERICAS,ARQ,South America,2008
Bolivia (Plurinational State of),15-16,Cannabis-type,1.11,"Herb, Capitals of departments",0.34,0.71,AMERICAS,ARQ,South America,2013
Bolivia (Plurinational State of),18 - 24,Cannabis-type,11.97,Herb,1.45,3.44,AMERICAS,ARQ,South America,2012
Bolivia (Plurinational State of),18 - 24,Cannabis-type,1.98,Resin,0.2,0.47,AMERICAS,ARQ,South America,2012
Bolivia (Plurinational State of),18 - 24,Cannabis-type,12.15,Herb,2.18,4.98,AMERICAS,OAS,South America,2016
Brazil,15 - 16,Cannabis-type,7.67, ,4.43,6.29,AMERICAS,CICAD/ OAS,South America,2005
Brazil, 10 - 19,Cannabis-type,5.7, ,2,3.7,AMERICAS,ARQ,South America,2010
Chile,(SS) 15 - 16,Cannabis-type,25.9,Herb,8.15,16.2,AMERICAS,ARQ,South America,2009
Chile,(SS) 15 - 16,Cannabis-type,26.9,Herb,12.35,20.5,AMERICAS,ARQ,South America,2011
Chile,(SS) 15 - 16,Cannabis-type,38.96,Herb,19.98,32.87,AMERICAS,ARQ,South America,2013
Chile,"(SS) 13, 15, 17",Cannabis-type,34.89,Herb,17.13,28.35,AMERICAS,CICAD/ OAS,South America,2013
Chile,(SS) 15 - 16,Cannabis-type,43.83,Herb only,20,34.79,AMERICAS,ARQ,South America,2015
Colombia,15 - 16,Cannabis-type,9.58, ,3.01,8.36,AMERICAS,CICAD/ OAS,South America,2005
Colombia,11-18,Cannabis-type,7,Herb,2.83,5.22,AMERICAS,ARQ,South America,2011
Colombia,University,Cannabis-type,31.16,Herb,7.14,15.01,AMERICAS,ARQ,South America,2012
Colombia,18 - 24,Cannabis-type,36.31, ,9.74,20.77,AMERICAS,Government,South America,2016
Ecuador,12 - 17,Cannabis-type,6.4, ,2.2,4.2,AMERICAS,ARQ,South America,2008
Ecuador,University,Cannabis-type,11.41, ,1.68,4.43,AMERICAS,ARQ,South America,2009
Ecuador,12 - 17,Cannabis-type,6.7,Herb,1.3,2.9,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Cannabis-type,0.5,Resin,0.1,0.2,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Cannabis-type,7.19, ,1.37,3.1,AMERICAS,ARQ,South America,2012
Ecuador,18 - 24,Cannabis-type,26.93,Herb,5.06,11.57,AMERICAS,OAS,South America,2016
Guyana,12 - 18,Cannabis-type,6.8, ,1.8,3.5,AMERICAS,ARQ,South America,2002
Guyana,SS,Cannabis-type,7.15, ,2.38,4.19,AMERICAS,CICAD/ OAS,South America,2013
Paraguay,15 - 16,Cannabis-type,4.2, ,1.6,3,AMERICAS,CICAD/ OAS,South America,2005
Paraguay,12+,Cannabis-type,5.7,"Herb, School in cities of at least 30000",2.3,3.7,AMERICAS,ARQ,South America,2014
Paraguay,12+,Cannabis-type,1,"Resin, School in cities of at least 30000",0,0,AMERICAS,ARQ,South America,2014
Peru,12 - 18,Cannabis-type,2, ,0.6,1.2,AMERICAS,DEVIDA,South America,2006
Peru,15 - 16,Cannabis-type,2.366,Herb,0.837,1.642,AMERICAS,ARQ,South America,2006
Peru,11 - 19,Cannabis-type,3.1, ,0.9,1.9,AMERICAS,DEVIDA,South America,2007
Peru,15-16,Cannabis-type,3.3,Herb,2.4,2.9,AMERICAS,ARQ,South America,2010
Peru,11-20,Cannabis-type,4.3,Herb,1.4,2.2,AMERICAS,DEVIDA,South America,2012
Peru,"(SS) 13, 15, 17",Cannabis-type,5.02,Herb,1.55,2.53,AMERICAS,CICAD/ OAS,South America,2012
Peru,14 - 16,Cannabis-type,4.97,Resin,1.67,2.63,AMERICAS,ARQ,South America,2012
Peru,18 - 24,Cannabis-type,14.77,Herb,1.55,5.17,AMERICAS,OAS,South America,2016
Suriname,SS,Cannabis-type,7.71, ,2.73,4.8,AMERICAS,CICAD/ OAS,South America,2006
Uruguay,13 - 17,Cannabis-type,16.2,Herb,6.8,12.5,AMERICAS,ARQ,South America,2009
Uruguay,13 - 17,Cannabis-type,16.4,Herb,7.5,12,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Cannabis-type,0.6,Resin,,,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Cannabis-type,20.1, ,9.5,17,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Cannabis-type,20.1,Herb,9.5,17,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Cannabis-type,0.8,Resin,0.2,0.6,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),(SS) 12 - 18,Cannabis-type,1.746839645,Herb,0.595073346,0.882812824,AMERICAS,ARQ,South America,2009
Venezuela (Bolivarian Republic of),15-17,Cannabis-type,3.16,Herb,1.09,1.84,AMERICAS,ARQ,South America,2011
Venezuela (Bolivarian Republic of),University,Cannabis-type,6.1,Herb,1.1,3.1,AMERICAS,ARQ,South America,2014
Armenia,15 - 16,Cannabis-type,3, ,,,ASIA,ESPAD,Central Asia and Transcaucasia,2007
Armenia,"11,13,15",Cannabis-type,2.82, ,2.73,3.21,ASIA,HBSC,Central Asia and Transcaucasia,2010
Georgia,(SS) 15 - 16,Cannabis-type,16.9,Select regions (capital);  Georgian Medical News No3 (180) 2010,3.6,9.6,ASIA,Research,Central Asia and Transcaucasia,2010
Georgia,16,Cannabis-type,11, ,4,4,ASIA, ESPAD,Central Asia and Transcaucasia,2015
Kazakhstan,15 - 16,Cannabis-type,4.6, ,,2.7,ASIA,ARQ,Central Asia and Transcaucasia,2007
Kazakhstan,"16, 19 and 21",Cannabis-type,11.2, ,3.6,6.5,ASIA,ARQ,Central Asia and Transcaucasia,2012
Kyrgyzstan,15 - 18,Cannabis-type,0.3, ,,,ASIA,ARQ,Central Asia and Transcaucasia,2001
"China, Hong Kong SAR",15-16,Cannabis-type,, ,,0.02,ASIA,ARQ,East and South-East Asia,2011
"China, Hong Kong SAR",11 - 20,Cannabis-type,,Central Registry,,0.01,ASIA,ARQ,East and South-East Asia,2014
"China, Hong Kong SAR",11 - 20,Cannabis-type,,Central Registry,,0.01,ASIA,ARQ,East and South-East Asia,2015
"China, Hong Kong SAR",11 - 20,Cannabis-type,,Central Registry,,0.01,ASIA,ARQ,East and South-East Asia,2016
"China, Macao SAR",18 - 25,Cannabis-type,2.8, ,,,ASIA,ARQ,East and South-East Asia,2002
"China, Taiwan Province of China",(SS) Grades 10 & 12,Cannabis-type,0.1, ,,,ASIA,Govt.,East and South-East Asia,2006
Indonesia,10 - 19,Cannabis-type,0.57,Herb,0.19,0.3,ASIA,ARQ,East and South-East Asia,2010
Indonesia,15-19,Cannabis-type,1.3,Resin,0.1,1.3,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15-19,Cannabis-type,1.9,Herb,0.07,1.3,ASIA,ARQ,East and South-East Asia,2011
Indonesia,(HHS)10-25,Cannabis-type,0.59,"Herb only, 20 provinces",,0.21,ASIA,ARQ,East and South-East Asia,2015
Japan,13 - 15,Cannabis-type,0.3, ,,,ASIA,ARQ,East and South-East Asia,2010
Japan,(SS) 15 - 16,Cannabis-type,0.2, ,,,ASIA,ARQ,East and South-East Asia,2011
Japan,(SS) 15 - 16,Cannabis-type,0.2, ,,,ASIA,ARQ,East and South-East Asia,2013
Japan,(SS) 15 - 16,Cannabis-type,0.2, ,,,ASIA,ARQ,East and South-East Asia,2014
Japan,(SS) 15 - 16,Cannabis-type,0.3, ,,,ASIA,ARQ,East and South-East Asia,2016
Myanmar,13 - 21,Cannabis-type,0.9, ,,0.5,ASIA,ARQ,East and South-East Asia,2004
Thailand,Youth (undefined),Cannabis-type,4.4,Ages not specified,,,ASIA,ARQ,East and South-East Asia,2003
Israel,(SS) Grade 10,Cannabis-type,, ,,4.2,ASIA,ARQ,Near and Middle East / South-West Asia,2009
Israel,12 - 18,Cannabis-type,7.08, ,4.44,5.66,ASIA,ARQ,Near and Middle East / South-West Asia,2009
Israel,12 - 18,Cannabis-type,5.73,Resin,3.63,4.66,ASIA,ARQ,Near and Middle East / South-West Asia,2009
Israel,12 - 18,Cannabis-type,5.16,Herb,3.51,4.15,ASIA,ARQ,Near and Middle East / South-West Asia,2009
Israel,(SS) 15 - 16,Cannabis-type,6.6, ,3.9,6.4,ASIA,ARQ,Near and Middle East / South-West Asia,2010
Israel,(SS) 15 - 16,Cannabis-type,8.5,Schools -except private schools,5.5,6,ASIA,ARQ,Near and Middle East / South-West Asia,2014
Jordan,18 - 25,Cannabis-type,, ,,2.5,ASIA,ARQ,Near and Middle East / South-West Asia,2001
Lebanon,(SS) 15 - 16,Cannabis-type,6.1,Cannabis Resin,,,ASIA,MedSPAD,Near and Middle East / South-West Asia,2009
Bangladesh,13 - 18,Cannabis-type,5, ,,3,ASIA,ARQ,Southern Asia,2001
Bhutan,Undefined,Cannabis-type,,"Herb, General population survey",,0.093,ASIA,ARQ,Southern Asia,2010
India,12 - 18,Cannabis-type,, ,3,,ASIA,ARQ,Southern Asia,2001
Belarus,15 - 16,Cannabis-type,5.3, ,0.6,2.4,EUROPE,ARQ,Eastern Europe,2010
Republic of Moldova,(SS) 15 - 16,Cannabis-type,4.8, ,1.3,2.8,EUROPE,ESPAD,Eastern Europe,2008
Republic of Moldova,(SS) 15 - 24,Cannabis-type,4.9, ,1.1,2.3,EUROPE,Govt.,Eastern Europe,2010
Republic of Moldova,(SS) 15 - 24,Cannabis-type,3.5, ,0.3,1.2,EUROPE,ARQ,Eastern Europe,2012
Republic of Moldova,(SS) 15 - 16,Cannabis-type,4, ,2,,EUROPE,ESPAD,Eastern Europe,2015
Russian Federation,15 - 16,Cannabis-type,18.6, ,,17,EUROPE,ARQ/ ESPAD,Eastern Europe,2007
Russian Federation,"11,13,15",Cannabis-type,7.11, ,5.21,4.76,EUROPE,HBSC,Eastern Europe,2010
Russian Federation,15-16,Cannabis-type,14.8, ,4,9.5,EUROPE,ARQ,Eastern Europe,2011
Russian Federation,0 - 18,Cannabis-type,0.001, ,,,EUROPE,ARQ,Eastern Europe,2013
Ukraine,(SS) 15 - 16,Cannabis-type,14, ,,,EUROPE,ESPAD,Eastern Europe,2007
Ukraine,15 - 34,Cannabis-type,9,Registered users,2,3,EUROPE,ARQ,Eastern Europe,2010
Ukraine,15-17,Cannabis-type,12.4,Registered users,3,7.3,EUROPE,ARQ,Eastern Europe,2011
Ukraine,14 - 17,Cannabis-type,,Registered users,,0.15,EUROPE,ARQ,Eastern Europe,2013
Ukraine,15 - 35,Cannabis-type,,Registered users,,2.1,EUROPE,ARQ,Eastern Europe,2014
Ukraine,(SS) 15 - 16,Cannabis-type,9, ,2,,EUROPE,ESPAD,Eastern Europe,2015
Albania,14 - 19,Cannabis-type,5.5, ,,,EUROPE,ARQ,South-Eastern Europe (including Turkey),2004
Albania,(SS) 15 - 16,Cannabis-type,7.1,Herb,3.4,5.5,EUROPE,ARQ / ESPAD,South-Eastern Europe (including Turkey),2015
Bosnia and Herzegovina,(SS) 15 - 16,Cannabis-type,, ,,10,EUROPE,ARQ,South-Eastern Europe (including Turkey),2008
Bosnia and Herzegovina,(SS) 15 - 16,Cannabis-type,4.5, ,1.4,3.3,EUROPE,ARQ,South-Eastern Europe (including Turkey),2011
Bosnia and Herzegovina,(SS) 15 - 16,Cannabis-type,,Resin,1,,EUROPE,ARQ,South-Eastern Europe (including Turkey),2011
Bosnia and Herzegovina,(SS) 15 - 16,Cannabis-type,1, ,,,EUROPE,ARQ,South-Eastern Europe (including Turkey),2012
Bosnia and Herzegovina,(SS) 15 - 16,Cannabis-type,0.8,Herb,,,EUROPE,ARQ,South-Eastern Europe (including Turkey),2012
Bosnia and Herzegovina,(SS) 15 - 16,Cannabis-type,0.2,Resin,,,EUROPE,ARQ,South-Eastern Europe (including Turkey),2012
Bulgaria,14 - 19,Cannabis-type,26, ,9.4,17,EUROPE,ARQ,South-Eastern Europe (including Turkey),2008
Bulgaria,14 - 19,Cannabis-type,11.4,Resin,3.7,6.8,EUROPE,ARQ,South-Eastern Europe (including Turkey),2008
Bulgaria,14 - 19,Cannabis-type,24.5,Herb,8.7,15.7,EUROPE,ARQ,South-Eastern Europe (including Turkey),2008
Bulgaria,(SS) 15 - 16,Cannabis-type,25.6, ,11.3,20.5,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2011
Bulgaria,15 - 18,Cannabis-type,26.2, ,11.1,19.6,EUROPE,ARQ,South-Eastern Europe (including Turkey),2013
Bulgaria,15 - 18,Cannabis-type,25.5,Herb,10.8,19,EUROPE,ARQ,South-Eastern Europe (including Turkey),2013
Bulgaria,15 - 18,Cannabis-type,8.1,Resin,3.3,6,EUROPE,ARQ,South-Eastern Europe (including Turkey),2013
Bulgaria,(SS) 15 - 16,Cannabis-type,27, ,12,,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2015
Bulgaria,(SS) 15 - 16,Cannabis-type,30.9, ,14.2,24.3,EUROPE,ARQ / ESPAD,South-Eastern Europe (including Turkey),2015
Croatia,16,Cannabis-type,18.3, ,,13.4,EUROPE,ARQ,South-Eastern Europe (including Turkey),2007
Croatia,15,Cannabis-type,13.4,Herb,5.5,10.2,EUROPE,ARQ,South-Eastern Europe (including Turkey),2010
Croatia,(SS) 15 - 16,Cannabis-type,21, ,8,,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2015
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Cannabis-type,5.5, ,2.2,4.3,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2008
The former Yugoslav Republic of Macedonia,"11,13,15",Cannabis-type,2.75, ,1.77,2.31,EUROPE,HBSC,South-Eastern Europe (including Turkey),2010
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Cannabis-type,5, ,2,,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2015
Montenegro,(SS) 16,Cannabis-type,5.5, ,2.8,3.9,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2011
Montenegro,(SS) 15 - 16,Cannabis-type,4, ,1.6,2.4,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2008
Montenegro,(SS) 16,Cannabis-type,8, ,3,6,EUROPE,ARQ,South-Eastern Europe (including Turkey),2015
Romania,(SS) 16,Cannabis-type,3.5, ,,1.9,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2007
Romania,(SS) 15 - 16,Cannabis-type,7.1, ,2.2,5.5,EUROPE,ARQ,South-Eastern Europe (including Turkey),2011
Romania,(SS) 15 - 17,Cannabis-type,8.1, ,2.9,6.1,EUROPE,ARQ,South-Eastern Europe (including Turkey),2015
Serbia,(SS) 15 - 16,Cannabis-type,6.7, ,,4.9,EUROPE,ARQ,South-Eastern Europe (including Turkey),2008
Serbia,(SS) 15 - 16,Cannabis-type,6.7, ,2.6,5,EUROPE,ESPAD,South-Eastern Europe (including Turkey),2011
Turkey,15 - 16,Cannabis-type,4.3, ,,3.31,EUROPE,ARQ,South-Eastern Europe (including Turkey),2003
Andorra,(SS) 15 - 16,Cannabis-type,, ,8.4,,EUROPE,ARQ,Western and Central Europe,2008
Andorra,(SS) 15,Cannabis-type,28.1, ,9.9,13.2,EUROPE,ARQ,Western and Central Europe,2014
Austria,(SS) 15 - 16,Cannabis-type,18, ,6.7,,EUROPE,ESPAD,Western and Central Europe,2007
Austria,14 - 17,Cannabis-type,19, ,7,15,EUROPE,ARQ,Western and Central Europe,2007
Austria,(SS) 15 - 16,Cannabis-type,19.9, ,9,16,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Belgium,15 - 16,Cannabis-type,24.04, ,9.22,15.36,EUROPE,ARQ,Western and Central Europe,2010
Belgium,(SS) 15 - 16,Cannabis-type,21.5, ,12,15,EUROPE,ARQ,Western and Central Europe,2011
Belgium,(SS) 15 - 16,Cannabis-type,20.9, ,11.2,13.6,EUROPE,ARQ,Western and Central Europe,2012
Belgium,(SS) 15 - 16,Cannabis-type,17,Flemish part,8,,EUROPE,ESPAD,Western and Central Europe,2015
Belgium,(SS) 15 - 16,Cannabis-type,17.9,Flemish part,6.3,13.5,EUROPE,ARQ / ESPAD,Western and Central Europe,2016
Belgium,(SS) 12 - 18,Cannabis-type,14.6,Flemish part,5.2,10.8,EUROPE,ARQ / ESPAD,Western and Central Europe,2016
Cyprus,(SS) 15 - 16,Cannabis-type,5, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Cyprus,16,Cannabis-type,5, ,3,4,EUROPE,ARQ,Western and Central Europe,2007
Cyprus,(SS) 15 - 16,Cannabis-type,7, ,5,7,EUROPE,ESPAD,Western and Central Europe,2011
Cyprus,15 - 24,Cannabis-type,10.9, ,2,4.3,EUROPE,ARQ,Western and Central Europe,2012
Cyprus,(SS) 15 - 16,Cannabis-type,7, ,5,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 34,Cannabis-type,17.2, ,2.2,2.2,EUROPE,ARQ,Western and Central Europe,2016
Czechia,(SS) 15 - 16,Cannabis-type,45.1, ,,35.4,EUROPE,ARQ./ ESPAD,Western and Central Europe,2007
Czechia,16,Cannabis-type,45.1, ,18.1,34.8,EUROPE,ARQ,Western and Central Europe,2007
Czechia,(SS) 15 - 16,Cannabis-type,42.3, ,14.6,29.7,EUROPE,ARQ,Western and Central Europe,2011
Czechia,(SS) 15 - 16,Cannabis-type,24,Male,8,,EUROPE,ARQ,Western and Central Europe,2014
Czechia,(SS) 15 - 16,Cannabis-type,24,Female,10,,EUROPE,ARQ,Western and Central Europe,2014
Czechia,(SS) 15 - 16,Cannabis-type,36.8, ,12.8,27,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Denmark,(SS) 15 - 16,Cannabis-type,25.5, ,,,EUROPE,ARQ,Western and Central Europe,2007
Denmark,(SS) 15 - 16,Cannabis-type,18.1, ,6.2,,EUROPE,ARQ / ESPAD,Western and Central Europe,2011
Denmark,(SS) 15 - 16,Cannabis-type,12.4, ,4.9,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Estonia,(SS) 15 - 16,Cannabis-type,26.2, ,6.2,19.2,EUROPE,ARQ,Western and Central Europe,2007
Estonia,"11,13,15",Cannabis-type,14.3, ,2.66,8.7,EUROPE,HBSC,Western and Central Europe,2010
Estonia,(SS) 15 - 19,Cannabis-type,24.2, ,,,EUROPE,ARQ,Western and Central Europe,2011
Estonia,(SS) 15 - 16,Cannabis-type,25, ,8,,EUROPE,ESPAD,Western and Central Europe,2015
Estonia,"(SS) 6, 8, 12 grades",Cannabis-type,15, ,,,EUROPE,ARQ,Western and Central Europe,2013
Estonia,(SS) 15 - 16,Cannabis-type,25, ,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Faroe Islands,(SS) 15 - 16,Cannabis-type,6, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Faroe Islands,(SS) 15 - 16,Cannabis-type,6, ,1,,EUROPE,ESPAD,Western and Central Europe,2015
Finland,(SS) 15 - 16,Cannabis-type,8, ,2,6,EUROPE,ARQ,Western and Central Europe,2007
Finland,(SS) 15 - 16,Cannabis-type,11, ,3,9,EUROPE,ARQ,Western and Central Europe,2011
Finland,(SS) 15 - 16,Cannabis-type,0.708333333, ,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Cannabis-type,8,Herb,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Cannabis-type,5.5,Resin,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Cannabis-type,8, ,2,7,EUROPE,ARQ (ESPAD),Western and Central Europe,2015
France,(SS) 15 - 16,Cannabis-type,31, ,,,EUROPE,ESPAD,Western and Central Europe,2007
France,17,Cannabis-type,41.5, ,6.5,34.6,EUROPE,ARQ,Western and Central Europe,2011
France,17,Cannabis-type,47.8,Urban areas (excluding overseas departments),25.5,38.2,EUROPE,ARQ,Western and Central Europe,2014
France,(SS) 15 - 16,Cannabis-type,31, ,17,,EUROPE,ESPAD,Western and Central Europe,2015
Germany,(SS) 15 - 16,Cannabis-type,25.2,Select regions,,17.2,EUROPE,ARQ,Western and Central Europe,2007
Germany,12 - 25,Cannabis-type,28.3, ,3.7,9.6,EUROPE,Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2008.,Western and Central Europe,2008
Germany,(SS) 15 - 16,Cannabis-type,22.2,Select regions,,,EUROPE,ARQ/ESPAD,Western and Central Europe,2011
Germany,(SS) 12 - 17,Cannabis-type,6.7, ,1.9,4.6,EUROPE,ARQ,Western and Central Europe,2011
Germany,(SS) 15 - 16,Cannabis-type,8.8,Region Frankfurt am Main,2.2,6.6,EUROPE,ARQ,Western and Central Europe,2015
Gibraltar,(SS) 12 - 18,Cannabis-type,, ,,13.2,EUROPE,ARQ,Western and Central Europe,2008
Greece,15 - 16,Cannabis-type,7.2, ,4.1,6.3,EUROPE,ARQ,Western and Central Europe,2010
Greece,15 - 16,Cannabis-type,8.4, ,4,6.9,EUROPE,ARQ,Western and Central Europe,2011
Greece,(SS)15 - 16,Cannabis-type,9.08, ,4.15,7.44,EUROPE,ESPAD,Western and Central Europe,2015
Hungary,(SS) 15 - 16,Cannabis-type,5.3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Hungary,(SS) 15 - 16,Cannabis-type,18.6, ,5.7,12.5,EUROPE,ESPAD,Western and Central Europe,2015
Iceland,(SS) 15 - 16,Cannabis-type,9, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Iceland,"11,13,15",Cannabis-type,8.75, ,3.64,6.9,EUROPE,HBSC,Western and Central Europe,2010
Iceland,(SS) 15 - 16,Cannabis-type,4, ,4,,EUROPE,ARQ,Western and Central Europe,2011
Iceland,(SS) 15 - 16,Cannabis-type,7, ,2,,EUROPE,ESPAD,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Cannabis-type,20, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Ireland,(SS) 15 - 16,Cannabis-type,18, ,7,14,EUROPE,ARQ,Western and Central Europe,2011
Ireland,(SS) 10 - 17,Cannabis-type,, ,8.17,13.5,EUROPE,ARQ,Western and Central Europe,2014
Ireland,(SS) 15 - 16,Cannabis-type,19, ,9.8,16.8,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Italy,15 - 16,Cannabis-type,12.3, ,7.2,10.8,EUROPE,ARQ,Western and Central Europe,2010
Italy,(SS) 15 - 19,Cannabis-type,12.55, ,7.66,11.1,EUROPE,ARQ,Western and Central Europe,2012
Italy,(SS) 15 - 19,Cannabis-type,14.41, ,9.39,13.2,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 17,Cannabis-type,29,Male,16.1,24.5,EUROPE,ARQ,Western and Central Europe,2014
Italy,(SS) 15 - 17,Cannabis-type,21,Female,10.3,17.2,EUROPE,ARQ,Western and Central Europe,2014
Italy,(SS) 15 - 19,Cannabis-type,33.1, ,16.6,26.5,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15 - 19,Cannabis-type,32.42, ,16.15,25.79,EUROPE,ARQ,Western and Central Europe,2016
Latvia,(SS) 15 - 16,Cannabis-type,22.7,Riga City,7.9,15.8,EUROPE,ARQ,Western and Central Europe,2010
Latvia,(SS) 15 - 16,Cannabis-type,24.5, ,6.3,16.4,EUROPE,ESPAD,Western and Central Europe,2011
Latvia,(SS) 15 - 16,Cannabis-type,21.34, ,5.77,14.24,EUROPE,ARQ,Western and Central Europe,2013
Latvia,(SS) 19,Cannabis-type,16.6, ,4.2,10.8,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,12 - 16,Cannabis-type,16.2, ,,11.2,EUROPE,ARQ,Western and Central Europe,2005
Liechtenstein,12 - 19,Cannabis-type,16.2, ,,24.4,EUROPE,ARQ,Western and Central Europe,2005
Liechtenstein,(SS) 15 - 16,Cannabis-type,21, ,8,16,EUROPE,ARQ,Western and Central Europe,2011
Liechtenstein,(SS) 15 - 16,Cannabis-type,30.8, ,11.6,26.2,EUROPE,ARQ,Western and Central Europe,2015
Lithuania,(SS) 15 - 16,Cannabis-type,18.2, ,4.7,11.7,EUROPE,ESPAD,Western and Central Europe,2007
Lithuania,(SS) 15 - 16,Cannabis-type,19.6, ,4.8,12.5,EUROPE,ARQ,Western and Central Europe,2011
Lithuania,(SS) 15 - 16,Cannabis-type,17.7, ,4.3,11.3,EUROPE,ARQ,Western and Central Europe,2015
Luxembourg,11 - 17,Cannabis-type,27.4, ,,22.4,EUROPE,ARQ,Western and Central Europe,1999
Luxembourg,12 - 18,Cannabis-type,15.5, ,6.3,12.1,EUROPE,ARQ,Western and Central Europe,2010
Luxembourg,"11,13,15",Cannabis-type,8.49, ,4.19,6.75,EUROPE,HBSC,Western and Central Europe,2010
Malta,(SS) 15 - 16,Cannabis-type,12.9, ,5.3,10.6,EUROPE,ARQ,Western and Central Europe,2007
Malta,(SS) 15 - 16,Cannabis-type,9.8, ,4,8,EUROPE,ESPAD,Western and Central Europe,2011
Malta,(SS) 15 - 16,Cannabis-type,12.6, ,5.4,10.4,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Monaco,(SS) 15 - 16,Cannabis-type,28, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Monaco,(SS) 15 - 16,Cannabis-type,31, ,12,,EUROPE,ESPAD,Western and Central Europe,2015
Netherlands,(SS) 15 - 16,Cannabis-type,28, ,,15,EUROPE,ESPAD,Western and Central Europe,2007
Netherlands,12 - 18,Cannabis-type,11.8, ,5.3,9.3,EUROPE,ARQ,Western and Central Europe,2007
Netherlands,12 - 18,Cannabis-type,17.4, ,7.7,,EUROPE,ARQ,Western and Central Europe,2010
Netherlands,15 - 16,Cannabis-type,9.2, ,4.6,7.9,EUROPE,ARQ,Western and Central Europe,2014
Netherlands,(SS) 15 - 16,Cannabis-type,22, ,12,,EUROPE,ESPAD,Western and Central Europe,2015
Netherlands,(SS) 12 - 16,Cannabis-type,9.7, ,4.9,8.2,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Norway,(SS) 15 - 16,Cannabis-type,6, ,,6,EUROPE,ESPAD,Western and Central Europe,2007
Norway,(SS) 15 - 16,Cannabis-type,5, ,2,4,EUROPE,ESPAD,Western and Central Europe,2011
Norway,(SS) 15 - 16,Cannabis-type,7, ,2,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,18 - 19,Cannabis-type,36, ,8,18,EUROPE,ARQ,Western and Central Europe,2010
Poland,(SS) 15 - 16,Cannabis-type,24.3, ,10.5,20.1,EUROPE,ARQ,Western and Central Europe,2012
Poland,(SS) 15 - 16,Cannabis-type,40.2, ,9,23.4,EUROPE,ARQ,Western and Central Europe,2013
Poland,(SS) 15 - 16,Cannabis-type,24, ,9,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,(SS) 15 - 16,Cannabis-type,42, ,9.9,21,EUROPE,ARQ,Western and Central Europe,2016
Portugal,(SS) 16,Cannabis-type,13, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Portugal,13 - 18,Cannabis-type,, ,,10,EUROPE,ESPAD,Western and Central Europe,2007
Portugal,(SS) 15 - 16,Cannabis-type,16, ,9,16,EUROPE,ESPAD,Western and Central Europe,2011
Portugal,(SS) 15-16,Cannabis-type,15, ,8,13,EUROPE,ARQ,Western and Central Europe,2015
Slovakia,15 - 16,Cannabis-type,18.8, ,6.1,14.3,EUROPE,ARQ,Western and Central Europe,2010
Slovakia,15 - 16,Cannabis-type,38.5, ,11.9,25.7,EUROPE,ARQ,Western and Central Europe,2015
Slovenia,(SS) 16,Cannabis-type,24, ,,17.6,EUROPE,ESPAD,Western and Central Europe,2007
Slovenia,15 - 16,Cannabis-type,22, ,9.5,17.6,EUROPE,ARQ,Western and Central Europe,2007
Slovenia,(SS) 15 - 16,Cannabis-type,23, ,10,19,EUROPE,ARQ,Western and Central Europe,2011
Slovenia,(SS) 15 - 16,Cannabis-type,25, ,12,,EUROPE,ESPAD,Western and Central Europe,2015
Spain,14 - 18,Cannabis-type,33, ,17.2,26.4,EUROPE,ARQ,Western and Central Europe,2010
Spain,"11,13,15",Cannabis-type,27.31, ,15.97,23.7,EUROPE,HBSC,Western and Central Europe,2010
Spain,14 - 18,Cannabis-type,33.6, ,16.1,26.6,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Cannabis-type,29.1, ,18.6,25.4,EUROPE,ARQ,Western and Central Europe,2014
Spain,(SS) 15 - 16,Cannabis-type,, ,14,,EUROPE,ESPAD,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cannabis-type,7, ,,5,EUROPE,ARQ,Western and Central Europe,2009
Sweden,(SS) 15 - 16,Cannabis-type,7.4,Male,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Cannabis-type,5.9,Female,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Cannabis-type,6.7,"Herb, male",,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Cannabis-type,4.8,"Herb, female",,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Cannabis-type,4.7,"Resin, male",,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Cannabis-type,3.7,"Resin, female",,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Cannabis-type,7.1,Male,,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cannabis-type,4,Female,,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cannabis-type,6.6,"Herb, male",,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cannabis-type,3.5,"Herb, female",,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cannabis-type,4.5,"Resin, male",,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cannabis-type,2.7,"Resin, female",,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cannabis-type,4.7, ,,,EUROPE,ARQ,Western and Central Europe,2016
Switzerland,(SS) 15 - 16,Cannabis-type,33, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Spain,"11,13,15",Cannabis-type,25.79, ,12.19,21.07,EUROPE,HBSC,Western and Central Europe,2010
Switzerland,(SS) 15 - 16,Cannabis-type,30,Male,14.2,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS) 15 - 16,Cannabis-type,19.2,Female,10.2,,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),15,Cannabis-type,24.3, ,11.3,21.2,EUROPE,ARQ,Western and Central Europe,2010
United Kingdom (England),15,Cannabis-type,21.1, ,10.1,18.8,EUROPE,ARQ,Western and Central Europe,2011
United Kingdom (England),15,Cannabis-type,22.5, ,10.2,18.6,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Cannabis-type,21.9, ,10.7,18.7,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Cannabis-type,18.7, ,9.7,15.8,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),15,Cannabis-type,22.1, ,10.5,18.5,EUROPE,Government,Western and Central Europe,2016
United Kingdom (Scotland),(SS) 15,Cannabis-type,17, ,9,15,EUROPE,Government,Western and Central Europe,2013
United Kingdom (Scotland),(SS) 15,Cannabis-type,16.5, ,9.5,14.7,EUROPE,Government,Western and Central Europe,2015
United Kingdom (Wales),"11,13,15",Cannabis-type,21.58, ,10.06,18.77,EUROPE,HBSC,Western and Central Europe,2010
Australia,12 - 17,Cannabis-type,9.3, ,,6.8,OCEANIA,ARQ,Australia and New Zealand,2007
Australia,14 - 19,Cannabis-type,21.5, ,7.8,15.7,OCEANIA,ARQ,Australia and New Zealand,2010
Australia,14 - 19,Cannabis-type,18, ,7.6,14.8,OCEANIA,ARQ,Australia and New Zealand,2013
Australia,14 - 19,Cannabis-type,18, ,7.6,,OCEANIA,ARQ,Australia and New Zealand,2013
Australia,14 - 19,Cannabis-type,, ,,12.2,OCEANIA,ARQ,Australia and New Zealand,2016
New Zealand,15-24,Cannabis-type,,Household survey,,23.7,OCEANIA,Govt,Australia and New Zealand,2013
New Zealand,Youth 16 - 17,Cannabis-type,37.3,Household survey,,24.8,OCEANIA,Govt.,Australia and New Zealand,2008
New Zealand,13 - 17,Cannabis-type,27,Herb,,,OCEANIA,ARQ,Australia and New Zealand,2007
Fiji,Secondary/ High School,Cannabis-type,13, ,,,OCEANIA,Govt.,Melanesia,2004
Vanuatu,(SS) 12 - 17,Cannabis-type,5.6, ,,,OCEANIA,UNICEF,Melanesia,2000
Guam,(SS) Grades 9 - 12,Cannabis-type,45.5,Youth Risk Behavior Survey,23.3,,OCEANIA,Govt.,Micronesia,2007
Marshall Islands,(SS) Grades 9 - 12,Cannabis-type,13.9,Youth Risk Behavior Survey,8.5,,OCEANIA,Govt.,Micronesia,2007
Micronesia (Federated States of),(SS) 12 - 17,Cannabis-type,1.4, ,,,OCEANIA,UNICEF,Micronesia,2001
Northern Mariana Islands,(SS) Grades 9 - 12,Cannabis-type,54.9,Youth Risk Behavior Survey,31.9,,OCEANIA,Govt.,Micronesia,2007
Palau,(SS) Grades 9 - 12,Cannabis-type,59.8,Youth Risk Behavior Survey,38.5,,OCEANIA,Govt.,Micronesia,2007
American Samoa,(SS) Grades 9 - 12,Cannabis-type,17.6,Youth Risk Behavior Survey,10.2,,OCEANIA,Govt.,Polynesia,2007
Tonga,Students (14-17),Cannabis-type,31.8, ,,,OCEANIA,UNICEF,Polynesia,2001
Mauritius,14 - 18,Opioids,1.2, ,,,AFRICA,ARQ,Eastern Africa,2004
Algeria,15 - 17,Opioids,0.45,Heroin,0.34,0.38,AFRICA,ARQ,Northern Africa,2016
Egypt,15- 16,Opioids,,Pharmaceutical opioids,,3,AFRICA,ARQ,Northern Africa,2013
Egypt,15- 17,Opioids,, ,,2,AFRICA,ARQ,Northern Africa,2013
Morocco,(SS) 15 - 17,Opioids,1, ,,,AFRICA,ARQ,Northern Africa,2013
South Africa,13 - 22,Opioids,6.2,Heroin,,,AFRICA,ARQ,Southern and South-Eastern Africa,2008
South Africa,(SS) grades 8- 10,Opioids,0.8,"Heroin, Western Cape Town only",,,AFRICA,ARQ,Southern and South-Eastern Africa,2011
Antigua and Barbuda,Secondary/ High School,Opioids,0.9, ,,,AMERICAS,OAS (MEM),Caribbean,2005
Bahamas,15-16,Opioids,0.3, ,,,AMERICAS,Govt.,Caribbean,2008
Barbados,12 - 18,Opioids,1.3, ,,0.7,AMERICAS,ARQ,Caribbean,2002
Barbados,"(SS) ages 13, 15, & 17",Opioids,1, ,,,AMERICAS,OAS (MEM),Caribbean,2006
Dominica,"(SS) ages 13, 15, & 17",Opioids,0.3, ,,,AMERICAS,OAS (MEM),Caribbean,2006
Dominican Republic,12 - 18,Opioids,0.2, ,,,AMERICAS,ARQ,Caribbean,2008
Grenada,15 - 16,Opioids,0.7, ,0.2,0.4,AMERICAS,Govt.,Caribbean,2005
Haiti,15 - 16,Opioids,3, ,,1.9,AMERICAS,ARQ,Caribbean,2005
Jamaica,Ages 11 - 19,Opioids,1.7, ,,,AMERICAS,OAS,Caribbean,2006
Puerto Rico,(SS) Grades 9 - 12,Opioids,1.6,Youth Risk Behavior Survey,,,AMERICAS,Govt.,Caribbean,2005
Saint Vincent and the Grenadines,"(SS) ages 13, 15, & 17",Opioids,0.2, ,,,AMERICAS,OAS (MEM),Caribbean,2006
Trinidad and Tobago,11 - 24,Opioids,0.6, ,,0.3,AMERICAS,ARQ,Caribbean,2002
Belize,"(SS) ages 13, 15, & 17",Opioids,1.2, ,0.3,0.6,AMERICAS,OAS (MEM),Central America (excluding Mexico),2002
Costa Rica,15-16,Opioids,0.28,Heroin,0.08,0.12,AMERICAS,ARQ,Central America (excluding Mexico),2012
Costa Rica,15-16,Opioids,0.28, ,0.08,0.12,AMERICAS,ARQ,Central America (excluding Mexico),2012
Costa Rica,15-16,Opioids,0.37,Heroin,0.17,0.17,AMERICAS,ARQ,Central America (excluding Mexico),2015
Costa Rica,15 - 16,Opioids,0.2, ,,0.2,AMERICAS,ARQ,Central America (excluding Mexico),2015
Costa Rica,15 - 16,Opioids,0.2,Pharmaceutical opioids,,0.2,AMERICAS,ARQ,Central America (excluding Mexico),2015
El Salvador,13 - 17,Opioids,0.51, ,,,AMERICAS,ARQ,Central America (excluding Mexico),2008
El Salvador,17-25,Opioids,0.7, ,0,0.4,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,17 - 25,Opioids,0.1,Morphine,,,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,17 - 25,Opioids,0.6,Opium,0,0.4,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,13 - 17,Opioids,0.8, ,,,AMERICAS,ARQ,Central America (excluding Mexico),2016
El Salvador,13 - 17,Opioids,0.8,Heroin,,,AMERICAS,ARQ,Central America (excluding Mexico),2016
Guatemala,12 - 19,Opioids,0.28, ,,0.08,AMERICAS,ARQ,Central America (excluding Mexico),2004
Guatemala,11 - 22,Opioids,0.8,Heroin,,,AMERICAS,ARQ,Central America (excluding Mexico),2014
Honduras,12 - 17,Opioids,, ,,0.18,AMERICAS,ARQ,Central America (excluding Mexico),2005
Panama,18-25,Opioids,0.04,Heroin,,,AMERICAS,ARQ,Central America (excluding Mexico),2013
Mexico,12 - 17,Opioids,0.1, ,0,0.04,AMERICAS,National Addiction Household Survey,Northern America (including Mexico),2011
Mexico,12 - 17,Opioids,0.1, ,,,AMERICAS,National Addiction Household Survey,Northern America (including Mexico),2008
Mexico,15  - 16,Opioids,0.1, ,,0.001,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15  - 16,Opioids,0.1,Opium,,0.001,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15  - 16,Opioids,0.001,Heroin,,0.001,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15-16,Opioids,0.9,Heroin,0.3,0.5,AMERICAS,ARQ,Northern America (including Mexico),2014
Mexico,12 - 17,Opioids,0.03,Opium,,,AMERICAS,ARQ,Northern America (including Mexico),2016
Mexico,12 - 17,Opioids,0.1,Pharmaceutical opioids,0.01,0.03,AMERICAS,ARQ,Northern America (including Mexico),2016
United States of America,(SS) Grade 10,Opioids,1.3, ,0.4,0.8,AMERICAS,Govt.,Northern America (including Mexico),2010
United States of America,(SS) Grade 10,Opioids,1.2,Heroin,0.4,0.8,AMERICAS,ARQ,Northern America (including Mexico),2011
United States of America, (SS) Grade 10,Opioids,1.1,Heroin,0.4,0.6,AMERICAS,ARQ,Northern America (including Mexico),2012
United States of America, (SS) Grade 10,Opioids,0.7,Heroin with needle,0.2,0.4,AMERICAS,ARQ,Northern America (including Mexico),2012
United States of America, (SS) Grade 10,Opioids,1,Heroin,0.3,0.6,AMERICAS,ARQ,Northern America (including Mexico),2013
United States of America,15 - 16,Opioids,0.9,Heroin,0.4,0.5,AMERICAS,ARQ,Northern America (including Mexico),2014
United States of America,(SS) 15 - 16,Opioids,0.7,Heroin. Monitoring the future,0.2,0.5,AMERICAS,ARQ,Northern America (including Mexico),2015
United States of America,(SS) Grade 10,Opioids,0.6,Heroin,0.2,0.3,AMERICAS,ARQ,Northern America (including Mexico),2016
Argentina,13 - 17,Opioids,0.9, ,,,AMERICAS,ARQ,South America,2007
Argentina,15 - 16,Opioids,1, ,,,AMERICAS,ARQ,South America,2009
Argentina,15 - 16,Opioids,0.7,Heroin,,,AMERICAS,ARQ,South America,2011
Argentina,15 - 16,Opioids,0.8,Pharmaceutical opioids,,,AMERICAS,ARQ,South America,2014
Bolivia (Plurinational State of),13 - 18,Opioids,0.6, ,0.2,0.3,AMERICAS,ARQ,South America,2004
Bolivia (Plurinational State of),18 - 24,Opioids,0.06,Heroin,0.01,0.01,AMERICAS,ARQ,South America,2012
Bolivia (Plurinational State of),18 - 24,Opioids,0.38,Morphine,0,0.01,AMERICAS,ARQ,South America,2012
Bolivia (Plurinational State of),18 - 24,Opioids,0.27,Heroin,0.08,0.08,AMERICAS,OAS,South America,2016
Brazil,10 - 19,Opioids,0.3,Heroin,,,AMERICAS,ARQ,South America,2010
Brazil,10 - 19,Opioids,0.6,Prescription opioids,,,AMERICAS,ARQ,South America,2010
Chile,(SS) 15 - 16,Opioids,3.5,Heroin,0.7,1.4,AMERICAS,ARQ,South America,2009
Chile,(SS) 15 - 16,Opioids,1.95,Heroin,0.45,1.39,AMERICAS,ARQ,South America,2011
Chile,(SS) 15 - 16,Opioids,2.01,Heroin,0.35,0.82,AMERICAS,ARQ,South America,2013
Chile,(SS) 15 - 16,Opioids,1.98, ,0.28,0.74,AMERICAS,ARQ,South America,2015
Chile,(SS) 15 - 16,Opioids,1.98,Heroin,0.28,0.74,AMERICAS,ARQ,South America,2015
Colombia,12 - 17,Opioids,1.3,Heroin,,1.2,AMERICAS,ARQ,South America,2004
Colombia,11-18,Opioids,0.51,Heroin,0.19,0.36,AMERICAS,ARQ,South America,2011
Colombia,University,Opioids,0.25,Heroin,0.03,0.07,AMERICAS,ARQ,South America,2012
Colombia,18 - 24,Opioids,0.39, ,0.01,0.04,AMERICAS,Government,South America,2016
Ecuador,12 - 17,Opioids,0.9, ,,0.5,AMERICAS,ARQ,South America,2005
Ecuador,12 - 17,Opioids,0.4,Opium,0.04,0.1,AMERICAS,IV ENCUESTA NACIONAL SOBRE EL USO DE DROGAS EN ESTUDIANTES DE  12 A 17 AÑOS,South America,2012
Ecuador,12 - 17,Opioids,1,Heroin,0.2,0.5,AMERICAS,IV ENCUESTA NACIONAL SOBRE EL USO DE DROGAS EN ESTUDIANTES DE  12 A 17 AÑOS,South America,2012
Ecuador,12 - 17,Opioids,0.4,MORPHINE,0.06,0.13,AMERICAS,IV ENCUESTA NACIONAL SOBRE EL USO DE DROGAS EN ESTUDIANTES DE  12 A 17 AÑOS,South America,2012
Ecuador,12 - 17,Opioids,1.3, ,0.24,0.63,AMERICAS,ARQ,South America,2012
Guyana,12 - 18,Opioids,0.7, ,0.2,0.3,AMERICAS,ARQ,South America,2002
Paraguay,Youth (undefined),Opioids,0.3,Ages not specified,,,AMERICAS,ARQ,South America,2005
Paraguay,12+,Opioids,0.5,Heroin. School in cities of at least 30000,0,0,AMERICAS,ARQ,South America,2014
Peru,(SS) ages 13-17,Opioids,1, ,,,AMERICAS,OAS (MEM),South America,2005
Suriname,Secondary/ High School,Opioids,0.5, ,0,0,AMERICAS,OAS (MEM),South America,2006
Uruguay,13 - 17,Opioids,0.5, ,,0.3,AMERICAS,ARQ,South America,2003
Uruguay,13 - 17,Opioids,0.5, ,,,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Opioids,0.2,Opium,,,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Opioids,0.03,Heroin,,,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Opioids,0.4,Prescription opioids,,,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Opioids,0.2,Heroin,,,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Opioids,0.1,Opium,,,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Opioids,0.3,Pharmaceutical opioids,,,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Opioids,0.5, ,,,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),(SS) 12 - 18,Opioids,0.421088092,Heroin,0.147380832,0.1,AMERICAS,ARQ,South America,2009
Venezuela (Bolivarian Republic of),University,Opioids,0.06,Heroin,,,AMERICAS,ARQ,South America,2014
Armenia,(SS) 15 - 16,Opioids,1, ,,,ASIA,ESPAD,Central Asia and Transcaucasia,2007
Georgia,(SS) 15 - 16,Opioids,0.6,Select regions (capital);  Georgian Medical News No3 (180) 2010,,,ASIA,Research,Central Asia and Transcaucasia,2010
Georgia,(SS) 15 - 16,Opioids,1.8,Heroin,,,ASIA,ARQ,Central Asia and Transcaucasia,2015
Kazakhstan,"16, 19 and 21",Opioids,0.9,6 provinces and 2 cities,0.4,0.6,ASIA,ARQ,Central Asia and Transcaucasia,2012
Kyrgyzstan,15 - 18,Opioids,1, ,,,ASIA,ARQ,Central Asia and Transcaucasia,2001
Tajikistan,18 - 34,Opioids,,Opium,,0.0001,ASIA,ARQ,Central Asia and Transcaucasia,2010
China,15 - 16,Opioids,, ,,15.7,ASIA,ARQ,East and South-East Asia,2016
"China, Hong Kong SAR",11 - 20,Opioids,, ,,0.007,ASIA,ARQ,East and South-East Asia,2007
"China, Hong Kong SAR",15 - 16,Opioids,,Heroin,,0.01,ASIA,ARQ,East and South-East Asia,2011
"China, Hong Kong SAR",15 - 16,Opioids,, ,,0.01,ASIA,ARQ,East and South-East Asia,2011
"China, Hong Kong SAR",11 - 20,Opioids,0.01, ,,,ASIA,ARQ,East and South-East Asia,2013
"China, Hong Kong SAR",11 - 20,Opioids,0.01,Heroin,,,ASIA,ARQ,East and South-East Asia,2013
"China, Hong Kong SAR",11 - 20,Opioids,,"Heroin, Central Registry",,0.01,ASIA,ARQ,East and South-East Asia,2014
"China, Hong Kong SAR",11 - 20,Opioids,,Central Registry,,0.01,ASIA,ARQ,East and South-East Asia,2014
"China, Hong Kong SAR",11 - 20,Opioids,,Central Registry,,0,ASIA,ARQ,East and South-East Asia,2014
"China, Hong Kong SAR",11 - 20,Opioids,,Central Registry,,0.01,ASIA,ARQ,East and South-East Asia,2015
"China, Hong Kong SAR",11 - 20,Opioids,,"Heroin, Central Registry",,0.01,ASIA,ARQ,East and South-East Asia,2015
"China, Macao SAR",10 - 25,Opioids,0.76, ,,,ASIA,ARQ,East and South-East Asia,2006
"China, Taiwan Province of China",(SS) Grades 10 & 12,Opioids,0.1, ,,,ASIA,Govt.,East and South-East Asia,2006
Indonesia,15 - 19,Opioids,0.2,Heroin,0.1,0.18,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 - 19,Opioids,0.1,Opium,0.1,0.1,ASIA,ARQ,East and South-East Asia,2011
Indonesia,10-25,Opioids,0.23,Opioids. 20 provinces,,0.21,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10-25,Opioids,0.16,Opium. 20 provinces,,0,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10-25,Opioids,0.09,Heroin. Male. 20 provinces,,,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10-25,Opioids,0,Heroin. Female. 20 provinces,,,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10-25,Opioids,0.17,Tramadol. 20 provinces,,0.15,ASIA,ARQ,East and South-East Asia,2015
Myanmar,13 - 21,Opioids,0.2, ,,0.2,ASIA,ARQ,East and South-East Asia,2004
Thailand,13 - 18,Opioids,0.23, ,,,ASIA,ARQ,East and South-East Asia,2005
Israel,(SS) Grade 10,Opioids,, ,,1.9,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,12 - 18,Opioids,3.59,Prescription opioids,2.78,2.99,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,15 - 16,Opioids,,"Heroin, Opium crack, cocaine together",,3.8,ASIA,ARQ,Near and Middle East /South-West Asia,2014
Israel,15 - 16,Opioids,,Prescription opioids,,4.1,ASIA,ARQ,Near and Middle East /South-West Asia,2014
Israel,15 - 16,Opioids,,Methadone,,3.9,ASIA,ARQ,Near and Middle East /South-West Asia,2014
Israel,(SS) 15 - 16,Opioids,,"Heroin, Opium crack, cocaine together",,2.6,ASIA,ARQ,Near and Middle East /South-West Asia,2014
Jordan,15 - 16,Opioids,, ,,0.9,ASIA,ARQ,Near and Middle East /South-West Asia,2001
Lebanon,15 - 16,Opioids,, ,,0.8,ASIA,ARQ,Near and Middle East /South-West Asia,2001
Oman,15 - 16,Opioids,, ,,3,ASIA,ARQ,Near and Middle East /South-West Asia,2002
Bangladesh,10 - 23,Opioids,, ,,0.7,ASIA,ARQ,Southern Asia,2001
Bhutan,Undefined,Opioids,,Prescription opioids. General population survey,,0.048,ASIA,ARQ,Southern Asia,2010
Belarus,15 - 16,Opioids,0.3,Heroin,,,EUROPE,ARQ,Eastern Europe,2010
Republic of Moldova,(SS) 15 - 16,Opioids,0.4, ,,,EUROPE,ESPAD,Eastern Europe,2008
Republic of Moldova,(SS) 15 - 24,Opioids,0.1, ,,,EUROPE,Govt.,Eastern Europe,2010
Republic of Moldova,15 - 24,Opioids,0.1,"Heroin, General population survey",0.1,0.1,EUROPE,ARQ,Eastern Europe,2012
Republic of Moldova,15 - 24,Opioids,0.5,"Opium, General Population Survey",0.1,0.2,EUROPE,ARQ,Eastern Europe,2012
Republic of Moldova,(SS) 15 - 16,Opioids,0,Heroin,,,EUROPE,ESPAD,Eastern Europe,2015
Russian Federation,15 - 16,Opioids,0.4,Heroin,,,EUROPE,ARQ,Eastern Europe,2007
Russian Federation,0 - 18,Opioids,0.001, ,,,EUROPE,ARQ,Eastern Europe,2013
Russian Federation,15 - 16,Opioids,0.9,Heroin,,,EUROPE,ARQ,Eastern Europe,2011
Ukraine,15 - 34,Opioids,,Heroin,0.1,0.1,EUROPE,ARQ,Eastern Europe,2010
Ukraine,15 -17,Opioids,0.9,"Heroin, Registered users",,,EUROPE,ARQ,Eastern Europe,2011
Ukraine,16 -17,Opioids,, ,,11,EUROPE,ARQ,Eastern Europe,2015
Albania,14 - 19,Opioids,1.8, ,,,EUROPE,ARQ,South-Eastern Europe,2004
Albania,(SS) 15 - 16,Opioids,1.6,Heroin,,,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Bosnia and Herzegovina,(SS) 15 - 16,Opioids,0.4,Heroin,,,EUROPE,ARQ,South-Eastern Europe,2011
Bosnia and Herzegovina,(SS) 15 - 16,Opioids,0.2,Pharmaceutical opioids,,,EUROPE,ARQ,South-Eastern Europe,2012
Bulgaria,14 - 19,Opioids,4.3, ,1.5,2.2,EUROPE,ARQ,South-Eastern Europe,2008
Bulgaria,14 - 19,Opioids,3.1,Heroin,1.1,1.6,EUROPE,ARQ,South-Eastern Europe,2008
Bulgaria,14 - 19,Opioids,3.2,Prescription opioids,1.2,1.6,EUROPE,ARQ,South-Eastern Europe,2008
Bulgaria,(SS) 15 - 16,Opioids,2.5,Heroin,,,EUROPE,ARQ,South-Eastern Europe,2011
Bulgaria,15-18,Opioids,2.9,Pharmaceutical opioids,1.6,2.2,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,15-18,Opioids,3.5, ,2.2,2.8,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,15-18,Opioids,2.7,Heroin,1.5,2.2,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,(SS) 15 - 16,Opioids,4.6,Heroin,,,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Bulgaria,(SS) 15 - 16,Opioids,4.2,Pharmaceutical opioids,,,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Croatia,16,Opioids,1.1, ,,,EUROPE,ARQ,South-Eastern Europe,2007
Croatia,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ESPAD,South-Eastern Europe,2015
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ESPAD,South-Eastern Europe,2015
Montenegro,(SS) 16,Opioids,1.2,Heroin,,,EUROPE,ESPAD,South-Eastern Europe,2011
Montenegro,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ESPAD,South-Eastern Europe,2008
Montenegro,(SS) 16,Opioids,2,Heroin,,,EUROPE,ARQ,South-Eastern Europe,2015
Romania,(SS) 16,Opioids,0.3, ,,,EUROPE,ESPAD,South-Eastern Europe,2007
Romania,(SS) 15 - 16,Opioids,1.1, ,,,EUROPE,ARQ,South-Eastern Europe,2011
Romania,(SS) 15 - 16,Opioids,1.8, ,,,EUROPE,ARQ,South-Eastern Europe,2015
Romania,(SS) 15 - 16,Opioids,1.8,Heroin,,,EUROPE,ARQ,South-Eastern Europe,2015
Serbia,16,Opioids,0.8, ,,,EUROPE,ARQ,South-Eastern Europe,2008
Serbia,(SS) 15 - 16,Opioids,1.1, ,,,EUROPE,ESPAD,South-Eastern Europe,2011
Turkey,(SS) 15 - 16,Opioids,1.5, ,,0.8,EUROPE,ESPAD,South-Eastern Europe,2003
Austria, ,Opioids,1.8, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Austria,14 - 17,Opioids,1.7,Heroin,,,EUROPE,ARQ,Western and Central Europe,2007
Austria,(SS) 15 - 16,Opioids,0.6,Heroin,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Belgium,15 - 16,Opioids,0.89,Heroin,,0.3,EUROPE,ARQ,Western and Central Europe,2010
Belgium,(SS) 15 - 16,Opioids,0.8,Heroin,,0.2,EUROPE,ARQ,Western and Central Europe,2011
Belgium,(SS) 15 - 16,Opioids,0.4,Heroin,,0.2,EUROPE,ARQ,Western and Central Europe,2012
Belgium,(SS) 15 - 16,Opioids,1,"Heroin, Flemish part",,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 16,Opioids,2, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Cyprus,16,Opioids,2,Heroin,,,EUROPE,ARQ,Western and Central Europe,2007
Cyprus,(SS) 15 - 16,Opioids,3,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2011
Cyprus,(SS) 15 - 16,Opioids,3, ,,,EUROPE,ESPAD,Western and Central Europe,2011
Cyprus,15 - 24,Opioids,,Heroin,,0.1,EUROPE,ARQ,Western and Central Europe,2012
Cyprus,(SS) 15 - 16,Opioids,3,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 34,Opioids,0.3,Heroin,,,EUROPE,ARQ,Western and Central Europe,2016
Czechia,(SS) 15 - 16,Opioids,2,Heroin and opiates,0.6,1.2,EUROPE,Govt./ ESPAD,Western and Central Europe,2007
Czechia,16,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2007
Czechia,(SS) 15 - 16,Opioids,1.4, ,0.3,0.7,EUROPE,ARQ,Western and Central Europe,2011
Czechia,(SS) 15 - 16,Opioids,0.7,Heroin,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Denmark,(SS) 15 - 16,Opioids,0.5, ,,,EUROPE,ARQ,Western and Central Europe,2007
Denmark,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Estonia,(SS) 15 - 16,Opioids,1.3, ,,,EUROPE,ARQ,Western and Central Europe,2007
Estonia,(SS) 15 - 19,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2011
Estonia,"(SS) 6, 8, 12 grades",Opioids,0.3,Heroin,,,EUROPE,ARQ,Western and Central Europe,2013
Estonia,"(SS) 6, 8, 12 grades",Opioids,0.2,"Pharmaceutical opioids, Fentanly",,,EUROPE,ARQ,Western and Central Europe,2013
Estonia,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Faroe Islands,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Faroe Islands,(SS) 15 - 16,Opioids,0,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Finland,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2007
Finland,(SS) 15 - 16,Opioids,1,Prescription opioids,,,EUROPE,ARQ,Western and Central Europe,2007
Finland,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2011
Finland,(SS) 15 - 16,Opioids,1,Prescription opioids,,,EUROPE,ARQ,Western and Central Europe,2011
Finland,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Opioids,1,Pharmaceutical opioids,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Opioids,2, ,6,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ARQ (ESPAD),Western and Central Europe,2015
France,(SS) 15 - 16,Opioids,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
France,17,Opioids,0.9, ,,0.6,EUROPE,ARQ,Western and Central Europe,2011
France,17,Opioids,1,Heroin. Urban areas (excluding overseas departments),,0.4,EUROPE,ARQ,Western and Central Europe,2014
France,(SS) 15 - 16,Opioids,2,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Germany,12 - 25,Opioids,0.3,Heroin,,,EUROPE,Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2008.,Western and Central Europe,2008
Germany,(SS) 15 - 16,Opioids,1.1,"Heroin, Select regions",,,EUROPE,ARQ,Western and Central Europe,2007
Germany,(SS) 15 - 16,Opioids,0.8,Heroin. Select regions,,,EUROPE,ARQ,Western and Central Europe,2011
Germany,(SS) 15 - 18,Opioids,0,Heroin.  Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2012
Germany,(SS) 15 - 16,Opioids,0.5,Heroin.  Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2015
Gibraltar,11 - 18,Opioids,, ,,1.5,EUROPE,ARQ,Western and Central Europe,2002
Greece,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Greece,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2011
Greece,(SS) 15 - 16,Opioids,0.66,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Greece,(SS) 15 - 16,Opioids,1.81,Pharmaceutical opioids.,,,EUROPE,ESPAD,Western and Central Europe,2015
Greenland,(SS) 15 - 16,Opioids,1, ,,1,EUROPE,ESPAD,Western and Central Europe,2003
Hungary,(SS) 15 - 16,Opioids,1.3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Hungary,(SS) 15 - 16,Opioids,10.1, ,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Hungary,(SS) 15 - 16,Opioids,1.4,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Iceland,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Iceland,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Ireland,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2011
Ireland,(SS) 15 - 16,Opioids,0.4,Heroin,,,EUROPE,ARQ,Western and Central Europe,2015
Italy,15 - 16,Opioids,0.8,Heroin,0.4,0.5,EUROPE,ARQ,Western and Central Europe,2010
Italy,(SS) 15 - 19,Opioids,0.33,Heroin,0.19,0.25,EUROPE,ARQ,Western and Central Europe,2012
Italy,(SS) 15 - 19,Opioids,1.22, ,0.38,0.71,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 19,Opioids,0.48,Heroin,0.19,0.32,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 17,Opioids,1.8,Heroin. Male.,1.3,1.5,EUROPE,ARQ,Western and Central Europe,2014
Italy,(SS) 15 - 17,Opioids,1,Heroin. Female.,0.6,0.8,EUROPE,ARQ,Western and Central Europe,2014
Italy,(SS) 15 - 19,Opioids,1.3, ,0.7,1,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15 - 19,Opioids,1.3,Heroin,0.7,1,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15 - 19,Opioids,1.47,Heroin,0.94,1.13,EUROPE,ARQ,Western and Central Europe,2016
Latvia,(SS) 15 - 16,Opioids,1.5,Heroin; Riga City,,,EUROPE,ARQ,Western and Central Europe,2010
Latvia,(SS) 15 - 16,Opioids,2.3,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2011
Latvia,(SS) 15 - 16,Opioids,1.6,Heroin,,,EUROPE,ARQ,Western and Central Europe,2015
Latvia,(SS) 19,Opioids,2.1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,12 - 16,Opioids,0.2, ,,0.2,EUROPE,ARQ,Western and Central Europe,2005
Liechtenstein,12 - 19,Opioids,0.2,Heroin,,0.3,EUROPE,ARQ,Western and Central Europe,2005
Liechtenstein,(SS) 15 - 16,Opioids,3,Heroin,,,EUROPE,ARQ,Western and Central Europe,2011
Liechtenstein,(SS) 15 - 16,Opioids,3, ,,,EUROPE,ARQ,Western and Central Europe,2011
Liechtenstein,(SS) 15 - 16,Opioids,0.3, ,,,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS) 15 - 16,Opioids,0.3,Heroin,,,EUROPE,ARQ,Western and Central Europe,2015
Lithuania,(SS) 15 - 16,Opioids,1.1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Lithuania,(SS) 15 - 16,Opioids,1.6,Heroin,,,EUROPE,ARQ,Western and Central Europe,2011
Lithuania,(SS) 15 - 16,Opioids,1.3,Heroin,,,EUROPE,ARQ,Western and Central Europe,2015
Luxembourg,11 - 17,Opioids,1.2, ,,0.6,EUROPE,ARQ,Western and Central Europe,1999
Luxembourg,12 - 18,Opioids,0.7, ,,0.5,EUROPE,ARQ,Western and Central Europe,2010
Malta,(SS) 15 - 16,Opioids,1.1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2007
Malta,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2011
Malta,(SS) 15 - 16,Opioids,0.8,Heroin,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Monaco,(SS) 15 - 16,Opioids,2, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Monaco,(SS) 15 - 16,Opioids,2,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Netherlands,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Netherlands,12 - 18,Opioids,0.8,Heroin,0.4,,EUROPE,ARQ,Western and Central Europe,2007
Netherlands,12 - 18,Opioids,0.6,Heroin,0.2,,EUROPE,ARQ,Western and Central Europe,2010
Netherlands,(SS) 15 - 16,Opioids,0.6,Heroin,0.2,,EUROPE,ARQ,Western and Central Europe,2011
Netherlands,(SS) 12 - 16,Opioids,0.4, ,0.3,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Norway,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Poland,(SS) 15 - 16,Opioids,1.4, ,,1,EUROPE,ARQ,Western and Central Europe,2007
Poland,18 - 19,Opioids,1.9,Heroin,0.5,0.8,EUROPE,ARQ,Western and Central Europe,2010
Poland,(SS) 15 - 16,Opioids,1.3,Heroin,,,EUROPE,ARQ,Western and Central Europe,2012
Poland,(SS) 15 - 16,Opioids,2.4,Polish Heroin,,,EUROPE,ARQ,Western and Central Europe,2012
Poland,(SS) 15 - 16,Opioids,1.6,Heroin,0.7,1,EUROPE,ARQ,Western and Central Europe,2013
Poland,(SS) 15 - 16,Opioids,1.5,Polish Heroin,0.4,0.7,EUROPE,ARQ,Western and Central Europe,2013
Poland,(SS) 15 - 16,Opioids,2,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,(SS) 15 - 16,Opioids,1.9,Heroin,0.7,0.7,EUROPE,ARQ,Western and Central Europe,2016
Portugal,16,Opioids,2.3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Portugal,(SS) 15 - 16,Opioids,2,Opium,,,EUROPE,ESPAD,Western and Central Europe,2011
Portugal,(SS) 15-16,Opioids,1, ,,,EUROPE,ARQ,Western and Central Europe,2015
Slovakia,15 - 16,Opioids,0.6,Heroin,0.2,0.2,EUROPE,ARQ,Western and Central Europe,2010
Slovakia,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2015
Slovenia,15 - 16,Opioids,1.6,Heroin,,,EUROPE,ARQ,Western and Central Europe,2007
Slovenia,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ARQ,Western and Central Europe,2011
Slovenia,(SS) 15 - 16,Opioids,1,Heroin,,,EUROPE,ESPAD,Western and Central Europe,2015
Spain,14 - 18,Opioids,1, ,0.5,0.6,EUROPE,ARQ,Western and Central Europe,2010
Spain,14 - 18,Opioids,1, ,0.6,0.7,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Opioids,1,Heroin,0.6,0.7,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Opioids,0.6, ,0.3,0.5,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Opioids,0.6,Heroin,0.3,0.5,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ARQ,Western and Central Europe,2009
Sweden,(SS) 15 - 16,Opioids,0.4,Heroin. Male.,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Opioids,0.3,Heroin. Female.,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Opioids,0.8,Heroin. Male.,,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Opioids,0.2,Heroin. Female.,,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Opioids,0.3,Heroin,,,EUROPE,ARQ,Western and Central Europe,2016
Switzerland,(SS) 15 - 16,Opioids,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Switzerland,(SS) 15 - 16,Opioids,0.7,Heroin. Male.,,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS) 15 - 16,Opioids,0.3,Heroin. Female.,,,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),15,Opioids,1.9,Any opiates,0.7,1.7,EUROPE,ARQ,Western and Central Europe,2010
United Kingdom (England),15,Opioids,1,Heroin,0.5,0.8,EUROPE,ARQ,Western and Central Europe,2011
United Kingdom (England),15,Opioids,1.2,Any opioids,0.5,0.9,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Opioids,0.7,Heroin,0.4,0.5,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Opioids,0.6,Methadone,0.2,0.5,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Opioids,0.7,Heroin,0.4,0.5,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Opioids,0.7,Methadone,0.3,0.6,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Opioids,1.3,Any opioids,0.5,0.9,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Opioids,0.6,Any opioids,0.3,0.5,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),15,Opioids,0.3,Heroin,0.1,0.3,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),15,Opioids,0.5,Methadone,0.2,0.4,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),15,Opioids,1,Any opioids,0.6,0.9,EUROPE,Government,Western and Central Europe,2016
United Kingdom (England),15,Opioids,0.7,Heroin,0.4,0.6,EUROPE,Government,Western and Central Europe,2016
United Kingdom (England),15,Opioids,0.3,Methadone,0.3,0.3,EUROPE,Government,Western and Central Europe,2016
United Kingdom (Scotland),(SS) 15,Opioids,1,"Heroin, methadone",1,1,EUROPE,Govt.,Western and Central Europe,2013
United Kingdom (Scotland),15,Opioids,1.6, ,1,1.4,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2015
United Kingdom (Scotland),15,Opioids,1.5,Heroin,0.9,1.3,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2015
United Kingdom (Scotland),15,Opioids,1.2,Methadone,0.8,1,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2015
Australia,12 - 17,Opioids,0.1, ,,0.1,OCEANIA,ARQ,Australia and New Zealand,2007
New Zealand,Youth 16-17,Opioids,1,Household survey,,1,OCEANIA,Govt.,Australia and New Zealand,2008
Guam,(SS) Grades 9 - 12,Opioids,3.6,Youth Risk Behavior Survey,,,OCEANIA,Govt.,Micronesia,2007
Northern Mariana Islands,(SS) Grades 9 - 12,Opioids,3.5,Youth Risk Behavior Survey,,,OCEANIA,Govt.,Micronesia,2007
Marshall Islands,(SS) Grades 9 - 12,Opioids,9.6,Youth Risk Behavior Survey,,,OCEANIA,Govt.,Micronesia,2007
American Samoa,(SS) Grades 9 - 12,Opioids,5.2,Youth Risk Behavior Survey,,,OCEANIA,Govt.,Polynesia,2007
Kenya, (HHS) age 15 - 17,Cocaine-type,0.2, ,0.2,,AFRICA,Govt.,Eastern Africa,2007
Algeria,15 - 17,Cocaine-type,0.71, ,0.38,0.48,AFRICA,ARQ,Northern Africa,2016
Morocco,(SS) 15 - 17,Cocaine-type,1.2,Cocaine,0.4,0.7,AFRICA,MedSPAD,Northern Africa,2009
Morocco,(SS) 15 - 17,Cocaine-type,0.7,Crack,0.4,0.4,AFRICA,MedSPAD,Northern Africa,2009
Morocco,(SS) 15 - 17,Cocaine-type,1.3,Cocaine,,,AFRICA,MedSPAD,Northern Africa,2013
Morocco,(SS) 15 - 17,Cocaine-type,1.2,Crack,,,AFRICA,MedSPAD,Northern Africa,2013
Morocco,(SS) 15 - 17,Cocaine-type,1.3,Cocaine salts,0.1,0.6,AFRICA,ARQ,Northern Africa,2013
Morocco,(SS) 15 - 17,Cocaine-type,1.2,Crack,0.1,0.6,AFRICA,ARQ,Northern Africa,2013
Namibia,15 - 16,Cocaine-type,3.2,"Cocaine, Crack Cocaine",,,AFRICA,Govt.,Southern and South-Eastern Africa,2015
South Africa,13 - 22,Cocaine-type,6.7,"Cocaine, any (HCl and/ or Crack); Select regions (Cape Town)",,,AFRICA,ARQ,Southern and South-Eastern Africa,2008
South Africa,(SS) grades 8- 10,Cocaine-type,1,Cape Town only,,,AFRICA,ARQ,Southern and South-Eastern Africa,2011
Ghana,13 - 15,Cocaine-type,,"Cocaine, any (HCl and/ or Crack)",,2.9,AFRICA,ARQ,West and Central Africa,2007
Antigua and Barbuda,Secondary/ High School,Cocaine-type,1.7,Ages not specified,0.7,1,AMERICAS,OAS (MEM),Caribbean,2005
Antigua and Barbuda,Secondary/ High School,Cocaine-type,1.7,Crack,0.5,0.8,AMERICAS,OAS (MEM),Caribbean,2005
Antigua and Barbuda,SS,Cocaine-type,3.26, ,1.52,1.85,AMERICAS,CICAD/ OAS,Caribbean,2013
Antigua and Barbuda,SS,Cocaine-type,2.76,Crack,1.26,1.7,AMERICAS,CICAD/ OAS,Caribbean,2013
Bahamas,15-16,Cocaine-type,0.3, ,,,AMERICAS,Govt.,Caribbean,2008
Bahamas,15-16,Cocaine-type,0.3,Crack,,0.2,AMERICAS,Govt.,Caribbean,2008
Bahamas,SS,Cocaine-type,1.5, ,0.29,0.7,AMERICAS,CICAD/ OAS,Caribbean,2011
Bahamas,SS,Cocaine-type,1.06,Crack,0.29,0.51,AMERICAS,CICAD/ OAS,Caribbean,2011
Barbados,"(SS) ages 13, 15, & 17",Cocaine-type,2,Crack,0.5,0.7,AMERICAS,OAS (MEM),Caribbean,2006
Barbados,"(SS) ages 13, 15, & 17",Cocaine-type,2, ,0.5,0.9,AMERICAS,OAS (MEM),Caribbean,2006
Barbados,SS,Cocaine-type,2.3,Crack,1.32,1.5,AMERICAS,CICAD/ OAS,Caribbean,2013
Barbados,SS,Cocaine-type,2.8, ,1.32,1.65,AMERICAS,CICAD/ OAS,Caribbean,2013
Dominica,"(SS) ages 13, 15, & 17",Cocaine-type,0.8,Crack,0.4,0.6,AMERICAS,OAS (MEM),Caribbean,2006
Dominica,"(SS) ages 13, 15, & 17",Cocaine-type,0.6, ,0.3,0.4,AMERICAS,OAS (MEM),Caribbean,2006
Dominica,SS,Cocaine-type,2.84, ,0.9,1.31,AMERICAS,CICAD/ OAS,Caribbean,2011
Dominica,SS,Cocaine-type,2.3,Crack,0.63,0.86,AMERICAS,CICAD/ OAS,Caribbean,2011
Dominican Republic,12 - 20,Cocaine-type,2.7,"Cocaine, any (HCl and/ or Crack)",,,AMERICAS,ARQ,Caribbean,2000
Dominican Republic,12 - 18,Cocaine-type,0.7,Crack,0.2,0.5,AMERICAS,ARQ,Caribbean,2008
Dominican Republic,12 - 18,Cocaine-type,0.8, ,0.2,0.5,AMERICAS,ARQ,Caribbean,2008
Grenada,15 - 16,Cocaine-type,0.9,Crack,0.2,0.5,AMERICAS,Govt.,Caribbean,2005
Grenada,SS,Cocaine-type,3.25,Mainly crack,1.61,2.2,AMERICAS,CICAD/ OAS,Caribbean,2013
Haiti,15 - 16,Cocaine-type,2.8,Crack,,1.6,AMERICAS,ARQ,Caribbean,2005
Haiti,15 - 16,Cocaine-type,3.2, ,,2,AMERICAS,ARQ,Caribbean,2005
Haiti,SS,Cocaine-type,2.16,Mainly crack,0.94,1.65,AMERICAS,CICAD/ OAS,Caribbean,2014
Jamaica,Ages 11 - 19,Cocaine-type,1.7,Crack,,,AMERICAS,OAS,Caribbean,2006
Jamaica,Ages 11 - 19,Cocaine-type,3.2, ,1.3,2.1,AMERICAS,OAS,Caribbean,2006
Jamaica,(SS) 15 - 16,Cocaine-type,1, ,,,AMERICAS,ARQ,Caribbean,2010
Jamaica,SS,Cocaine-type,2.08,Mainly crack,0.51,1.08,AMERICAS,CICAD/ OAS,Caribbean,2013
Puerto Rico,(SS) Grades 9 - 12,Cocaine-type,2.1,Youth Risk Behavior Survey,1.3,,AMERICAS,Govt.,Caribbean,2005
Saint Kitts and Nevis,15 - 16,Cocaine-type,2.45, ,0.91,1.29,AMERICAS,Govt.,Caribbean,2006
Saint Kitts and Nevis,15 - 16,Cocaine-type,2.58,Crack,1.04,1.3,AMERICAS,Govt.,Caribbean,2006
Saint Kitts and Nevis,SS,Cocaine-type,2.93,Cocaine salts,1.12,1.77,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Kitts and Nevis,SS,Cocaine-type,3.38,Crack,1.78,2.1,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Lucia,"(SS) ages 13, 15, & 17",Cocaine-type,1.5, ,0.5,0.8,AMERICAS,OAS (MEM),Caribbean,2005
Saint Lucia,SS,Cocaine-type,2.96,Cocaine salts,1.12,1.77,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Lucia,SS,Cocaine-type,2.34,Crack,1.24,1.62,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Vincent and the Grenadines,"(SS) ages 13, 15, & 17",Cocaine-type,0.32,Crack,0.11,0.21,AMERICAS,OAS (MEM),Caribbean,2006
Saint Vincent and the Grenadines,"(SS) ages 13, 15, & 17",Cocaine-type,0.6, ,0.21,0.32,AMERICAS,OAS (MEM),Caribbean,2006
Saint Vincent and the Grenadines,SS,Cocaine-type,1.21,Cocaine salts,0.64,0.64,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Vincent and the Grenadines,SS,Cocaine-type,0.72,Crack,0.57,0.65,AMERICAS,CICAD/ OAS,Caribbean,2013
Trinidad and Tobago,"(SS) ages 13, 15, & 17",Cocaine-type,0.74,Crack,,,AMERICAS,OAS (MEM),Caribbean,2006
Trinidad and Tobago,"(SS) ages 13, 15, & 17",Cocaine-type,0.83, ,,,AMERICAS,OAS (MEM),Caribbean,2006
Trinidad and Tobago,SS,Cocaine-type,2.81,Cocaine salts,0.86,1.49,AMERICAS,CICAD/ OAS,Caribbean,2013
Trinidad and Tobago,SS,Cocaine-type,2.17,Crack,0.7,1.14,AMERICAS,CICAD/ OAS,Caribbean,2013
Turks and Caicos Islands,11 - 20,Cocaine-type,,Crack,,0.8,AMERICAS,ARQ,Caribbean,2002
Turks and Caicos Islands,11 - 20,Cocaine-type,1.7, ,,0.7,AMERICAS,ARQ,Caribbean,2002
Belize,"(SS) ages 13, 15, & 17",Cocaine-type,1.9,Crack,0.4,0.8,AMERICAS,OAS (MEM),Central America (excluding Mexico),2002
Belize,"(SS) ages 13, 15, & 17",Cocaine-type,1.4, ,0.5,0.7,AMERICAS,OAS (MEM),Central America (excluding Mexico),2002
Belize,SS,Cocaine-type,2.98, ,0.82,1.64,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2013
Belize,SS,Cocaine-type,1.75,Crack,0.56,0.72,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2013
Costa Rica,(SS) Grade 10,Cocaine-type,1,Crack,0.35,0.5,AMERICAS,ARQ/ Govt.,Central America (excluding Mexico),2009
Costa Rica,(SS) Grade 10,Cocaine-type,2, ,0.7,1.2,AMERICAS,ARQ/ Govt.,Central America (excluding Mexico),2009
Costa Rica,14 - 17,Cocaine-type,2.55,Cocaine salts,0.64,1.22,AMERICAS,ARQ,Central America (excluding Mexico),2009
Costa Rica,14 - 17,Cocaine-type,1.25,Crack,0.38,0.57,AMERICAS,ARQ,Central America (excluding Mexico),2009
Costa Rica,15-16,Cocaine-type,1.54,Cocaine overall,0.3,0.81,AMERICAS,ARQ,Central America (excluding Mexico),2012
Costa Rica,15-16,Cocaine-type,1.35,Cocaine salts,0.23,0.64,AMERICAS,ARQ,Central America (excluding Mexico),2012
Costa Rica,15-16,Cocaine-type,0.63,Crack,0.21,0.39,AMERICAS,ARQ,Central America (excluding Mexico),2012
Costa Rica,15 - 16,Cocaine-type,2.158, ,0.28,1.9,AMERICAS,ARQ,Central America (excluding Mexico),2015
Costa Rica,15 - 16,Cocaine-type,1.87,Cocaine salts only,,1.6,AMERICAS,ARQ,Central America (excluding Mexico),2015
Costa Rica,15 - 16,Cocaine-type,0.447,Crack,0.285,0.28,AMERICAS,ARQ,Central America (excluding Mexico),2015
El Salvador,13 - 17,Cocaine-type,1.94, ,0.5,1.08,AMERICAS,ARQ,Central America (excluding Mexico),2008
El Salvador,13 - 17,Cocaine-type,1.2,Crack,0.4,0.6,AMERICAS,ARQ,Central America (excluding Mexico),2008
El Salvador,17 - 25,Cocaine-type,2.7, ,0.2,0.4,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,17 - 25,Cocaine-type,2.3,Cocaine salts,0.2,0.4,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,17 - 25,Cocaine-type,0.4,Crack,0,0,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,13 - 17,Cocaine-type,4.7, ,0.8,1.4,AMERICAS,ARQ,Central America (excluding Mexico),2016
El Salvador,13 - 17,Cocaine-type,3,Cocaine salts,0.5,0.9,AMERICAS,ARQ,Central America (excluding Mexico),2016
El Salvador,13 - 17,Cocaine-type,1.7,Crack,0.3,0.5,AMERICAS,ARQ,Central America (excluding Mexico),2016
Guatemala,12 - 19,Cocaine-type,0.37,Crack,,0.13,AMERICAS,ARQ,Central America (excluding Mexico),2004
Guatemala,12 - 19,Cocaine-type,1.26, ,,0.54,AMERICAS,ARQ,Central America (excluding Mexico),2004
Guatemala,11 - 22,Cocaine-type,3.6,Cocaine salts,0.82,1.4,AMERICAS,ARQ,Central America (excluding Mexico),2014
Guatemala,11 - 22,Cocaine-type,2.84,Crack,0.55,0.94,AMERICAS,ARQ,Central America (excluding Mexico),2014
Honduras,Secondary/ High School,Cocaine-type,0.43,Crack,0.1,0.21,AMERICAS,OAS (MEM),Central America (excluding Mexico),2005
Honduras,13 - 25,Cocaine-type,2.8,Crack; Central District,,1,AMERICAS,ARQ,Central America (excluding Mexico),2008
Honduras,Secondary/ High School,Cocaine-type,2.14, ,0.4,0.88,AMERICAS,OAS (MEM),Central America (excluding Mexico),2005
Honduras,12 - 17,Cocaine-type,, ,,0.88,AMERICAS,ARQ,Central America (excluding Mexico),2005
Honduras,15 - 16,Cocaine-type,10,Cocaine salts,1.6,3.2,AMERICAS,ARQ,Central America (excluding Mexico),2014
Honduras,14-17,Cocaine-type,6.8, ,1.1,3.4,AMERICAS,ARQ,Central America (excluding Mexico),2015
Nicaragua,12 - 18,Cocaine-type,1.2,Crack,,,AMERICAS,ARQ,Central America (excluding Mexico),2004
Nicaragua,12 - 18,Cocaine-type,2.3, ,,,AMERICAS,ARQ,Central America (excluding Mexico),2004
Panama,SS,Cocaine-type,2.2, ,1.2,1.5,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2008
Panama,SS,Cocaine-type,1.2,Crack,1,1,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2008
Panama,18-25,Cocaine-type,1.27,Cocaine salts,0.11,0.28,AMERICAS,ARQ,Central America (excluding Mexico),2013
Canada,15 - 19,Cocaine-type,2.6, ,,1.4,AMERICAS,ARQ,Northern America (including Mexico),2010
Mexico,12 - 17,Cocaine-type,0.73, ,0.18,0.4,AMERICAS,National Adiction Household Survey,Northern America (including Mexico),2011
Mexico,12 - 17,Cocaine-type,, ,,0.4,AMERICAS,National Adiction Household Survey,Northern America (including Mexico),2008
Mexico,12 - 17,Cocaine-type,, ,,0.2,AMERICAS,National Adiction Household Survey,Northern America (including Mexico),2002
Mexico,12 - 17,Cocaine-type,0.73,Cocaine salts,0.18,0.4,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15 - 16,Cocaine-type,0.7, ,,0.4,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15 - 16,Cocaine-type,0.1,Crack,,0.0001,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15 - 16,Cocaine-type,3.3, ,0.9,1.7,AMERICAS,ARQ,Northern America (including Mexico),2014
Mexico,15 - 16,Cocaine-type,1.6,Crack,,,AMERICAS,ARQ,Northern America (including Mexico),2014
Mexico,12 - 17,Cocaine-type,1.1, ,0.2,0.6,AMERICAS,ARQ,Northern America (including Mexico),2016
Mexico,12 - 17,Cocaine-type,0.4,Crack,0.1,0.3,AMERICAS,ARQ,Northern America (including Mexico),2016
United States of America,(SS) Grade 10,Cocaine-type,1.8,Crack,0.5,1,AMERICAS,Govt.,Northern America (including Mexico),2010
United States of America,(SS) Grade 10,Cocaine-type,3.7,(non-crack form),0.9,2.2,AMERICAS,Govt.,Northern America (including Mexico),2010
United States of America,(SS) Grade 10,Cocaine-type,3.3, ,0.7,1.9,AMERICAS,ARQ,Northern America (including Mexico),2011
United States of America,(SS) Grade 10,Cocaine-type,1.6,Crack,0.4,0.9,AMERICAS,ARQ,Northern America (including Mexico),2011
United States of America,(SS) Grade 10,Cocaine-type,3,Other  coca type,0.6,1.7,AMERICAS,ARQ,Northern America (including Mexico),2011
United States of America,(SS) Grade 10,Cocaine-type,3.3, ,0.8,2,AMERICAS,ARQ,Northern America (including Mexico),2012
United States of America,(SS) Grade 10,Cocaine-type,1.4,Crack,0.4,0.8,AMERICAS,ARQ,Northern America (including Mexico),2012
United States of America,(SS) Grade 10,Cocaine-type,3,Other  coca type,0.7,1.8,AMERICAS,ARQ,Northern America (including Mexico),2012
United States of America,(SS) Grade 10,Cocaine-type,3.3, ,0.8,1.9,AMERICAS,ARQ,Northern America (including Mexico),2013
United States of America,(SS) Grade 10,Cocaine-type,1.5,Crack,0.4,0.8,AMERICAS,ARQ,Northern America (including Mexico),2013
United States of America,15 - 16,Cocaine-type,2.6, ,0.6,1.9,AMERICAS,ARQ,Northern America (including Mexico),2014
United States of America,15 - 16,Cocaine-type,1,Crack,0.3,0.5,AMERICAS,ARQ,Northern America (including Mexico),2014
United States of America,(SS) 15 - 16,Cocaine-type,2.7,Cocaine salts. Monitoring the future,0.8,1.8,AMERICAS,ARQ,Northern America (including Mexico),2015
United States of America,(SS) 15 - 16,Cocaine-type,1.1,Other coca type. Monitoring the future,0.3,0.7,AMERICAS,ARQ,Northern America (including Mexico),2015
United States of America,(SS) Grade 10,Cocaine-type,2.1, ,0.4,1.3,AMERICAS,ARQ,Northern America (including Mexico),2016
United States of America,(SS) Grade 10,Cocaine-type,0.8,Crack,0.2,0.4,AMERICAS,ARQ,Northern America (including Mexico),2016
Argentina,13 - 17,Cocaine-type,0.8,Crack,,,AMERICAS,ARQ,South America,2007
Argentina,13 - 17,Cocaine-type,4.1, ,,2.5,AMERICAS,ARQ,South America,2007
Argentina,15 - 16,Cocaine-type,2.7,Coca paste / coca base,1,1.5,AMERICAS,ARQ,South America,2009
Argentina,15 - 16,Cocaine-type,4.8,Cocaine salts,1.8,2.9,AMERICAS,ARQ,South America,2009
Argentina,15 - 16,Cocaine-type,1.1,Crack,,,AMERICAS,ARQ,South America,2009
Argentina,15 - 16,Cocaine-type,0.8,Crack,,,AMERICAS,ARQ,South America,2011
Argentina,15 - 16,Cocaine-type,4.8, ,1.5,2.8,AMERICAS,ARQ,South America,2011
Argentina,15 - 16,Cocaine-type,2,Cocaine paste (paco),0.6,1.1,AMERICAS,ARQ,South America,2011
Argentina,16 - 27,Cocaine-type,3.2,Cocaine salts,,,AMERICAS,ARQ,South America,2011
Argentina,15 - 16,Cocaine-type,0.8,Crack,,,AMERICAS,ARQ,South America,2014
Argentina,15 - 16,Cocaine-type,3.8,Cocaine salts,1,2.1,AMERICAS,ARQ,South America,2014
Argentina,15 - 16,Cocaine-type,1.8,Cocaine paste (paco),0.4,0.9,AMERICAS,ARQ,South America,2014
Bolivia (Plurinational State of),13 - 18,Cocaine-type,3.1,Cocaine,1.2,1.9,AMERICAS,ARQ,South America,2008
Bolivia (Plurinational State of),13 - 18,Cocaine-type,1.9,Coca paste / coca base,0.8,1.3,AMERICAS,ARQ,South America,2008
Bolivia (Plurinational State of),12 - 17,Cocaine-type,0.4,Cocaine salts,0.02,0.11,AMERICAS,ARQ,South America,2013
Bolivia (Plurinational State of),12 - 17,Cocaine-type,0.02,Coca paste / coca base,0.02,0.02,AMERICAS,ARQ,South America,2013
Bolivia (Plurinational State of),18 - 24,Cocaine-type,1.55,Cocaine salts,0.03,0.24,AMERICAS,ARQ,South America,2012
Bolivia (Plurinational State of),18 - 24,Cocaine-type,0.17,Crack,0,0,AMERICAS,ARQ,South America,2012
Bolivia (Plurinational State of),18 - 24,Cocaine-type,0.3,Coca paste / coca base,0,0.1,AMERICAS,ARQ,South America,2012
Bolivia (Plurinational State of),18 - 24,Cocaine-type,1.39,Cocaine salts,0.22,0.41,AMERICAS,OAS,South America,2016
Brazil,15 - 16,Cocaine-type,1.94,"Cocaine, includes coca paste",1.19,1.77,AMERICAS,CICAD/ OAS,South America,2005
Brazil,10 - 19,Cocaine-type,2.5,Cocaine salts,1,1.8,AMERICAS,ARQ,South America,2010
Brazil,University,Cocaine-type,7.7,Cocaine salts,1.8,3,AMERICAS,CICAD/ OAS,South America,2012
Brazil,10 - 19,Cocaine-type,0.6,Crack,0.3,0.4,AMERICAS,ARQ,South America,2010
Chile,15 - 16,Cocaine-type,5.43285,Coca paste / coca base,1.40826,2.85625,AMERICAS,ARQ,South America,2009
Chile,15 - 16,Cocaine-type,8.48331, ,2.58402,4.94272,AMERICAS,ARQ,South America,2009
Chile,15 - 16,Cocaine-type,6.54473,Cocaine salts,1.70828,3.38003,AMERICAS,ARQ,South America,2009
Chile,15 - 16,Cocaine-type,3.42408,Crack,0.98271,1.77214,AMERICAS,ARQ,South America,2009
Chile,15 - 16,Cocaine-type,7.12, ,2.38,4.72,AMERICAS,ARQ,South America,2011
Chile,15 - 16,Cocaine-type,5.46,Cocaine salts,1.56,3.55,AMERICAS,ARQ,South America,2011
Chile,15 - 16,Cocaine-type,4.11,Coca paste / coca base,1.31,2.36,AMERICAS,ARQ,South America,2011
Chile,15 - 16,Cocaine-type,7.27, ,2.22,4.47,AMERICAS,ARQ,South America,2013
Chile,15 - 16,Cocaine-type,5.56,Cocaine salts,1.49,3.32,AMERICAS,ARQ,South America,2013
Chile,15 - 16,Cocaine-type,4.15,Coca paste / coca base,1.13,2.25,AMERICAS,ARQ,South America,2013
Chile,(SS) 15 - 16,Cocaine-type,8.19, ,2.26,4.97,AMERICAS,ARQ,South America,2015
Chile,(SS) 15 - 16,Cocaine-type,6.34,Cocaine salts,1.49,3.84,AMERICAS,ARQ,South America,2015
Chile,(SS) 15 - 16,Cocaine-type,4.7,Coca paste,1.23,2.63,AMERICAS,ARQ,South America,2015
Colombia,15 - 16,Cocaine-type,2, ,0.5,1.74,AMERICAS,CICAD/ OAS,South America,2005
Colombia,12 - 17,Cocaine-type,1.4,Coca paste / coca base,,1.2,AMERICAS,CICAD,South America,2004
Colombia,12 - 17,Cocaine-type,1.8, ,,1.6,AMERICAS,CICAD,South America,2004
Colombia,11-18,Cocaine-type,2.77,Cocaine salts,1.02,1.87,AMERICAS,ARQ,South America,2011
Colombia,11-18,Cocaine-type,0.66,Coca paste / coca base (Basuco),0.22,0.47,AMERICAS,ARQ,South America,2011
Colombia,University,Cocaine-type,7,Cocaine salts,0.87,2.12,AMERICAS,ARQ,South America,2012
Colombia,University,Cocaine-type,0.64,Coca paste / coca base (Basuco),0.03,0.08,AMERICAS,ARQ,South America,2012
Colombia,18 - 24,Cocaine-type,6.94,Cocaine salts,1.19,2.71,AMERICAS,OAS,South America,2016
Colombia,18 - 24,Cocaine-type,0.57,coca base (Basuco),0.05,0.14,AMERICAS,Government,South America,2016
Ecuador,12 - 17,Cocaine-type,0.6,Crack,,,AMERICAS,ARQ,South America,2005
Ecuador,12 - 17,Cocaine-type,2.2, ,,1.3,AMERICAS,ARQ,South America,2008
Ecuador,University,Cocaine-type,1.39,Coca paste / coca base,0.13,0.28,AMERICAS,ARQ,South America,2009
Ecuador,University,Cocaine-type,2.12,Cocaine salts,0.29,0.57,AMERICAS,ARQ,South America,2009
Ecuador,12 - 17,Cocaine-type,0.7,Crack,0.12,0.31,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Cocaine-type,1.2,Coca paste / coca base,0.2,0.6,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Cocaine-type,2.92, ,0.5,1.3,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Cocaine-type,2.2,Cocaine salts,0.4,1,AMERICAS,ARQ,South America,2012
Ecuador,18 - 24,Cocaine-type,4.41,Cocaine salts,0.47,1.52,AMERICAS,OAS,South America,2016
Guyana,12 - 18,Cocaine-type,0.5,Crack; Limited Geography,0.1,0.2,AMERICAS,ARQ,South America,2002
Guyana,12 - 18,Cocaine-type,0.7,Limited geography,0.1,0.3,AMERICAS,ARQ,South America,2002
Guyana,SS,Cocaine-type,6.8, ,3.4,1.7,AMERICAS,CICAD/ OAS,South America,2013
Guyana,SS,Cocaine-type,1.52, ,0.66,1.05,AMERICAS,CICAD/ OAS,South America,2013
Guyana,SS,Cocaine-type,2.07,Crack,0.45,1.1,AMERICAS,CICAD/ OAS,South America,2013
Paraguay,15 - 16,Cocaine-type,1.09, ,0.51,0.73,AMERICAS,CICAD/ OAS,South America,2005
Paraguay,Students (undefined),Cocaine-type,0.3,Crack; Ages not specified,,,AMERICAS,OAS (MEM),South America,2005
Paraguay,12+,Cocaine-type,2,Cocaine salts. Schools in city with more than 30000,0.7,1.7,AMERICAS,Survey in school,South America,2014
Paraguay,12+,Cocaine-type,1,Crack. Schools in city with more than 30000,0.3,0.6,AMERICAS,Survey in school,South America,2014
Peru,11 - 19,Cocaine-type,2.6,Cocaine includes coca Pasta,0.6,1.2,AMERICAS,DEVIDA,South America,2007
Peru,12 - 18,Cocaine-type,1,Cocaine includes coca Pasta,0.3,0.5,AMERICAS,DEVIDA,South America,2006
Peru,15 - 16,Cocaine-type,1.13,Coca paste / coca base,0.696,1.13,AMERICAS,ARQ,South America,2006
Peru,15 - 16,Cocaine-type,1.43, ,0.686,1.113,AMERICAS,ARQ,South America,2006
Peru,15 - 16,Cocaine-type,1.018,Cocaine salts,0.696,0.696,AMERICAS,ARQ,South America,2006
Peru,15-16,Cocaine-type,0.441547216,Cocaine salts,0.406976110,0.406976110,AMERICAS,ARQ,South America,2010
Peru,15-16,Cocaine-type,0.957033650,Other  coca type PBC,0.300282080,0.668887502,AMERICAS,ARQ,South America,2010
Peru,11-20,Cocaine-type,1.8,Cocaine salts,0.7,0.9,AMERICAS,DEVIDA,South America,2012
Peru,11-20,Cocaine-type,1.9,Pasta Basica,0.7,0.9,AMERICAS,DEVIDA,South America,2012
Peru,11-20,Cocaine-type,0.3,Crack,,,AMERICAS,DEVIDA,South America,2012
Peru,14 - 16,Cocaine-type,2.14, ,0.81,1.02,AMERICAS,ARQ,South America,2012
Peru,14 - 16,Cocaine-type,2.14,Cocaine salts,0.81,1.02,AMERICAS,ARQ,South America,2012
Peru,14 - 16,Cocaine-type,2.22,Pasta Basica,0.79,1,AMERICAS,ARQ,South America,2012
Peru,18 - 24,Cocaine-type,1.82,Cocaine salts,0.15,0.29,AMERICAS,OAS,South America,2016
Suriname,Secondary/ High School,Cocaine-type,0.6, ,0.1,0.2,AMERICAS,OAS (MEM),South America,2006
Suriname,Secondary/ High School,Cocaine-type,0.7, ,0.07,0.17,AMERICAS,OAS (MEM),South America,2006
Uruguay,13 - 17,Cocaine-type,1.3,Coca paste / coca base,0.2,0.6,AMERICAS,ARQ,South America,2009
Uruguay,13 - 17,Cocaine-type,4, ,1.1,2.6,AMERICAS,ARQ,South America,2009
Uruguay,13 - 17,Cocaine-type,3.9,Cocaine salts,1.1,2.5,AMERICAS,ARQ,South America,2009
Uruguay,13 - 17,Cocaine-type,3.1, ,0.6,1.6,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Cocaine-type,2.6,Cocaine salts,0.6,1.4,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Cocaine-type,0.2,Crack,,,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Cocaine-type,0.9,Other  coca type,0.2,0.4,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Cocaine-type,3, ,0.9,2.3,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Cocaine-type,2.7,Cocaine salts,0.9,2.1,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Cocaine-type,0.2,Crack,,,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Cocaine-type,0.9,Coca paste / coca base,0.1,0.5,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),(SS) 12 - 18,Cocaine-type,0.8, ,0.5,0.5,AMERICAS,ARQ,South America,2009
Venezuela (Bolivarian Republic of),(SS) 12 - 18,Cocaine-type,0.5,Crack,0.2,0.2,AMERICAS,ARQ,South America,2009
Venezuela (Bolivarian Republic of),15 -17,Cocaine-type,0.49,Cocaine salts,0.07,0.25,AMERICAS,ARQ,South America,2011
Venezuela (Bolivarian Republic of),University,Cocaine-type,0.08,Crack,,,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),University,Cocaine-type,0.06,Coca paste / coca base,,,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),University,Cocaine-type,0.65,Cocaine salts,0.06,0.29,AMERICAS,ARQ,South America,2014
Armenia,(SS) 15 - 16,Cocaine-type,1, ,,,ASIA,ESPAD,Central Asia and Transcaucasia,2007
Georgia,(SS) 15 - 16,Cocaine-type,1.1,Crack; select regions (capital);  Georgian Medical News No3 (180) 2010,,,ASIA,Research,Central Asia and Transcaucasia,2010
Georgia,(SS) 15 - 16,Cocaine-type,0.6,Select regions (capital);  Georgian Medical News No3 (180) 2010,,,ASIA,Research,Central Asia and Transcaucasia,2010
Georgia,17,Cocaine-type,3.2,Cocaine salts,,1.6,ASIA,ARQ,Central Asia and Transcaucasia,2014
Georgia,17,Cocaine-type,1.1,Crack,,0.4,ASIA,ARQ,Central Asia and Transcaucasia,2014
Georgia,(SS) 15 - 16,Cocaine-type,1.8, ,,1.2,ASIA,ARQ / ESPAD,Central Asia and Transcaucasia,2015
Georgia,(SS) 15 - 16,Cocaine-type,1,Crack,,1.4,ASIA,ARQ / ESPAD,Central Asia and Transcaucasia,2015
Kazakhstan,16 - 24,Cocaine-type,0.8, ,,,ASIA,ARQ,Central Asia and Transcaucasia,2012
"China, Hong Kong SAR",15 - 16,Cocaine-type,, ,,0.052,ASIA,ARQ,East and South-East Asia,2011
"China, Hong Kong SAR",11 - 20,Cocaine-type,,Central Registry,,0.03,ASIA,ARQ,East and South-East Asia,2014
"China, Hong Kong SAR",11-20,Cocaine-type,0.03,Cocaine salts. Central registry of drug abuse,,,ASIA,ARQ,East and South-East Asia,2015
Indonesia,15 -19,Cocaine-type,0.15,Cocaine salts,0.1,0.15,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 -19,Cocaine-type,0.15,Crack,0.1,0.15,ASIA,ARQ,East and South-East Asia,2011
Thailand,Youth (undefined),Cocaine-type,0.3,"Cocaine, any (HCl and/ or Crack); Ages not specified",,,ASIA,ARQ,East and South-East Asia,2003
Israel,(SS) Grade 10,Cocaine-type,,Crack,,2,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,(SS) Grade 10,Cocaine-type,, ,,1.6,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,12 - 18,Cocaine-type,3.39,Cocaine salts,2.86,0.99,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,12 - 18,Cocaine-type,2.63,Crack,2.14,0.27,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Lebanon,15 - 16,Cocaine-type,,"Cocaine, any (HCl and/ or Crack); Rapid Assessment",,1.2,ASIA,ARQ,Near and Middle East /South-West Asia,2001
Belarus,15 - 16,Cocaine-type,0.4,"Cocaine, any (HCl and/ or Crack); Limited geography",,,EUROPE,ARQ,Eastern Europe,2007
Belarus,15 - 16,Cocaine-type,0.2,Crack; Limited geography,,,EUROPE,ARQ,Eastern Europe,2007
Belarus,15 - 16,Cocaine-type,0.2,Limited geography,,,EUROPE,ARQ,Eastern Europe,2007
Republic of Moldova,(SS) 15 - 24,Cocaine-type,0.1, ,,,EUROPE,Govt.,Eastern Europe,2010
Republic of Moldova,15 - 16,Cocaine-type,0.8, ,,,EUROPE,ESPAD,Eastern Europe,2008
Republic of Moldova,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Eastern Europe,2015
Republic of Moldova,(SS) 15 - 16,Cocaine-type,0,Crack,,,EUROPE,ESPAD,Eastern Europe,2015
Russian Federation,15 - 16,Cocaine-type,0.6,Crack,,,EUROPE,ARQ/ ESPAD,Eastern Europe,2007
Russian Federation,15 - 16,Cocaine-type,0.4, ,,,EUROPE,ARQ/ ESPAD,Eastern Europe,2007
Russian Federation,15 - 16,Cocaine-type,1.9, ,,,EUROPE,ARQ,Eastern Europe,2011
Russian Federation,15 - 16,Cocaine-type,1.4,Cocaine salts,,,EUROPE,ARQ,Eastern Europe,2011
Ukraine,15 - 16,Cocaine-type,0,Crack,,,EUROPE,ESPAD,Eastern Europe,2007
Ukraine,15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Eastern Europe,2007
Ukraine,15 - 34,Cocaine-type,, ,0.1,0.2,EUROPE,ARQ,Eastern Europe,2010
Ukraine,15 - 17,Cocaine-type,0.9,Crack,,,EUROPE,ARQ,Eastern Europe,2011
Ukraine,15 - 17,Cocaine-type,1.1, ,,,EUROPE,ARQ,Eastern Europe,2011
Ukraine,16 -17,Cocaine-type,, ,,0,EUROPE,ARQ,Eastern Europe,2015
Albania,14 - 19,Cocaine-type,1.4,"Cocaine, any (HCl and/ or Crack)",,,EUROPE,ARQ,South-Eastern Europe,2004
Albania,14 - 19,Cocaine-type,1.4, ,,,EUROPE,ARQ,South-Eastern Europe,2004
Albania,(SS) 15 - 16,Cocaine-type,3.4,Cocaine salts,,3.1,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Albania,(SS) 15 - 16,Cocaine-type,1.9,Crack,,1.9,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Bulgaria,14 - 19,Cocaine-type,6,Cocaine salts,2.5,3.9,EUROPE,ARQ,South-Eastern Europe,2008
Bulgaria,(SS) 15 - 16,Cocaine-type,4,Cocaine salts,,,EUROPE,ESPAD,South-Eastern Europe,2011
Bulgaria,(SS) 15 - 16,Cocaine-type,2.4,Crack,,,EUROPE,ESPAD,South-Eastern Europe,2011
Bulgaria,15 - 19,Cocaine-type,4.3, ,2.1,3.4,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,15 - 19,Cocaine-type,4.3,Cocaine salts,2.1,3.4,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,(SS) 15 - 16,Cocaine-type,7, ,,6.1,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Bulgaria,(SS) 15 - 16,Cocaine-type,5,Crack,,4.5,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Croatia,16,Cocaine-type,1.6, ,,,EUROPE,ARQ,South-Eastern Europe,2007
Croatia,16,Cocaine-type,1.5,Crack,,,EUROPE,ARQ,South-Eastern Europe,2007
Croatia,(SS) 15 - 16,Cocaine-type,2, ,,,EUROPE,ESPAD,South-Eastern Europe,2015
Croatia,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,South-Eastern Europe,2015
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,South-Eastern Europe,2015
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,South-Eastern Europe,2015
Montenegro,(SS) 16,Cocaine-type,1.5, ,,,EUROPE,ESPAD,South-Eastern Europe,2011
Montenegro,(SS) 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,South-Eastern Europe,2011
Montenegro,15 - 16,Cocaine-type,1.3, ,,,EUROPE,ESPAD,South-Eastern Europe,2008
Ghana,13 - 15,Amphetamines,,Amphetamines (inclds. non-ATS stimulants),,7.6,AFRICA,ARQ,West and Central Africa,2007
Ghana,13 - 15,Amphetamines,,Methamphetamine,,5,AFRICA,ARQ,West and Central Africa,2007
South Africa,13 - 22,Amphetamines,6.6,Methamphetamine,,,AFRICA,ARQ,Southern and South-Eastern Africa,2008
South Africa,Secondary/ High School,Amphetamines,6.9,Stimulants (inclds Amphetamines),,,AFRICA,ARQ,Southern and South-Eastern Africa,2008
South Africa,(SS) grades 8- 10,Amphetamines,2,Cape Town only,,,AFRICA,ARQ,Southern and South-Eastern Africa,2011
Namibia,15 - 16,Amphetamines,8,Prescription stimulants,4,7,AFRICA,Govt.,Southern and South-Eastern Africa,2015
South Africa,13 - 17,Ecstasy,3.2,Select regions (Cape Town),,1.2,AFRICA,ARQ,Southern and South-Eastern Africa,2006
Kenya, (HHS) age 15 - 17,Ecstasy,0.6, ,0.6,,AFRICA,Govt.,Eastern Africa,2007
South Africa,13 - 22,Ecstasy,6.8, ,,,AFRICA,ARQ,Southern and South-Eastern Africa,2008
South Africa,(SS) grades 8- 10,Ecstasy,1,Cape Town only,,,AFRICA,ARQ,Southern and South-Eastern Africa,2011
Namibia,15 - 16,Ecstasy,3.1, ,,,AFRICA,Govt.,Southern and South-Eastern Africa,2015
Algeria,15 - 17,Ecstasy,0.81, ,0.71,1.09,AFRICA,ARQ,Northern Africa,2016
South Africa,13 - 22,Tranquillizers and Sedatives,7.4,Methaqualone,,,AFRICA,,Southern and South-Eastern Africa,2008
Morocco,(SS) 15 - 17,Tranquillizers and Sedatives,4, ,1.3,2.2,AFRICA,MedSPAD,Northern Africa,2009
Algeria,15 - 16,Tranquillizers and Sedatives,0.17, ,0.03,0.03,AFRICA,ARQ,Northern Africa,2010
South Africa,(SS) grades 8- 10,Tranquillizers and Sedatives,2.1,Methaqualone,,,AFRICA,ARQ,Southern and South-Eastern Africa,2011
Morocco,(SS) 15 - 17,Tranquillizers and Sedatives,5.4, ,2.3,3.7,AFRICA,MedSPAD,Northern Africa,2013
Morocco,(SS) 15 - 17,Tranquillizers and Sedatives,4,Benzodiazepines,2,3,AFRICA,MedSPAD,Northern Africa,2013
Namibia,15 - 16,Tranquillizers and Sedatives,0.4,Methaqualone,0.1,0.4,AFRICA,Govt.,Southern and South-Eastern Africa,2015
Turks and Caicos Islands,11 - 20,Amphetamines,0.9,Methamphetamine,,0.3,AMERICAS,ARQ,Caribbean,2002
Guatemala,12 - 19,Amphetamines,7.3,Amphetamine,,3.8,AMERICAS,ARQ,Central America (excluding Mexico),2002
Belize,"(SS) ages 13, 15, & 17",Amphetamines,0.4,Methamphetamine,0.1,0.1,AMERICAS,OAS (MEM),Central America (excluding Mexico),2002
Belize,"(SS) ages 13, 15, & 17",Amphetamines,4.6,Stimulants (inclds Amphetamines),1.9,2.7,AMERICAS,OAS (MEM),Central America (excluding Mexico),2002
Guyana,12 - 18,Amphetamines,2, ,0.4,0.7,AMERICAS,ARQ,South America,2002
Guyana,12 - 18,Amphetamines,1.5,Methamphetamine,0.3,0.8,AMERICAS,ARQ,South America,2002
Colombia,12 - 17,Amphetamines,5.6,Amphetamine,,,AMERICAS,ARQ,South America,2004
Bolivia (Plurinational State of),13 - 18,Amphetamines,6.8,Stimulants,1.8,3,AMERICAS,CICAD/ OAS,South America,2004
Grenada, ,Amphetamines,3.4,Stimulants (inclds Amphetamines),1.5,2.2,AMERICAS,Govt.,Caribbean,2005
Grenada,15 - 16,Amphetamines,0.3,Methamphetamine,0.2,0.2,AMERICAS,Govt.,Caribbean,2005
Puerto Rico,(SS) Grades 9 - 12,Amphetamines,1.9,Methamphetamine/ Youth Risk Behavior Survey,,,AMERICAS,Govt.,Caribbean,2005
Antigua and Barbuda,Secondary/ High School,Amphetamines,2.6,Stimulants (inclds Amphetamines),1.1,1.5,AMERICAS,OAS (MEM),Caribbean,2005
Haiti,Secondary/ High School,Amphetamines,24.4,Stimulants (inclds Amphetamines),7.5,11.7,AMERICAS,OAS (MEM),Caribbean,2005
Saint Lucia,"(SS) ages 13, 15, & 17",Amphetamines,6,Stimulants (inclds Amphetamines),2.2,3.7,AMERICAS,OAS (MEM),Caribbean,2005
Honduras,SS,Amphetamines,7.43,Prescription stimulants,1.98,3.05,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2005
Argentina,15 - 16,Amphetamines,4.54, ,1.92,3,AMERICAS,CICAD/ OAS,South America,2005
Brazil,15 - 16,Amphetamines,4.86, ,2.96,4.3,AMERICAS,CICAD/ OAS,South America,2005
Colombia,15 - 16,Amphetamines,6.36, ,2.83,3.69,AMERICAS,CICAD/ OAS,South America,2005
Ecuador,15 - 16,Amphetamines,3.03, ,1.11,1.58,AMERICAS,CICAD/ OAS,South America,2005
Paraguay,15 - 16,Amphetamines,4.07, ,1.15,2.56,AMERICAS,CICAD/ OAS,South America,2005
Peru,15 - 16,Amphetamines,1.2, ,0.37,0.59,AMERICAS,CICAD/ OAS,South America,2005
Saint Kitts and Nevis,15 - 16,Amphetamines,2.99,Stimulants (inclds Amphetamines),1.32,1.58,AMERICAS,Govt.,Caribbean,2006
Jamaica,Ages 11 - 19,Amphetamines,6.3,Stimulants (inclds Amphetamines),2.4,3.5,AMERICAS,OAS,Caribbean,2006
Barbados,"(SS) ages 13, 15, & 17",Amphetamines,3.5,Stimulants (inclds Amphetamines),1.6,2.4,AMERICAS,OAS (MEM),Caribbean,2006
Dominica,"(SS) ages 13, 15, & 17",Amphetamines,4.3,Stimulants (inclds Amphetamines),1.6,2.2,AMERICAS,OAS (MEM),Caribbean,2006
Saint Vincent and the Grenadines,"(SS) ages 13, 15, & 17",Amphetamines,2.91,Stimulants (inclds Amphetamines),1.21,1.66,AMERICAS,OAS (MEM),Caribbean,2006
Trinidad and Tobago,"(SS) ages 13, 15, & 17",Amphetamines,3.41,Stimulants (inclds Amphetamines),1.6,2.12,AMERICAS,OAS (MEM),Caribbean,2006
Suriname,SS,Amphetamines,5.06,Prescription stimulants,1.76,3,AMERICAS,CICAD/ OAS,South America,2006
Suriname,Secondary/ High School,Amphetamines,4.8,Stimulants (inclds Amphetamines),1.5,2.7,AMERICAS,OAS (MEM),South America,2006
Dominican Republic,SS,Amphetamines,9.12,Prescription stimulants,2.83,4.21,AMERICAS,CICAD/ OAS,Caribbean,2008
Bahamas,15-16,Amphetamines,1.4, ,,0.9,AMERICAS,Govt.,Caribbean,2008
El Salvador,13 - 17,Amphetamines,1.7, ,0.9,1.1,AMERICAS,ARQ,Central America (excluding Mexico),2008
Honduras,13-25,Amphetamines,4.3,Stimulants (inclds Amphetamines); Central District,,2.3,AMERICAS,ARQ,Central America (excluding Mexico),2008
Panama,SS,Amphetamines,4.7,Prescription stimulants,0.5,1.2,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2008
Bolivia (Plurinational State of),13 - 18,Amphetamines,9.1,Prescription stimulants,2.4,4,AMERICAS,CICAD/ OAS,South America,2008
Costa Rica,14 - 17,Amphetamines,7.1,Other stimulants,2.1,3.8,AMERICAS,ARQ,Central America (excluding Mexico),2009
Costa Rica,(SS) Grade 10,Amphetamines,9.6,Any amphetamines without prescription,3.59,6.85,AMERICAS,ARQ/ Govt.,Central America (excluding Mexico),2009
Argentina,15 - 16,Amphetamines,3.3,Prescription stimulants,1.2,2,AMERICAS,ARQ,South America,2009
Chile,(SS) 15 - 16,Amphetamines,6.80833, ,1.30823,2.73695,AMERICAS,ARQ,South America,2009
Chile,(SS) 15 - 16,Amphetamines,5.32236,Prescription stimulants,0.87926,1.92404,AMERICAS,ARQ,South America,2009
Ecuador,University,Amphetamines,0.35,Amphetamine,0.1,0.13,AMERICAS,ARQ,South America,2009
Ecuador,University,Amphetamines,0.49,Methamphetamine,0.01,0.25,AMERICAS,ARQ,South America,2009
Ecuador,University,Amphetamines,1.17,Prescription stimulants,0.11,0.32,AMERICAS,ARQ,South America,2009
Uruguay,13 - 17,Amphetamines,3,ATS,,,AMERICAS,ARQ,South America,2009
Uruguay,13 - 17,Amphetamines,2.1,Prescription stimulants,0.5,1.2,AMERICAS,ARQ,South America,2009
Venezuela (Bolivarian Republic of),(SS) 12 - 18,Amphetamines,2.6,Prescription stimulants,0.8,1.2,AMERICAS,ARQ,South America,2009
Venezuela (Bolivarian Republic of),(SS) 12 - 18,Amphetamines,0.433180501,methamphetamine,0.164552333,0.246125285,AMERICAS,ARQ,South America,2009
Jamaica,(SS) 15 - 16,Amphetamines,2.5,Amphetamine,,,AMERICAS,ARQ,Caribbean,2010
Jamaica,(SS) 15 - 16,Amphetamines,1.4,Methamphetamine,,,AMERICAS,ARQ,Caribbean,2010
Canada,15 - 19,Amphetamines,7.4, ,1.6,4.3,AMERICAS,ARQ,Northern America (including Mexico),2010
Canada,15 - 19,Amphetamines,3.4,Amphetamine,,2,AMERICAS,ARQ,Northern America (including Mexico),2010
United States of America,Grade 10,Amphetamines,10.6,Any amphetamines without prescription,3.3,7.6,AMERICAS,Govt.,Northern America (including Mexico),2010
United States of America,Grade 10,Amphetamines,2.5,Methamphetamine,0.7,1.6,AMERICAS,Govt.,Northern America (including Mexico),2010
Brazil,10 - 19,Amphetamines,0.3,Methamphetamine,,,AMERICAS,ARQ,South America,2010
Brazil,10 - 19,Amphetamines,2.2,Prescription stimulants,0.9,1.7,AMERICAS,ARQ,South America,2010
Peru,15-16,Amphetamines,0.149034893,Prescription stimulants,0,0.0001,AMERICAS,ARQ,South America,2010
Bahamas,SS,Amphetamines,3.33,Prescription stimulants,1.14,1.83,AMERICAS,CICAD/ OAS,Caribbean,2011
Dominica,SS,Amphetamines,15.58,Prescription stimulants,2.93,6.39,AMERICAS,CICAD/ OAS,Caribbean,2011
Mexico,15 - 16,Amphetamines,0.3, ,,0.1,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15 - 16,Amphetamines,0.001,Amphetamine,0.001,,AMERICAS,ARQ,Northern America (including Mexico),2011
United States of America,Grade 10,Amphetamines,9,Amphetamine,3.1,6.6,AMERICAS,ARQ,Northern America (including Mexico),2011
United States of America,Grade 10,Amphetamines,2.1,Methamphetamine,0.5,1.4,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,12 - 17,Amphetamines,0.3,Amphetamine,0,0.1,AMERICAS,National Addiction Household Survey,Northern America (including Mexico),2011
Argentina,15 - 16,Amphetamines,2.8, ,0.9,1.4,AMERICAS,ARQ,South America,2011
Chile,(SS) 15 - 16,Amphetamines,3.12, ,0.56,1.66,AMERICAS,ARQ,South America,2011
Chile,(SS) 15 - 16,Amphetamines,2.42,Prescription stimulants,0.44,1.18,AMERICAS,ARQ,South America,2011
Colombia,11-18,Amphetamines,0.33,Prescription stimulants,0.1,0.21,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Amphetamines,2.9, ,0.2,1.2,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Amphetamines,1.6,Non-specified ATS,,,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Amphetamines,1.5,Prescription stimulants,,1,AMERICAS,ARQ,South America,2011
Venezuela (Bolivarian Republic of),15 - 17,Amphetamines,1.31,Prescription stimulants,,,AMERICAS,ARQ,South America,2011
Costa Rica,15 - 16,Amphetamines,3.55, ,0.9,1.3,AMERICAS,ARQ,Central America (excluding Mexico),2012
Costa Rica,15-16,Amphetamines,3.69, ,1.3,1.97,AMERICAS,ARQ,Central America (excluding Mexico),2012
Costa Rica,15-16,Amphetamines,3.2,Prescription stimulants,1.1,1.63,AMERICAS,ARQ,Central America (excluding Mexico),2012
El Salvador,17 - 25,Amphetamines,2.4,Use amongst young population without medical prescription,0.7,0.7,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
United States of America,Grade 10,Amphetamines,8.9, ,2.8,6.5,AMERICAS,ARQ,Northern America (including Mexico),2012
United States of America,Grade 10,Amphetamines,1.8,Methamphetamine,0.6,1,AMERICAS,ARQ,Northern America (including Mexico),2012
Bolivia (Plurinational State of),18 - 24,Amphetamines,0.45,Amphetamine,,,AMERICAS,ARQ,South America,2012
Bolivia (Plurinational State of),18 - 24,Amphetamines,0.41,Methamphetamine,,,AMERICAS,ARQ,South America,2012
Colombia,University,Amphetamines,0.77,Amphetamine,0.02,0.12,AMERICAS,ARQ,South America,2012
Colombia,University,Amphetamines,0.36,Methamphetamine,0.05,0.09,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Amphetamines,5.31, ,1.28,2.83,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Amphetamines,0.41,Amphetamine,0.1,0.13,AMERICAS,ARQ,South America,2012
Peru,14 - 16,Amphetamines,0.14, ,,,AMERICAS,ARQ,South America,2012
Peru,14 - 16,Amphetamines,2.77,Prescription stimulants,1.21,1.71,AMERICAS,ARQ,South America,2012
Ecuador,SS,Amphetamines,3.8,Prescription stimulants,1,2.2,AMERICAS,CICAD/ OAS,South America,2012
Peru,11-20,Amphetamines,0.1,Amphetamines,,,AMERICAS,DEVIDA,South America,2012
Peru,11-20,Amphetamines,2.4,Prescription stimulants,1,1.5,AMERICAS,DEVIDA,South America,2012
Antigua and Barbuda,SS,Amphetamines,2.74,Prescription stimulants,1.33,1.64,AMERICAS,CICAD/ OAS,Caribbean,2013
Barbados,SS,Amphetamines,3.66,Prescription stimulants,1.59,1.95,AMERICAS,CICAD/ OAS,Caribbean,2013
Grenada,SS,Amphetamines,4.35,Prescription stimulants,1.8,2.88,AMERICAS,CICAD/ OAS,Caribbean,2013
Jamaica,SS,Amphetamines,3.46,Prescription stimulants,1.15,1.79,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Kitts and Nevis,SS,Amphetamines,4.05,Prescription stimulants,1.14,2.29,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Lucia,SS,Amphetamines,5.01,Prescription stimulants,2.54,3.4,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Vincent and the Grenadines,SS,Amphetamines,3,Prescription stimulants,1.53,2.03,AMERICAS,CICAD/ OAS,Caribbean,2013
Trinidad and Tobago,SS,Amphetamines,3.91,Prescription stimulants,1,1.38,AMERICAS,CICAD/ OAS,Caribbean,2013
Panama,18-25,Amphetamines,0.53, ,0.14,0.32,AMERICAS,ARQ,Central America (excluding Mexico),2013
Panama,18-25,Amphetamines,0.35,Amphetamine,0,0.11,AMERICAS,ARQ,Central America (excluding Mexico),2013
Panama,18-25,Amphetamines,0.7,Methamphetamine,0.1,0.2,AMERICAS,ARQ,Central America (excluding Mexico),2013
Belize,SS,Amphetamines,3.25,Prescription stimulants,1.03,1.6,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2013
United States of America,Grade 10,Amphetamines,8.1, ,2.8,5.9,AMERICAS,ARQ,Northern America (including Mexico),2013
United States of America,Grade 10,Amphetamines,1.6,Methamphetamine,0.4,1,AMERICAS,ARQ,Northern America (including Mexico),2013
Bolivia (Plurinational State of),12 - 17,Amphetamines,0.31,Prescription stimulants,0.05,0.05,AMERICAS,,South America,2013
Chile,(SS) 15 - 16,Amphetamines,6.61, ,1.61,3.68,AMERICAS,ARQ,South America,2013
Chile,(SS) 15 - 16,Amphetamines,4.27,Prescription stimulants,0.88,2.01,AMERICAS,ARQ,South America,2013
Guyana,SS,Amphetamines,2.87,Prescription stimulants,0.86,1.15,AMERICAS,CICAD/ OAS,South America,2013
Haiti,SS,Amphetamines,7.65,Prescription stimulants,1.55,3.36,AMERICAS,CICAD/ OAS,Caribbean,2014
Guatemala,11 - 22,Amphetamines,3.74, ,0.97,1.35,AMERICAS,ARQ,Central America (excluding Mexico),2014
Honduras,15 - 16,Amphetamines,8.4,Prescription stimulants,1.2,2,AMERICAS,ARQ,Central America (excluding Mexico),2014
Mexico,15 - 16,Amphetamines,2.5,Amphetamine,0.9,1.8,AMERICAS,ARQ,Northern America (including Mexico),2014
Mexico,15 - 16,Amphetamines,2,Methamphetamine,0.7,1.3,AMERICAS,ARQ,Northern America (including Mexico),2014
United States of America,Grade 10,Amphetamines,1.4,Methamphetamine,0.3,0.8,AMERICAS,ARQ,Northern America (including Mexico),2014
United States of America,SS,Amphetamines,3.5,Prescription stimulants,0.8,2.2,AMERICAS,CICAD/ OAS,Northern America (including Mexico),2014
Argentina,15 - 16,Amphetamines,0.9,Amphetamine,,,AMERICAS,ARQ,South America,2014
Argentina,15 - 16,Amphetamines,2.8,Prescription stimulants,1,1.5,AMERICAS,ARQ,South America,2014
Paraguay,12+,Amphetamines,2.3,Prescription stimulants. Cities with at least 30000,0.8,1.4,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Amphetamines,1.9, ,0.3,1.4,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Amphetamines,0.2,Amphetamine,0.1,0.2,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Amphetamines,1.1,Prescription stimulants,,0.6,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Amphetamines,0.3,methamphetamine,0.1,0.3,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),University,Amphetamines,0.11,Amphetamine,,,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),University,Amphetamines,0.07,Methamphetamine,,,AMERICAS,ARQ,South America,2014
Costa Rica,15 - 16,Amphetamines,1.848, ,,1.76,AMERICAS,ARQ,Central America (excluding Mexico),2015
Costa Rica,15 - 16,Amphetamines,0.18,Prescription stimulants,,0.09,AMERICAS,ARQ,Central America (excluding Mexico),2015
Honduras,14-17,Amphetamines,6.8, ,1.1,3.4,AMERICAS,ARQ,Central America (excluding Mexico),2015
United States of America,(SS) 15 - 16,Amphetamines,9.7,Amphetamine. Monitoring the future,3.1,6.8,AMERICAS,ARQ,Northern America (including Mexico),2015
United States of America,(SS) 15 - 16,Amphetamines,1.3,Methamphetamine. Monitoring the future,0.3,0.8,AMERICAS,ARQ,Northern America (including Mexico),2015
Chile,(SS) 15 - 16,Amphetamines,7.62, ,1.65,3.88,AMERICAS,ARQ,South America,2015
Chile,(SS) 15 - 16,Amphetamines,4.8,Prescription stimulants,0.7,1.9,AMERICAS,ARQ,South America,2015
El Salvador,13 - 17,Amphetamines,2.7, ,0.6,0.9,AMERICAS,ARQ,Central America (excluding Mexico),2016
El Salvador,13 - 17,Amphetamines,2.7,Prescription stimulants,0.6,0.9,AMERICAS,ARQ,Central America (excluding Mexico),2016
Mexico,12 - 17,Amphetamines,0.6, ,0.1,0.2,AMERICAS,ARQ,Northern America (including Mexico),2016
Mexico,12 - 17,Amphetamines,0.1,Amphetamine,0,0.1,AMERICAS,ARQ,Northern America (including Mexico),2016
Mexico,12 - 17,Amphetamines,0.66,Methamphetamine,,,AMERICAS,ARQ,Northern America (including Mexico),2016
United States of America,(SS) Grade 10,Amphetamines,8.8,Amphetamine,2.7,6.1,AMERICAS,ARQ,Northern America (including Mexico),2016
United States of America,(SS) Grade 10,Amphetamines,0.7,Methamphetamine,0.2,0.4,AMERICAS,ARQ,Northern America (including Mexico),2016
Colombia,18 - 24,Amphetamines,1.06,Amphetamine,0.06,0.27,AMERICAS,Government,South America,2016
Colombia,18 - 24,Amphetamines,0.53,Methamphetamine,0.03,0.13,AMERICAS,Government,South America,2016
Colombia,18 - 24,Amphetamines,0.96,Prescription stimulants,0.17,0.37,AMERICAS,Government,South America,2016
Turks and Caicos Islands,11 - 20,Ecstasy,2.2, ,,1.6,AMERICAS,ARQ,Caribbean,2002
Belize,"(SS) ages 13, 15, & 17",Ecstasy,1.2, ,0.3,0.7,AMERICAS,OAS (MEM),Central America (excluding Mexico),2002
Guyana,12 - 18,Ecstasy,0.9, ,0.3,0.5,AMERICAS,ARQ,South America,2002
Guatemala,12 - 19,Ecstasy,0.32, ,,0.15,AMERICAS,ARQ,Central America (excluding Mexico),2004
Nicaragua,12 - 18,Ecstasy,0.5, ,,,AMERICAS,ARQ,Central America (excluding Mexico),2004
Colombia,12 - 17,Ecstasy,3.3, ,,2.8,AMERICAS,ARQ,South America,2004
Haiti,15 - 16,Ecstasy,3, ,,2,AMERICAS,ARQ,Caribbean,2005
Grenada,15 - 16,Ecstasy,1, ,0.2,0.5,AMERICAS,Govt.,Caribbean,2005
Puerto Rico,(SS) Grades 9 - 12,Ecstasy,2.2,Youth Risk Behavior Survey,,,AMERICAS,Govt.,Caribbean,2005
Antigua and Barbuda,Secondary/ High School,Ecstasy,1.2, ,,,AMERICAS,OAS (MEM),Caribbean,2005
Honduras,12 - 17,Ecstasy,0.24, ,0.05,0.08,AMERICAS,OAS (MEM),Central America (excluding Mexico),2005
Colombia,15 - 16,Ecstasy,4.32, ,1.04,3.68,AMERICAS,CICAD/ OAS,South America,2005
Paraguay,15 - 16,Ecstasy,0.5, ,0.32,0.41,AMERICAS,CICAD/ OAS,South America,2005
Saint Kitts and Nevis,15 - 16,Ecstasy,2.06, ,0.52,0.91,AMERICAS,Govt.,Caribbean,2006
Jamaica,Ages 11 - 19,Ecstasy,3, ,,,AMERICAS,OAS,Caribbean,2006
Barbados,"(SS) ages 13, 15, & 17",Ecstasy,1.8, ,0.4,0.6,AMERICAS,OAS (MEM),Caribbean,2006
Dominica,"(SS) ages 13, 15, & 17",Ecstasy,0.6, ,,,AMERICAS,OAS (MEM),Caribbean,2006
Saint Vincent and the Grenadines,"(SS) ages 13, 15, & 17",Ecstasy,0.54, ,0,0.11,AMERICAS,OAS (MEM),Caribbean,2006
Trinidad and Tobago,"(SS) ages 13, 15, & 17",Ecstasy,0.87, ,,,AMERICAS,OAS (MEM),Caribbean,2006
Peru,15 - 16,Ecstasy,0.285, ,,,AMERICAS,ARQ,South America,2006
Suriname,SS,Ecstasy,1.45, ,,,AMERICAS,CICAD/ OAS,South America,2006
Suriname,Secondary/ High School,Ecstasy,1.2, ,0.2,0.2,AMERICAS,OAS (MEM),South America,2006
Argentina,13 - 17,Ecstasy,2, ,,,AMERICAS,ARQ,South America,2007
Peru,11 - 17,Ecstasy,1.2, ,,0.6,AMERICAS,ARQ,South America,2007
Dominican Republic,12 - 18,Ecstasy,0.5, ,,,AMERICAS,ARQ,Caribbean,2008
Bahamas,15-16,Ecstasy,0.9, ,,0.4,AMERICAS,Govt.,Caribbean,2008
El Salvador,13 - 17,Ecstasy,0.8, ,,,AMERICAS,ARQ,Central America (excluding Mexico),2008
Panama,SS,Ecstasy,1.4, ,0.9,1,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2008
Bolivia (Plurinational State of),13 - 18,Ecstasy,1.6, ,,,AMERICAS,ARQ,South America,2008
Ecuador,12 - 17,Ecstasy,1.3, ,,0.7,AMERICAS,ARQ,South America,2008
Costa Rica,14 - 17,Ecstasy,2.1, ,,,AMERICAS,ARQ,Central America (excluding Mexico),2009
Chile,(SS) 15 - 16,Ecstasy,3.7, ,0.82,1.6,AMERICAS,ARQ,South America,2009
Ecuador,University,Ecstasy,1.18, ,0.1,0.23,AMERICAS,ARQ,South America,2009
Uruguay,13 - 17,Ecstasy,1.2, ,,,AMERICAS,ARQ,South America,2009
Venezuela (Bolivarian Republic of),(SS) 12 - 18,Ecstasy,0.529248300, ,0.206741447,0.266789585,AMERICAS,ARQ,South America,2009
Canada,15 - 19,Ecstasy,6.6, ,,3.5,AMERICAS,ARQ,Northern America (including Mexico),2010
United States of America,Grade 10,Ecstasy,6.4, ,1.9,4.7,AMERICAS,Govt.,Northern America (including Mexico),2010
Brazil,10 - 19,Ecstasy,1.3, ,,,AMERICAS,ARQ,South America,2010
Peru,15-16,Ecstasy,0.114410576, ,,0.114410576,AMERICAS,ARQ,South America,2010
Brazil,University,Ecstasy,7.5, ,1.9,3.1,AMERICAS,CICAD/ OAS,South America,2010
Bahamas,SS,Ecstasy,1.06, ,,,AMERICAS,CICAD/ OAS,Caribbean,2011
Dominica,SS,Ecstasy,2.57, ,,,AMERICAS,CICAD/ OAS,Caribbean,2011
United States of America,Grade 10,Ecstasy,6.6, ,1.6,4.5,AMERICAS,ARQ,Northern America (including Mexico),2011
Argentina,15 - 16,Ecstasy,2.3, ,0.7,1.4,AMERICAS,ARQ,South America,2011
Chile,(SS) 15 - 16,Ecstasy,2.09, ,0.3,1.18,AMERICAS,ARQ,South America,2011
Colombia,11-18,Ecstasy,1.22, ,0.38,0.79,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Ecstasy,0.5, ,0.2,0.3,AMERICAS,ARQ,South America,2011
Costa Rica,15-16,Ecstasy,0.67, ,0.32,0.52,AMERICAS,ARQ,Central America (excluding Mexico),2012
El Salvador,17 - 25,Ecstasy,0.2, ,0,0,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
United States of America,Grade 10,Ecstasy,5, ,1,3,AMERICAS,ARQ,Northern America (including Mexico),2012
Bolivia (Plurinational State of),18 - 24,Ecstasy,0.57, ,0.01,0.01,AMERICAS,ARQ,South America,2012
Colombia,University,Ecstasy,3.15, ,0.21,0.75,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Ecstasy,1.1, ,0.2,0.5,AMERICAS,ARQ,South America,2012
Peru,14 - 16,Ecstasy,1.68, ,0.71,1.09,AMERICAS,ARQ,South America,2012
Ecuador,University,Ecstasy,1.42, ,0.06,0.27,AMERICAS,CICAD/ OAS,South America,2012
Peru,University,Ecstasy,1.09, ,0.08,0.28,AMERICAS,CICAD/ OAS,South America,2012
Peru,11-20,Ecstasy,1.6, ,0.7,1,AMERICAS,DEVIDA,South America,2012
Antigua and Barbuda,SS,Ecstasy,3.73, ,,,AMERICAS,CICAD/ OAS,Caribbean,2013
Barbados,SS,Ecstasy,2.4, ,,,AMERICAS,CICAD/ OAS,Caribbean,2013
Grenada,SS,Ecstasy,1.88, ,,,AMERICAS,CICAD/ OAS,Caribbean,2013
Jamaica,SS,Ecstasy,1.62, ,,,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Kitts and Nevis,SS,Ecstasy,1.45, ,,,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Lucia,SS,Ecstasy,1.78, ,,,AMERICAS,CICAD/ OAS,Caribbean,2013
Saint Vincent and the Grenadines,SS,Ecstasy,0.39, ,,,AMERICAS,CICAD/ OAS,Caribbean,2013
Trinidad and Tobago,SS,Ecstasy,1.55, ,,,AMERICAS,CICAD/ OAS,Caribbean,2013
Panama,18-25,Ecstasy,0.71, ,0.04,0.18,AMERICAS,ARQ,Central America (excluding Mexico),2013
Belize,SS,Ecstasy,2.42, ,,,AMERICAS,CICAD/ OAS,Central America (excluding Mexico),2013
United States of America,Grade 10,Ecstasy,5.7, ,1.2,3.6,AMERICAS,ARQ,Northern America (including Mexico),2013
Bolivia (Plurinational State of),12 - 17,Ecstasy,0.02, ,,0.02,AMERICAS,ARQ,South America,2013
Chile,(SS) 15 - 16,Ecstasy,3.82, ,0.95,2.21,AMERICAS,ARQ,South America,2013
Guyana,SS,Ecstasy,1.69, ,,,AMERICAS,CICAD/ OAS,South America,2013
Haiti,SS,Ecstasy,0.88, ,,,AMERICAS,CICAD/ OAS,Caribbean,2014
United States of America,15 - 16,Ecstasy,3.7, ,0.8,2.3,AMERICAS,ARQ,Northern America (including Mexico),2014
Argentina,15 - 16,Ecstasy,2.4, ,1,1.6,AMERICAS,ARQ,South America,2014
Paraguay,12+,Ecstasy,1,Cities with more than 30000,0.4,0.7,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Ecstasy,1, ,0.2,0.8,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),University,Ecstasy,0.45, ,0.08,0.24,AMERICAS,ARQ,South America,2014
Costa Rica,15 - 16,Ecstasy,1.66, ,,1.66,AMERICAS,ARQ,Central America (excluding Mexico),2015
United States of America,(SS) 15 - 16,Ecstasy,3.8,Monitoring the future,0.9,2.4,AMERICAS,ARQ,Northern America (including Mexico),2015
Chile,(SS) 15 - 16,Ecstasy,4.73, ,1.11,2.57,AMERICAS,ARQ,South America,2015
El Salvador,13 - 17,Ecstasy,1.6, ,0.1,0.3,AMERICAS,ARQ,Caribbean,2016
Mexico,12 - 17,Ecstasy,0.01, ,,,AMERICAS,ARQ,Northern America (including Mexico),2016
United States of America,(SS) Grade 10,Ecstasy,2.8, ,0.5,1.8,AMERICAS,ARQ,Northern America (including Mexico),2016
Bolivia (Plurinational State of),18 - 24,Ecstasy,0.54, ,0.13,0.24,AMERICAS,OAS,South America,2016
Colombia,18 - 24,Ecstasy,4.77, ,0.52,2,AMERICAS,OAS,South America,2016
Ecuador,18 - 24,Ecstasy,1.62, ,0.07,0.43,AMERICAS,OAS,South America,2016
Peru,18 - 24,Ecstasy,0.51, ,0.03,0.06,AMERICAS,OAS,South America,2016
Colombia,12 - 17,Tranquillizers and Sedatives,9.9,Benzodiazepines,,6.3,AMERICAS,,South America,2004
Honduras,SS,Tranquillizers and Sedatives,12.39, ,2.82,4.91,AMERICAS,CICAD/OAS,Central America (excluding Mexico),2005
Paraguay,SS,Tranquillizers and Sedatives,12.3, ,4.7,7.4,AMERICAS,CICAD/OAS,South America,2005
Peru,15 - 16,Tranquillizers and Sedatives,2.171, ,0.161,1.291,AMERICAS,,South America,2006
Suriname,SS,Tranquillizers and Sedatives,10.91, ,3.78,6.35,AMERICAS,CICAD/OAS,South America,2006
Dominican Republic,SS,Tranquillizers and Sedatives,12.81, ,3.22,6.19,AMERICAS,CICAD/OAS,Caribbean,2008
Panama,SS,Tranquillizers and Sedatives,7.4, ,1,1.6,AMERICAS,CICAD/OAS,Central America (excluding Mexico),2008
El Salvador,13 - 17,Tranquillizers and Sedatives,2.8, ,1.3,1.8,AMERICAS,"Segundo Estudio Nacional sobre Consumo de Sustancias Psicoactivas en Población Escolar de El Salvador, 2008.",Central America (excluding Mexico),2008
Bolivia (Plurinational State of),13 - 18,Tranquillizers and Sedatives,14.3,Tranquillizers,3.6,6.9,AMERICAS,Govt.,South America,2008
Costa Rica,14 - 17,Tranquillizers and Sedatives,8,Benzodiazepines,2.6,4.6,AMERICAS,,Central America (excluding Mexico),2009
United States of America,Grade 10,Tranquillizers and Sedatives,7, ,2,5,AMERICAS,,Northern America (including Mexico),2009
United States of America,Grade 10,Tranquillizers and Sedatives,0.7,Benzodiazepines,0.3,0.4,AMERICAS,,Northern America (including Mexico),2009
Argentina,15 - 16,Tranquillizers and Sedatives,4.4, ,1.4,2.7,AMERICAS,,South America,2009
Chile,15 - 16,Tranquillizers and Sedatives,10.54832, ,2.93727,5.27,AMERICAS,,South America,2009
Uruguay,13 - 17,Tranquillizers and Sedatives,6.1, ,1.3,3.4,AMERICAS,,South America,2009
Venezuela (Bolivarian Republic of),12 - 18,Tranquillizers and Sedatives,3.9, ,1.1,2,AMERICAS,,South America,2009
Ecuador,University,Tranquillizers and Sedatives,4.41, ,0.37,1.46,AMERICAS,ARQ,South America,2009
Jamaica,15 - 16,Tranquillizers and Sedatives,3.2,Benzodiazepines,,,AMERICAS,,Caribbean,2010
Brazil,10 - 19,Tranquillizers and Sedatives,5.3,Benzodiazepines,1.3,2.6,AMERICAS,,South America,2010
Peru,15-16,Tranquillizers and Sedatives,0.717, ,0.0605,0.251,AMERICAS,ARQ,South America,2010
Bahamas,SS,Tranquillizers and Sedatives,3.99, ,1.1,1.98,AMERICAS,CICAD/OAS,Caribbean,2011
Dominica,SS,Tranquillizers and Sedatives,11.44, ,1.98,2.84,AMERICAS,CICAD/OAS,Caribbean,2011
United States of America,Grade 10,Tranquillizers and Sedatives,1.2,Benzodiazepines,0.3,0.6,AMERICAS,,Northern America (including Mexico),2011
Mexico, 12 - 17,Tranquillizers and Sedatives,0.4,Benzodiazepines,,0.1,AMERICAS,ARQ,Northern America (including Mexico),2011
Mexico,15 - 16,Tranquillizers and Sedatives,0.1,Barbiturates,,,AMERICAS,ARQ,Northern America (including Mexico),2011
United States of America,Grade 10,Tranquillizers and Sedatives,6.8, ,2.2,4.5,AMERICAS,ARQ,Northern America (including Mexico),2011
Argentina,15 - 16,Tranquillizers and Sedatives,5.2, ,0.7,2.7,AMERICAS,ARQ,South America,2011
Argentina,16 - 24,Tranquillizers and Sedatives,2.5, ,,,AMERICAS,ARQ,South America,2011
Chile,15 - 16,Tranquillizers and Sedatives,16.2, ,2.92,7.62,AMERICAS,ARQ,South America,2011
Colombia,11-18,Tranquillizers and Sedatives,1.09, ,0.37,0.78,AMERICAS,ARQ,South America,2011
Uruguay,13 - 17,Tranquillizers and Sedatives,7.6, ,,3.8,AMERICAS,ARQ,South America,2011
Venezuela (Bolivarian Republic of),15-17,Tranquillizers and Sedatives,4.21, ,,,AMERICAS,ARQ,South America,2011
Costa Rica,15 - 16,Tranquillizers and Sedatives,4.8, ,1.3,2.4,AMERICAS,,Central America (excluding Mexico),2012
Costa Rica,15-16,Tranquillizers and Sedatives,5.64, ,1.64,3.19,AMERICAS,ARQ,Central America (excluding Mexico),2012
El Salvador,17 - 25,Tranquillizers and Sedatives,7.5, ,0.4,2.1,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
El Salvador,17 - 25,Tranquillizers and Sedatives,7.5,Benzodiazepines,0.4,2.1,AMERICAS,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Central America (excluding Mexico),2012
United States of America,Grade 10,Tranquillizers and Sedatives,6.3, ,1.7,4.3,AMERICAS,ARQ,Northern America (including Mexico),2012
Colombia,University,Tranquillizers and Sedatives,3.34, ,0.64,1.43,AMERICAS,ARQ,South America,2012
Ecuador,12 - 17,Tranquillizers and Sedatives,5.4, ,1.4,2.9,AMERICAS,ARQ,South America,2012
Peru,14 - 16,Tranquillizers and Sedatives,4.64, ,1.45,2.55,AMERICAS,ARQ,South America,2012
Peru,11-20,Tranquillizers and Sedatives,4, ,1.3,2.3,AMERICAS,DEVIDA,South America,2012
Antigua and Barbuda,SS,Tranquillizers and Sedatives,3.98, ,1.42,1.96,AMERICAS,CICAD/OAS,Caribbean,2013
Barbados,SS,Tranquillizers and Sedatives,3.02, ,0.88,1.92,AMERICAS,CICAD/OAS,Caribbean,2013
Grenada,SS,Tranquillizers and Sedatives,4, ,1.85,3.01,AMERICAS,CICAD/OAS,Caribbean,2013
Jamaica,SS,Tranquillizers and Sedatives,3.24, ,0.96,1.74,AMERICAS,CICAD/OAS,Caribbean,2013
Saint Kitts and Nevis,SS,Tranquillizers and Sedatives,3.85, ,1.3,2.57,AMERICAS,CICAD/OAS,Caribbean,2013
Saint Lucia,SS,Tranquillizers and Sedatives,4.78, ,2.02,3.09,AMERICAS,CICAD/OAS,Caribbean,2013
Saint Vincent and the Grenadines,SS,Tranquillizers and Sedatives,1.95, ,0.83,1.09,AMERICAS,CICAD/OAS,Caribbean,2013
Trinidad and Tobago,SS,Tranquillizers and Sedatives,2.87, ,0.91,1.52,AMERICAS,CICAD/OAS,Caribbean,2013
Panama,18-25,Tranquillizers and Sedatives,3.2, ,0.3,1.1,AMERICAS,ARQ,Central America (excluding Mexico),2013
Belize,SS,Tranquillizers and Sedatives,4.68, ,1.49,2.72,AMERICAS,CICAD/OAS,Central America (excluding Mexico),2013
Bolivia (Plurinational State of),12 - 17,Tranquillizers and Sedatives,1.4,Benzodiazepines,,,AMERICAS,ARQ,South America,2013
Chile,15 - 16,Tranquillizers and Sedatives,16.39,Benzodiazepines,3.96,9.96,AMERICAS,ARQ,South America,2013
Guyana,SS,Tranquillizers and Sedatives,3.31, ,0.95,1.43,AMERICAS,CICAD/OAS,South America,2013
Haiti,SS,Tranquillizers and Sedatives,11.21, ,4.36,6.46,AMERICAS,CICAD/OAS,Caribbean,2014
Guatemala,11 - 22,Tranquillizers and Sedatives,7, ,1.81,2.79,AMERICAS,ARQ,Central America (excluding Mexico),2014
Honduras,15 - 16,Tranquillizers and Sedatives,14.8,Benzodiazepines,3.2,6,AMERICAS,ARQ,Central America (excluding Mexico),2014
Mexico,15 - 16,Tranquillizers and Sedatives,3.7, ,1.3,2.6,AMERICAS,ARQ,Northern America (including Mexico),2014
United States of America,SS,Tranquillizers and Sedatives,5.3, ,1.5,3.4,AMERICAS,CICAD/OAS,Northern America (including Mexico),2014
Argentina,15 - 16,Tranquillizers and Sedatives,5.2, ,1.5,2.9,AMERICAS,ARQ,South America,2014
Paraguay,12+,Tranquillizers and Sedatives,6.1,Cities with more than 30000,2,3.6,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Tranquillizers and Sedatives,6.1, ,,3.1,AMERICAS,ARQ,South America,2014
Uruguay,13 - 17,Tranquillizers and Sedatives,6.1,Hide,,3.1,AMERICAS,ARQ,South America,2014
Venezuela (Bolivarian Republic of),University,Tranquillizers and Sedatives,5.3, ,0.8,2.7,AMERICAS,ARQ,South America,2014
Costa Rica,15 - 16,Tranquillizers and Sedatives,0.09,Benzodiazepines,,0.09,AMERICAS,ARQ,Central America (excluding Mexico),2015
Costa Rica,15-16,Tranquillizers and Sedatives,4.8, ,1.52,2.78,AMERICAS,ARQ,Central America (excluding Mexico),2015
Honduras,14-17,Tranquillizers and Sedatives,8.3, ,1.9,4.2,AMERICAS,ARQ,Central America (excluding Mexico),2015
Chile,(SS) 15 - 16,Tranquillizers and Sedatives,16.9, ,3.66,9.97,AMERICAS,ARQ,South America,2015
Chile,(SS) 15 - 16,Tranquillizers and Sedatives,16.9,Benzodiazepines,3.66,9.97,AMERICAS,ARQ,South America,2015
El Salvador,13 - 17,Tranquillizers and Sedatives,4.8, ,1,1.9,AMERICAS,ARQ,Central America (excluding Mexico),2016
Mexico,12 - 17,Tranquillizers and Sedatives,0.4, ,0,0.3,AMERICAS,ARQ,Northern America (including Mexico),2016
Colombia,18 - 24,Tranquillizers and Sedatives,4.98, ,0.58,1.81,AMERICAS,Government,South America,2016
Jordan,18 - 25,Amphetamines,,Unversity students,,2.6,ASIA,ARQ,Near and Middle East /South-West Asia,2001
Lebanon,15 - 16,Amphetamines,,Rapid Situation Assesment,,0.5,ASIA,ARQ,Near and Middle East /South-West Asia,2001
Thailand,Youth (undefined),Amphetamines,,Methamphetamine; Ages not specified,,2.4,ASIA,ARQ,East and South-East Asia,2003
Myanmar,13 - 21,Amphetamines,0.4,Methamphetamine; Yangon,,0.2,ASIA,ARQ,East and South-East Asia,2004
"China, Taiwan Province of China",(SS) Grades 10 & 12,Amphetamines,0.05,Methamphetamine,,,ASIA,Govt.,East and South-East Asia,2006
Kazakhstan,Youth (undefined),Amphetamines,0.8,Ages not specified,,,ASIA,ARQ,Central Asia and Transcaucasia,2007
Kazakhstan,Youth (undefined),Amphetamines,0.5,Amphetamine; Ages not specified,,,ASIA,ARQ,Central Asia and Transcaucasia,2007
Armenia,15 - 16,Amphetamines,0, ,,,ASIA,ESPAD,Central Asia and Transcaucasia,2007
"China, Hong Kong SAR",11 - 20,Amphetamines,, ,,0.108,ASIA,,East and South-East Asia,2007
Israel,(SS) Grade 10,Amphetamines,,Amphetamine,,2.1,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,(SS) Grade 10,Amphetamines,,Cathinone (hagigat),,6.8,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,12 - 18,Amphetamines,4.38,Amphetamine,2.73,3.27,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,12 - 18,Amphetamines,,Other stimulants,,8.3,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Georgia,(SS) 15 - 16,Amphetamines,1.9,Amphetamine; select regions (capital); Georgian Medical News No3 (180) 2010,,,ASIA,Research,Central Asia and Transcaucasia,2010
Indonesia,10 - 19,Amphetamines,0.25, ,0.11,0.11,ASIA,ARQ,East and South-East Asia,2010
Japan,13 - 15,Amphetamines,0.3, ,,,ASIA,ARQ,East and South-East Asia,2010
Israel,(SS) 15 - 16,Amphetamines,1.9,Methamphetamine,,,ASIA,ARQ,Near and Middle East /South-West Asia,2010
Israel,(SS) 15 - 16,Amphetamines,,Other stimulants,0.9,,ASIA,ARQ,Near and Middle East /South-West Asia,2010
"China, Hong Kong SAR",15 - 16,Amphetamines,,Amphetamine,,0.072,ASIA,ARQ,East and South-East Asia,2011
"China, Hong Kong SAR",15 - 16,Amphetamines,,Methamphetamine,,0.069,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 - 19,Amphetamines,0.2,Amphetamine,0.1,0.17,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 - 19,Amphetamines,0.21,Amphetamine,0.35,0.32,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 - 19,Amphetamines,0.3,Methamphetamine,0.2,0.26,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 - 19,Amphetamines,0.35,Methamphetamine,0.45,0.45,ASIA,ARQ,East and South-East Asia,2011
Japan,(SS) 15 - 16,Amphetamines,0.2,Methamphetamine,,,ASIA,ARQ,East and South-East Asia,2011
Kazakhstan,16 - 21,Amphetamines,1,Amphetamine,,,ASIA,ARQ,Central Asia and Transcaucasia,2012
Kazakhstan,16 - 21,Amphetamines,0.6,Prescription stimulants,,,ASIA,ARQ,Central Asia and Transcaucasia,2012
Kazakhstan,"16, 19 and 21",Amphetamines,1,Amphetamine . 6 regions and 2 cities,,,ASIA,ARQ,Central Asia and Transcaucasia,2012
Kazakhstan,"16, 19 and 21",Amphetamines,0.6,Prescription stimulants. 6 regions and 2 cities.,,,ASIA,ARQ,Central Asia and Transcaucasia,2012
Japan,(SS) 15 - 16,Amphetamines,0.2,Methamphetamine,,,ASIA,ARQ,East and South-East Asia,2012
"China, Hong Kong SAR",11 - 20,Amphetamines,, ,,0.05,ASIA,ARQ,East and South-East Asia,2013
"China, Hong Kong SAR",11 - 20,Amphetamines,,Methamphetamine,,0.05,ASIA,ARQ,East and South-East Asia,2013
Japan,(SS) 15 - 16,Amphetamines,0.2,Methamphetamine,,,ASIA,ARQ,East and South-East Asia,2013
"China, Hong Kong SAR",11 - 20,Amphetamines,,Central Registry,,0.04,ASIA,ARQ,East and South-East Asia,2014
"China, Hong Kong SAR",11 - 20,Amphetamines,,Methamphetamine,,0.04,ASIA,ARQ,East and South-East Asia,2014
Japan,(SS) 15 - 16,Amphetamines,0.2,Methamphetamine,,,ASIA,ARQ,East and South-East Asia,2014
Israel,(SS) 15 - 16,Amphetamines,,Prescription stimulants - Ritalin,3.2,,ASIA,ARQ,Near and Middle East /South-West Asia,2014
Georgia,(SS) 15 - 16,Amphetamines,3,Amphetamine,,1.1,ASIA,ARQ / ESPAD,Central Asia and Transcaucasia,2015
Georgia,(SS) 15 - 16,Amphetamines,1.1,Methamphetamine,,0.7,ASIA,ARQ / ESPAD,Central Asia and Transcaucasia,2015
"China, Hong Kong SAR",11 - 20,Amphetamines,,Central registry of drug abuse,,0.04,ASIA,ARQ,East and South-East Asia,2015
"China, Hong Kong SAR",11 - 20,Amphetamines,,Methamphetamine,,0.04,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10.-25,Amphetamines,0.42,20 provinces,,0.19,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10.-25,Amphetamines,0.02,Amphetamine. 20 provinces,,0.02,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10.-25,Amphetamines,0.3,Methamphetamine. 20 provinces,,0.15,ASIA,ARQ,East and South-East Asia,2015
China,15 - 16,Amphetamines,, ,,81.1,ASIA,ARQ,East and South-East Asia,2016
Japan,(SS) 15 - 16,Amphetamines,0.3,Methamphetamine,,,ASIA,ARQ,East and South-East Asia,2016
Thailand,Youth (undefined),Ecstasy,0.3,Ages not specified,,,ASIA,ARQ,East and South-East Asia,2003
"China, Taiwan Province of China",(SS) Grades 10 & 12,Ecstasy,0.52, ,,,ASIA,Govt.,East and South-East Asia,2006
Kazakhstan, ,Ecstasy,0.3, ,,,ASIA,ARQ,Central Asia  and Transcaucasia,2007
Armenia,15 - 16,Ecstasy,1, ,,,ASIA,ESPAD,Central Asia  and Transcaucasia,2007
Israel,(SS) Grade 10,Ecstasy,, ,,2.6,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Israel,12 - 18,Ecstasy,3.63, ,2.8,3.1,ASIA,ARQ,Near and Middle East /South-West Asia,2009
Lebanon,(SS) 15 - 16,Ecstasy,3.9, ,,,ASIA,MedSPAD,Near and Middle East /South-West Asia,2009
Georgia,(SS) 15 - 16,Ecstasy,7.5,Select regions (capital);  Georgian Medical News No3 (180) 2010,1.4,4.5,ASIA,Research,Central Asia  and Transcaucasia,2010
Israel,(SS) 15 - 16,Ecstasy,, ,,4.5,ASIA,ARQ,Near and Middle East /South-West Asia,2010
"China, Hong Kong SAR",15 - 16,Ecstasy,0.008, ,,,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 -19,Ecstasy,0.4, ,0.2,0.34,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 -19,Ecstasy,0.29, ,0.43,0.37,ASIA,ARQ,East and South-East Asia,2011
Kazakhstan,"16, 19 and 21",Ecstasy,2.3, ,0.7,1,ASIA,ARQ,Central Asia  and Transcaucasia,2012
Georgia,(SS) 15 - 16,Ecstasy,4.4, ,,2.7,ASIA,ARQ / ESPAD,Central Asia  and Transcaucasia,2015
Indonesia,10.-25,Ecstasy,0.15,20 provinces,,0.02,ASIA,ARQ,East and South-East Asia,2015
Israel,12 - 18,Tranquillizers and Sedatives,9,Benzodiazepines,4.29,5.99,ASIA,,Near and Middle East /South-West Asia,2009
Indonesia,10 - 19,Tranquillizers and Sedatives,0.11,Benzodiazepines,0.02,0.04,ASIA,,East and South-East Asia,2010
Indonesia,15 -19,Tranquillizers and Sedatives,40,Benzodiazepines,0.1,0.34,ASIA,,East and South-East Asia,2011
"China, Hong Kong SAR",15 - 16,Tranquillizers and Sedatives,, ,,0.01,ASIA,ARQ,East and South-East Asia,2011
"China, Hong Kong SAR",15 - 16,Tranquillizers and Sedatives,,Benzodiazepines,,0.01,ASIA,ARQ,East and South-East Asia,2011
Indonesia,15 -19,Tranquillizers and Sedatives,0.1,Barbiturates,0.1,0.09,ASIA,ARQ,East and South-East Asia,2011
Kazakhstan,16 - 21,Tranquillizers and Sedatives,0.6,Other sedatives and tranquillizers,,,ASIA,ARQ,Central Asia  and Transcaucasia,2012
Kazakhstan,16 - 24,Tranquillizers and Sedatives,2.1, ,,,ASIA,ARQ,Central Asia  and Transcaucasia,2012
Kazakhstan,"16, 19 and 21",Tranquillizers and Sedatives,1.5, ,,,ASIA,ARQ,Central Asia  and Transcaucasia,2012
Georgia,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,ASIA,ESPAD,Central Asia  and Transcaucasia,2015
Indonesia,10.-25,Tranquillizers and Sedatives,0.21, ,,0.11,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10.-25,Tranquillizers and Sedatives,0.17, ,,0.15,ASIA,ARQ,East and South-East Asia,2015
Indonesia,10.-25,Tranquillizers and Sedatives,0.06,Barbiturates. 20 provincies,,0,ASIA,ARQ,East and South-East Asia,2015
Luxembourg,11 - 17,Amphetamines,3.7, ,,2.2,EUROPE,,Western and Central Europe,1999
Turkey,(SS) 15 - 16,Amphetamines,1.9, ,,0.8,EUROPE,ESPAD,South-Eastern Europe,2003
Greenland,(SS) 15 - 16,Amphetamines,0, ,,0,EUROPE,ESPAD,Western and Central Europe,2003
Albania,14 - 19,Amphetamines,4.9, ,,,EUROPE,ARQ,South-Eastern Europe,2004
Liechtenstein,12 - 16,Amphetamines,1.1, ,,0.4,EUROPE,ARQ,Western and Central Europe,2005
Liechtenstein,12 - 19,Amphetamines,1.1,Amphetamine,,0.8,EUROPE,ARQ,Western and Central Europe,2005
Russian Federation,15 - 16,Amphetamines,1.3,Amphetamine,,,EUROPE,ARQ/ ESPAD,Eastern Europe,2007
Ukraine,(SS) 15 - 16,Amphetamines,1, ,,,EUROPE,ESPAD,Eastern Europe,2007
Croatia,16,Amphetamines,1.7,Amphetamine,,,EUROPE,ARQ,South-Eastern Europe,2007
Romania,(SS) 16,Amphetamines,0.6,Amphetamine,,,EUROPE,ESPAD,South-Eastern Europe,2007
Cyprus,(SS) 16,Amphetamines,3,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2007
Denmark,(SS) 15 - 16,Amphetamines,5, ,,,EUROPE,ARQ,Western and Central Europe,2007
Estonia,(SS) 15 - 16,Amphetamines,3.8, ,,,EUROPE,ARQ,Western and Central Europe,2007
Finland,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2007
Germany,(SS) 15 - 16,Amphetamines,5.8,Amphetamine. Select regions,,,EUROPE,ARQ,Western and Central Europe,2007
Hungary,(SS) 15 - 16,Amphetamines,3.5,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2007
Latvia,15 - 16,Amphetamines,5.6,Amphetamine,,3.7,EUROPE,ARQ,Western and Central Europe,2007
Malta,(SS) 15 - 16,Amphetamines,5.2,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2007
Netherlands,12 - 18,Amphetamines,1.9,Amphetamine,0.8,,EUROPE,ARQ,Western and Central Europe,2007
Slovenia,15 - 16,Amphetamines,2.2,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2007
Czechia,(SS) 15 - 16,Amphetamines,3.5,Methamphetamine,,2.1,EUROPE,ARQ./ ESPAD,Western and Central Europe,2007
Austria,(SS) 15 - 16,Amphetamines,7.7,May include non-ATS stimulants,,,EUROPE,ESPAD,Western and Central Europe,2007
Cyprus,(SS) 15 - 16,Amphetamines,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Faroe Islands,(SS) 15 - 16,Amphetamines,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
France,(SS) 15 - 16,Amphetamines,4, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Greece,(SS) 15 - 16,Amphetamines,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Iceland,(SS) 15 - 16,Amphetamines,4, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Ireland,(SS) 15 - 16,Amphetamines,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Lithuania,(SS) 15 - 16,Amphetamines,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Netherlands,(SS) 15 - 16,Amphetamines,2, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Norway,(SS) 15 - 16,Amphetamines,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Portugal,(SS) 16,Amphetamines,2.5, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Slovenia,(SS) 16,Amphetamines,2.3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Switzerland,15 - 16,Amphetamines,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Republic of Moldova,(SS) 15 - 16,Amphetamines,1.5, ,,,EUROPE,ESPAD,Eastern Europe,2008
Bosnia and Herzegovina,(SS) 15 - 16,Amphetamines,, ,,4,EUROPE,ARQ,South-Eastern Europe,2008
Bulgaria,14 - 19,Amphetamines,10.4, ,3.8,6.7,EUROPE,ARQ,South-Eastern Europe,2008
Bulgaria,14 - 19,Amphetamines,8.5,Amphetamine,3.1,5.4,EUROPE,ARQ,South-Eastern Europe,2008
Bulgaria,14 - 19,Amphetamines,2.6,Methamphetamine,1.3,1.5,EUROPE,ARQ,South-Eastern Europe,2008
Serbia,16,Amphetamines,1.5,Stimulants (inclds Amphetamines),,,EUROPE,ARQ,South-Eastern Europe,2008
Montenegro,(SS) 15 - 16,Amphetamines,1, ,,,EUROPE,ESPAD,South-Eastern Europe,2008
Gibraltar,12 - 18,Amphetamines,, ,,0.2,EUROPE,ARQ,Western and Central Europe,2008
Germany,12 - 25,Amphetamines,2.7,Amphetamine,0.4,1,EUROPE,Govt.,Western and Central Europe,2008
Belgium,(SS) 15 - 16,Amphetamines,,Select regions (Flanders),,1.4,EUROPE,ARQ,Western and Central Europe,2009
Sweden,(SS) 15 - 16,Amphetamines,1, ,,1,EUROPE,ARQ,Western and Central Europe,2009
Republic of Moldova,(SS) 15 - 24,Amphetamines,0.1,Amphetamine,0.1,0.1,EUROPE,Govt.,Eastern Europe,2010
Belgium,15 - 16,Amphetamines,2.77,Amphetamine,,1.33,EUROPE,ARQ,Western and Central Europe,2010
Italy,(SS) 15 - 16,Amphetamines,0.8,Amphetamine,0.3,0.5,EUROPE,ARQ,Western and Central Europe,2010
Latvia,School survey,Amphetamines,3.8,Riga City,1.7,2.7,EUROPE,ARQ,Western and Central Europe,2010
Luxembourg,12 - 18,Amphetamines,1.4, ,,1.1,EUROPE,ARQ,Western and Central Europe,2010
Netherlands,12 - 18,Amphetamines,1.8,Amphetamine,0.6,,EUROPE,ARQ,Western and Central Europe,2010
Poland,18 - 19,Amphetamines,7,Amphetamine,2,3,EUROPE,ARQ,Western and Central Europe,2010
Slovakia,(SS) 15 - 16,Amphetamines,1.4,Methamphetamine,0.5,0.8,EUROPE,ARQ,Western and Central Europe,2010
Spain,14 - 18,Amphetamines,2.6,Amphetamine,0.9,1.6,EUROPE,ARQ,Western and Central Europe,2010
Spain,14 -18,Amphetamines,0.8,Methamphetamine,0.4,0.6,EUROPE,ARQ,Western and Central Europe,2010
United Kingdom (England),15,Amphetamines,2.1,Amphetamines,0.6,1.7,EUROPE,ARQ,Western and Central Europe,2010
Russian Federation,15-16,Amphetamines,3,Amphetamine,,,EUROPE,ARQ,Eastern Europe,2011
Ukraine, 15 - 17,Amphetamines,2,Amphetamine,,,EUROPE,ARQ,Eastern Europe,2011
Bosnia and Herzegovina,(SS) 15 - 16,Amphetamines,0.9,Amphetamine,,,EUROPE,ARQ,South-Eastern Europe,2011
Romania,15 -16,Amphetamines,1.7,Amphetamine,,,EUROPE,ARQ,South-Eastern Europe,2011
Bulgaria,(SS) 15 - 16,Amphetamines,8.4,Amphetamine,,,EUROPE,ESPAD,South-Eastern Europe,2011
Bulgaria,(SS) 15 - 16,Amphetamines,3.3,Methamphetamine,,,EUROPE,ESPAD,South-Eastern Europe,2011
Serbia,(SS) 15 - 16,Amphetamines,1.7,Amphetamine,,,EUROPE,ESPAD,South-Eastern Europe,2011
Belgium,(SS) 15 - 16,Amphetamines,2.1,Amphetamine,,0.6,EUROPE,ARQ,Western and Central Europe,2011
Czechia,(SS) 15 - 16,Amphetamines,1.9,Methamphetamine,0.5,1.2,EUROPE,ARQ,Western and Central Europe,2011
Denmark,(SS) 15 - 16,Amphetamines,2.5, ,,,EUROPE,ARQ,Western and Central Europe,2011
Estonia,(SS) 15 - 19,Amphetamines,2.8,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2011
Finland,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2011
Finland,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2011
France,17,Amphetamines,2.4,Amphetamine,,1.9,EUROPE,ARQ,Western and Central Europe,2011
Germany, 12 - 17,Amphetamines,,Amphetamine,,0.4,EUROPE,ARQ,Western and Central Europe,2011
Germany,(SS) 15 - 16,Amphetamines,6,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2011
Greece,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2011
Ireland,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2011
Liechtenstein,(SS) 15 - 16,Amphetamines,5, ,,,EUROPE,ARQ,Western and Central Europe,2011
Lithuania,(SS) 15 - 16,Amphetamines,2.8,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2011
Netherlands,(SS) 15 - 16,Amphetamines,1.8,Amphetamine,0.6,,EUROPE,ARQ,Western and Central Europe,2011
Portugal,(SS) 15 - 16,Amphetamines,3, ,,,EUROPE,ARQ,Western and Central Europe,2011
Slovenia,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2011
United Kingdom (England),15,Amphetamines,1.9, ,0.9,1.8,EUROPE,ARQ,Western and Central Europe,2011
Cyprus,15-  16,Amphetamines,4,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2011
Iceland,(SS) 15 - 16,Amphetamines,3,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2011
Latvia,15 - 16,Amphetamines,3.8,Amphetamine,1.6,2.7,EUROPE,ESPAD,Western and Central Europe,2011
Malta,(SS) 15 - 16,Amphetamines,3,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2011
Malta,(SS) 15 - 16,Amphetamines,3.5,Mephedrone,,,EUROPE,ESPAD,Western and Central Europe,2011
Norway,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2011
Republic of Moldova,(SS) 15 - 24,Amphetamines,0.1,Amphetamine,,0.1,EUROPE,ARQ,Eastern Europe,2012
Republic of Moldova,(SS) 15 - 24,Amphetamines,,Methamphetamine,0.1,,EUROPE,ARQ,Eastern Europe,2012
Belgium,(SS) 15 - 16,Amphetamines,1.8,Amphetamine,,0.8,EUROPE,ARQ,Western and Central Europe,2012
Cyprus,15 - 24,Amphetamines,0.4,Amphetamine,0.2,0.3,EUROPE,ARQ,Western and Central Europe,2012
Germany,(SS) 15 - 18,Amphetamines,1,Methamphetamine. Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2012
Italy,(SS) 15 - 19,Amphetamines,1.1, ,0.38,0.71,EUROPE,ARQ,Western and Central Europe,2012
Italy,(SS) 15 - 19,Amphetamines,0.57,Amphetamine,0.2,0.35,EUROPE,ARQ,Western and Central Europe,2012
Poland,(SS) 15 - 16,Amphetamines,4.6,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Amphetamines,2.4,Amphetamine,1,1.7,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 -18,Amphetamines,0.9,Methamphetamine,0.4,0.7,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Amphetamines,1.8, ,0.5,1.7,EUROPE,ARQ,Western and Central Europe,2012
Russian Federation,0 - 18,Amphetamines,0.0003,Other stimulants,,,EUROPE,ARQ,Eastern Europe,2013
Bulgaria,15 - 16,Amphetamines,7.9, ,3.2,5.6,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,15 - 16,Amphetamines,6.4,Amphetamine,2.3,4.3,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,15 - 16,Amphetamines,4.2,Methamphetamine,1.9,3.2,EUROPE,ARQ,South-Eastern Europe,2013
Denmark,(SS) 15 - 16,Amphetamines,2.5, ,,,EUROPE,ARQ,Western and Central Europe,2013
Estonia,"(SS) 6, 8, 12 grades",Amphetamines,0.9,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2013
Estonia,"(SS) 6, 8, 12 grades",Amphetamines,0.4,Methamphetamine,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Amphetamines,6, ,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Amphetamines,2, ,6,,EUROPE,ARQ,Western and Central Europe,2013
Germany,(SS) 15 - 18,Amphetamines,1,Methamphetamine. Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 19,Amphetamines,1.14, ,0.42,0.74,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 19,Amphetamines,0.6,Amphetamine,0.21,0.36,EUROPE,ARQ,Western and Central Europe,2013
Poland,(SS) 15 - 16,Amphetamines,6.9,Amphetamine,1.7,3.4,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Amphetamines,1,Amphetamine,0.3,0.8,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (Scotland),(SS) 15,Amphetamines,1,Amphetamines,1,1,EUROPE,Govt.,Western and Central Europe,2013
France,17,Amphetamines,2.3,Amphetamine.  Urban areas (excluding overseas departments),,1.3,EUROPE,ARQ,Western and Central Europe,2014
Germany,(SS) 15 - 18,Amphetamines,5, Region Frankfurt am Main,1,,EUROPE,ARQ,Western and Central Europe,2014
Germany,(SS) 15 - 18,Amphetamines,0,Methamphetamine. Region Frankfurt am Main,1,,EUROPE,ARQ,Western and Central Europe,2014
Germany,(SS) 15 - 18,Amphetamines,4,Speed. Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2014
Italy,(SS) 15 - 17,Amphetamines,1.9,Female,0.8,1.3,EUROPE,ARQ,Western and Central Europe,2014
Italy,(SS) 15 - 17,Amphetamines,3.3,Male,1.7,2.5,EUROPE,ARQ,Western and Central Europe,2014
Netherlands,(SS) 15 - 16,Amphetamines,1.8,Amphetamine,,0.6,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Amphetamines,1.4,Amphetamine,0.5,0.9,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Amphetamines,0.8,Methamphetamine,0.3,0.5,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Amphetamines,0.8,Amphetamine. Female,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Amphetamines,0.7,Amphetamine. Male,,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS) 15 - 16,Amphetamines,1.1,Amphetamine. Female,,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS) 15 - 16,Amphetamines,1.3,Amphetamine. Male,,,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),(SS) 15,Amphetamines,1.5,Amphetamine,0.6,1.1,EUROPE,ARQ,Western and Central Europe,2014
Ukraine,16 -17,Amphetamines,,Amphetamine,,0,EUROPE,ARQ,Eastern Europe,2015
Republic of Moldova,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ESPAD,Eastern Europe,2015
Republic of Moldova,(SS) 15 - 16,Amphetamines,0,Methamphetamine,,,EUROPE,ESPAD,Eastern Europe,2015
Montenegro,(SS) 16,Amphetamines,3,Amphetamine,,2,EUROPE,ARQ,South-Eastern Europe,2015
Montenegro,(SS) 16,Amphetamines,2,Methamphetamine,,1,EUROPE,ARQ,South-Eastern Europe,2015
Romania,(SS) 16,Amphetamines,1.1,Amphetamine,,,EUROPE,ARQ,South-Eastern Europe,2015
Romania,(SS) 16,Amphetamines,1,Methamphetamine,,,EUROPE,ARQ,South-Eastern Europe,2015
Albania,(SS) 15 - 16,Amphetamines,1.5,Amphetamine,,1.4,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Albania,(SS) 15 - 16,Amphetamines,1.6,Methamphetamine,,1.5,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Bulgaria,(SS) 15 - 16,Amphetamines,8.6,Amphetamine,,7.4,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Bulgaria,(SS) 15 - 16,Amphetamines,6.9,Methamphetamine,,6.2,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Croatia,(SS) 15 - 16,Amphetamines,3,Amphetamine,,,EUROPE,ESPAD,South-Eastern Europe,2015
Croatia,(SS) 15 - 16,Amphetamines,1,Methamphetamine,,,EUROPE,ESPAD,South-Eastern Europe,2015
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ESPAD,South-Eastern Europe,2015
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Amphetamines,1,Methamphetamine,,,EUROPE,ESPAD,South-Eastern Europe,2015
Germany,(SS) 15 - 16,Amphetamines,,Amphetamine.   Region Frankfurt am Main,,0.3,EUROPE,ARQ,Western and Central Europe,2015
Germany,(SS) 15 - 16,Amphetamines,0.5,Methamphetamine. Region Frankfurt am Main,,0,EUROPE,ARQ,Western and Central Europe,2015
Germany,(SS) 15 - 16,Amphetamines,6,Speed. Region Frankfurt am Main,2,,EUROPE,ARQ,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Amphetamines,1.9,Amphetamine,,1.3,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15 - 19,Amphetamines,3.8, ,1.6,2.6,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15 - 19,Amphetamines,1.8,Amphetamine,0.9,1.3,EUROPE,ARQ,Western and Central Europe,2015
Latvia,(SS) 19,Amphetamines,2.9,Amphetamine,,1.5,EUROPE,ARQ,Western and Central Europe,2015
Latvia,(SS) 19,Amphetamines,2.4,Methamphetamine,,1,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS) 15 - 16,Amphetamines,1.8, ,,,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS) 15 - 16,Amphetamines,1.5,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS) 15 - 16,Amphetamines,0.3,Methamphetamine,,,EUROPE,ARQ,Western and Central Europe,2015
Lithuania,(SS) 15 - 16,Amphetamines,1.2,Amphetamine,,0.9,EUROPE,ARQ,Western and Central Europe,2015
Lithuania,(SS) 15 - 16,Amphetamines,1.4,Methamphetamine,,0.8,EUROPE,ARQ,Western and Central Europe,2015
Portugal,(SS) 15-16,Amphetamines,1,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2015
Portugal,(SS) 15-16,Amphetamines,1,Methamphetamine,,,EUROPE,ARQ,Western and Central Europe,2015
Slovakia,(SS) 15 - 16,Amphetamines,1.3,Amphetamine,,0.7,EUROPE,ARQ,Western and Central Europe,2015
Slovakia,(SS) 15 - 16,Amphetamines,3.4,Amphetamine type stimulants,,1.9,EUROPE,ARQ,Western and Central Europe,2015
Slovakia,(SS) 15 - 16,Amphetamines,2.1,Methamphetamine,,1.2,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Amphetamines,0.6,Amphetamine. Female,,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Amphetamines,0.7,Amphetamine. Male,,,EUROPE,ARQ,Western and Central Europe,2015
Finland,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ARQ (ESPAD),Western and Central Europe,2015
Finland,(SS) 15 - 16,Amphetamines,0,Methamphetamine,,,EUROPE,ARQ (ESPAD),Western and Central Europe,2015
Austria,(SS) 15 - 16,Amphetamines,2.7,Amphetamine,,1.8,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Czechia,(SS) 15 - 16,Amphetamines,0.9,Amphetamine,0.2,0.4,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Denmark,(SS) 15 - 16,Amphetamines,0.9,Amphetamine,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Amphetamines,1.7,Amphetamine,,1.1,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Netherlands,(SS) 12 - 16,Amphetamines,1.1,Amphetamine,0.6,0.9,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Austria,(SS) 15 - 16,Amphetamines,1,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Belgium,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Belgium,(SS) 15 - 16,Amphetamines,1,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 16,Amphetamines,3,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 16,Amphetamines,2,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Czechia,(SS) 15 - 16,Amphetamines,1,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Denmark,(SS) 15 - 16,Amphetamines,0,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Estonia,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Faroe Islands,(SS) 15 - 16,Amphetamines,0,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Faroe Islands,(SS) 15 - 16,Amphetamines,0,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
France,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
France,(SS) 15 - 16,Amphetamines,2,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Greece,(SS) 15 - 16,Amphetamines,1.55,Amphetamine,,1.15,EUROPE,ESPAD,Western and Central Europe,2015
Greece,(SS) 15 - 16,Amphetamines,0.94,Methamphetamine,,0.65,EUROPE,ESPAD,Western and Central Europe,2015
Hungary,(SS) 15 - 16,Amphetamines,4.2,Amphetamine. ESPAD,,2.5,EUROPE,ESPAD,Western and Central Europe,2015
Hungary,(SS) 15 - 16,Amphetamines,2.9,Methamphetamine. ESPAD,,1.6,EUROPE,ESPAD,Western and Central Europe,2015
Iceland,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Iceland,(SS) 15 - 16,Amphetamines,1,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Amphetamines,3,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Amphetamines,2,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Amphetamines,1,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Monaco,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Monaco,(SS) 15 - 16,Amphetamines,2,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Netherlands,(SS) 15 - 16,Amphetamines,2,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Netherlands,(SS) 15 - 16,Amphetamines,1,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Norway,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,(SS) 15 - 16,Amphetamines,4,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,(SS) 15 - 16,Amphetamines,3,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Slovenia,(SS) 15 - 16,Amphetamines,1,Amphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
Slovenia,(SS) 15 - 16,Amphetamines,2,Methamphetamine,,,EUROPE,ESPAD,Western and Central Europe,2015
United Kingdom (Scotland),15,Amphetamines,2.3,Amphetamines,1.1,2,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2015
Latvia,(SS)15-16,Amphetamines,2.9,Amphetamine,,1.5,EUROPE,Govt.,Western and Central Europe,2015
Latvia,(SS)15-16,Amphetamines,2.4,Methamphetamine,,1,EUROPE,Govt.,Western and Central Europe,2015
Cyprus,(SS) 15 - 34,Amphetamines,0.6,Amphetamine,0.1,0.1,EUROPE,ARQ,Western and Central Europe,2016
Italy,(SS) 15 - 19,Amphetamines,3.6, ,1.55,2.42,EUROPE,ARQ,Western and Central Europe,2016
Italy,(SS) 15 - 19,Amphetamines,2.04,Amphetamine,1,1.46,EUROPE,ARQ,Western and Central Europe,2016
Italy,(SS) 15 - 19,Amphetamines,1.26,Methamphetamine,0.7,0.89,EUROPE,ARQ,Western and Central Europe,2016
Poland,(SS) 15 - 16,Amphetamines,7.2,Amphetamine,1.4,3.3,EUROPE,ARQ,Western and Central Europe,2016
Sweden,(SS) 15 - 16,Amphetamines,0.5,Amphetamine,,,EUROPE,ARQ,Western and Central Europe,2016
United Kingdom (England),15,Amphetamines,1.3,Amphetamines,0.5,1.1,EUROPE,Government report,Western and Central Europe,2016
Luxembourg,15 - 16,Cocaine-type,1.5, ,,1.5,EUROPE,ARQ,Western and Central Europe,1999
Turkey,15 - 16,Cocaine-type,1.6,"Cocaine, any (HCl and/ or Crack)",,0.8,EUROPE,ARQ,South-Eastern Europe,2003
Greenland,(SS) 15 - 16,Cocaine-type,1, ,,1,EUROPE,ESPAD,Western and Central Europe,2003
Liechtenstein,12 - 16,Cocaine-type,0.8,"Cocaine, any (HCl and/ or Crack)",,0.6,EUROPE,ARQ,Western and Central Europe,2005
Slovenia,(SS) 16,Cocaine-type,2.8, ,,,EUROPE,ESPAD,Western and Central Europe,2006
Slovenia,(SS) 16,Cocaine-type,1.6,Crack,,,EUROPE,ESPAD,Western and Central Europe,2006
Romania,16,Cocaine-type,1.5, ,,,EUROPE,ESPAD,South-Eastern Europe,2007
Romania,16,Cocaine-type,0.3,Crack,,,EUROPE,ESPAD,South-Eastern Europe,2007
Austria,14 - 17,Cocaine-type,3.4, ,,,EUROPE,ARQ,Western and Central Europe,2007
Cyprus,(SS) 15 - 16,Cocaine-type,3,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2007
Cyprus,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ARQ,Western and Central Europe,2007
Czechia,(SS) 15 - 16,Cocaine-type,1,Cocaine salts,0.3,0.5,EUROPE,ARQ,Western and Central Europe,2007
Czechia,(SS) 15 - 16,Cocaine-type,0.8,Crack,,,EUROPE,ARQ,Western and Central Europe,2007
Denmark,(SS) 15 - 16,Cocaine-type,3.2,"Cocaine, any (HCl and/ or Crack)",,,EUROPE,ARQ,Western and Central Europe,2007
Estonia,(SS) 15 - 16,Cocaine-type,2.5, ,,,EUROPE,ARQ,Western and Central Europe,2007
Estonia,(SS) 15 - 16,Cocaine-type,2.1,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2007
Estonia,(SS) 15 - 16,Cocaine-type,2.9,Crack,,,EUROPE,ARQ,Western and Central Europe,2007
Finland,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ARQ,Western and Central Europe,2007
Germany,(SS) 15 - 16,Cocaine-type,3.5,Cocaine salts. Select regions,,,EUROPE,ARQ,Western and Central Europe,2007
Germany,(SS) 15 - 16,Cocaine-type,2.3,Crack. Select regions,,,EUROPE,ARQ,Western and Central Europe,2007
Hungary,15 - 16,Cocaine-type,1.9, ,,,EUROPE,ARQ,Western and Central Europe,2007
Hungary,15 - 16,Cocaine-type,1.3,Crack,,,EUROPE,ARQ,Western and Central Europe,2007
Latvia,15 - 16,Cocaine-type,1.6, ,,,EUROPE,ARQ,Western and Central Europe,2007
Latvia,15 - 16,Cocaine-type,1.4,Crack,,,EUROPE,ARQ,Western and Central Europe,2007
Malta,15 - 16,Cocaine-type,3.7,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2007
Malta,15 - 16,Cocaine-type,1.9,Crack,,,EUROPE,ARQ,Western and Central Europe,2007
Netherlands,12 - 18,Cocaine-type,1.7, ,0.8,,EUROPE,ARQ,Western and Central Europe,2007
Poland,(SS) 15 - 16,Cocaine-type,0.9,Crack,,0.3,EUROPE,ARQ,Western and Central Europe,2007
Slovenia,15 - 16,Cocaine-type,3, ,,,EUROPE,ARQ,Western and Central Europe,2007
Austria,(SS) 15 - 16,Cocaine-type,3.2, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Austria,(SS) 15 - 16,Cocaine-type,2.3,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Faroe Islands,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Faroe Islands,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Finland,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
France,(SS) 15 - 16,Cocaine-type,5, ,,,EUROPE,ESPAD,Western and Central Europe,2007
France,(SS) 15 - 16,Cocaine-type,6,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Greece,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Greece,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Iceland,(SS) 15 - 16,Cocaine-type,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Iceland,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Ireland,(SS) 15 - 16,Cocaine-type,4, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Ireland,(SS) 15 - 16,Cocaine-type,4,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Lithuania,(SS) 15 - 16,Cocaine-type,1.5,"Cocaine, any (HCl and/ or Crack)",,,EUROPE,ESPAD,Western and Central Europe,2007
Lithuania,(SS) 15 - 16,Cocaine-type,1.2,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Monaco,(SS) 15 - 16,Cocaine-type,6, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Monaco,(SS) 15 - 16,Cocaine-type,4,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Netherlands,(SS) 15 - 16,Cocaine-type,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Netherlands,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Norway,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Norway,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Portugal,(SS) 16,Cocaine-type,2.3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Portugal,(SS) 16,Cocaine-type,1.8,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Switzerland,(SS) 15 - 16,Cocaine-type,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Switzerland,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ESPAD,Western and Central Europe,2007
Serbia,16,Cocaine-type,0.9,"Cocaine, any (HCl and/ or Crack)",,,EUROPE,ARQ,South-Eastern Europe,2008
Montenegro,15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,South-Eastern Europe,2008
Andorra,(SS) 15,Cocaine-type,, ,0.85,,EUROPE,ARQ,Western and Central Europe,2008
Germany,12 - 25,Cocaine-type,, ,0.3,0.9,EUROPE,ARQ,Western and Central Europe,2008
Gibraltar,12 - 18,Cocaine-type,, ,,2.6,EUROPE,ARQ,Western and Central Europe,2008
Gibraltar,12 - 18,Cocaine-type,,Crack,,1.9,EUROPE,ARQ,Western and Central Europe,2008
Poland,(SS) 15 - 16,Cocaine-type,2.2,"Cocaine, any (HCl and/ or Crack)",,1.1,EUROPE,ARQ,Western and Central Europe,2008
Sweden,(SS) 15 - 16,Cocaine-type,1,"Cocaine, any (HCl and/ or Crack)",,,EUROPE,ARQ,Western and Central Europe,2009
Belgium,15 - 16,Cocaine-type,2.52, ,,1.14,EUROPE,ARQ,Western and Central Europe,2010
Italy,(SS) 15 - 16,Cocaine-type,2.2, ,0.9,1.6,EUROPE,ARQ,Western and Central Europe,2010
Italy,(SS) 15 - 16,Cocaine-type,1.6,Cocaine salts,0.7,1.2,EUROPE,ARQ,Western and Central Europe,2010
Italy,(SS) 15 - 16,Cocaine-type,1.3,Crack,0.5,0.9,EUROPE,ARQ,Western and Central Europe,2010
Latvia,School survey,Cocaine-type,2.9,Riga City,,,EUROPE,ARQ,Western and Central Europe,2010
Luxembourg,12 - 18,Cocaine-type,1.7, ,,1.3,EUROPE,ARQ,Western and Central Europe,2010
Netherlands,12 - 18,Cocaine-type,1.7, ,0.8,,EUROPE,ARQ,Western and Central Europe,2010
Poland,18 - 19,Cocaine-type,2.3, ,0.6,0.7,EUROPE,ARQ,Western and Central Europe,2010
Poland,18 - 19,Cocaine-type,2.3,Crack,0.5,0.6,EUROPE,ARQ,Western and Central Europe,2010
Slovakia,(SS) 15 - 16,Cocaine-type,1,Cocaine salts,0.3,0.6,EUROPE,ARQ,Western and Central Europe,2010
Spain,14 - 18,Cocaine-type,3.2,Cocaine HCL,1.2,2,EUROPE,ARQ,Western and Central Europe,2010
Spain,14 - 18,Cocaine-type,3.9,Powder and or crack,1.5,2.6,EUROPE,ARQ,Western and Central Europe,2010
United Kingdom (England),15,Cocaine-type,2.7,Cocaine salts,0.6,2.1,EUROPE,ARQ,Western and Central Europe,2010
United Kingdom (England),15,Cocaine-type,0.9,Crack,0.2,0.5,EUROPE,ARQ,Western and Central Europe,2010
Romania,15 -16,Cocaine-type,2, ,,,EUROPE,ARQ,South-Eastern Europe,2011
Romania,15 -16,Cocaine-type,0.9,Crack,,,EUROPE,ARQ,South-Eastern Europe,2011
Serbia,(SS) 15 - 16,Cocaine-type,1.4,"Cocaine, any (HCl and/ or Crack)",,,EUROPE,ESPAD,South-Eastern Europe,2011
Serbia,(SS) 15 - 16,Cocaine-type,1.2,Crack,,,EUROPE,ESPAD,South-Eastern Europe,2011
Belgium,(SS) 15 - 16,Cocaine-type,2, ,,0.6,EUROPE,ARQ,Western and Central Europe,2011
Czechia,(SS) 15 - 16,Cocaine-type,1.1,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2011
Czechia,(SS) 15 - 16,Cocaine-type,0.7,Crack,,,EUROPE,ARQ,Western and Central Europe,2011
Denmark,(SS) 15 - 16,Cocaine-type,1.9, ,,,EUROPE,ARQ,Western and Central Europe,2011
Estonia,(SS) 15 - 19,Cocaine-type,1.7,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2011
Estonia,(SS) 15 - 19,Cocaine-type,1.8,Crack,,,EUROPE,ARQ,Western and Central Europe,2011
Finland,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ARQ,Western and Central Europe,2011
France,17,Cocaine-type,3,Cocaine salts,,2.2,EUROPE,ARQ,Western and Central Europe,2011
France,17,Cocaine-type,0.8,Crack,,0.5,EUROPE,ARQ,Western and Central Europe,2011
Germany,(SS) 12 - 17,Cocaine-type,,Cocaine salts.,,0.2,EUROPE,ARQ,Western and Central Europe,2011
Germany,(SS) 12 - 17,Cocaine-type,,Crack,,0,EUROPE,ARQ,Western and Central Europe,2011
Germany,(SS) 15 - 16,Cocaine-type,3.1,Cocaine salts. Select regions,,,EUROPE,ARQ,Western and Central Europe,2011
Germany,(SS) 15 - 16,Cocaine-type,1.9,Crack. Select regions,,,EUROPE,ARQ,Western and Central Europe,2011
Greece,(SS) 15 - 16,Cocaine-type,1.5, ,,,EUROPE,ARQ,Western and Central Europe,2011
Greece,(SS) 15 - 16,Cocaine-type,1.1,Crack,,,EUROPE,ARQ,Western and Central Europe,2011
Ireland,(SS) 15 - 16,Cocaine-type,3,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2011
Ireland,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ARQ,Western and Central Europe,2011
Liechtenstein,(SS) 15 - 16,Cocaine-type,4,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2011
Lithuania,(SS) 15 - 16,Cocaine-type,2.4,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2011
Lithuania,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ARQ,Western and Central Europe,2011
Netherlands,(SS) 15 - 16,Cocaine-type,1.7, ,0.8,,EUROPE,ARQ,Western and Central Europe,2011
Slovenia,(SS) 15 - 16,Cocaine-type,3, ,,,EUROPE,ARQ,Western and Central Europe,2011
Slovenia,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ARQ,Western and Central Europe,2011
United Kingdom (England),15,Cocaine-type,2.2, ,0.7,1.8,EUROPE,ARQ,Western and Central Europe,2011
United Kingdom (England),15,Cocaine-type,2.8,Cocaine any (HCL and/or crack),0.9,2.3,EUROPE,ARQ,Western and Central Europe,2011
United Kingdom (England),15,Cocaine-type,1.1,Crack,0.4,0.7,EUROPE,ARQ,Western and Central Europe,2011
Cyprus,(SS) 15 - 16,Cocaine-type,4,Cocaine salts,,,EUROPE,ESPAD,Western and Central Europe,2011
Iceland,(SS) 15 - 16,Cocaine-type,2,Cocaine salts,,,EUROPE,ESPAD,Western and Central Europe,2011
Latvia,15 - 16,Cocaine-type,3.5,Cocaine salts,,,EUROPE,ESPAD,Western and Central Europe,2011
Latvia,15 - 16,Cocaine-type,1.9,Crack,,,EUROPE,ESPAD,Western and Central Europe,2011
Malta,15 - 16,Cocaine-type,4,Cocaine salts,,,EUROPE,ESPAD,Western and Central Europe,2011
Malta,15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2011
Norway,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Western and Central Europe,2011
Portugal,(SS) 15 - 16,Cocaine-type,3,Cocaine salts,,,EUROPE,ESPAD,Western and Central Europe,2011
Portugal,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2011
Belgium,(SS) 15 - 16,Cocaine-type,1.7, ,,0.8,EUROPE,ARQ,Western and Central Europe,2012
Cyprus,15 - 24,Cocaine-type,1.1, ,0.1,0.1,EUROPE,ARQ,Western and Central Europe,2012
Germany,(SS) 15 - 18,Cocaine-type,4,Cocaine salts.   Region Frankfurt am Main,1,,EUROPE,ARQ,Western and Central Europe,2012
Germany,(SS) 15 - 18,Cocaine-type,1,Crack.   Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2012
Italy,(SS) 15 - 19,Cocaine-type,1.47, ,0.65,1.09,EUROPE,ARQ,Western and Central Europe,2012
Italy,(SS) 15 - 19,Cocaine-type,0.91,Cocaine salts,0.42,0.68,EUROPE,ARQ,Western and Central Europe,2012
Italy,(SS) 15 - 19,Cocaine-type,0.81,Crack,0.36,0.6,EUROPE,ARQ,Western and Central Europe,2012
Poland,(SS) 15 - 16,Cocaine-type,3.3, ,,,EUROPE,ARQ,Western and Central Europe,2012
Poland,(SS) 15 - 16,Cocaine-type,2.1,Crack,,,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Cocaine-type,2.9,Cocaine HCL,1.1,2,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Cocaine-type,3.6,Powder and or crack,1.5,2.5,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Cocaine-type,2.8, ,0.9,2.2,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Cocaine-type,3.2,Cocaine any (HCL and/or crack),1.1,2.6,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Cocaine-type,1.1,Crack,0.3,0.8,EUROPE,ARQ,Western and Central Europe,2012
Denmark,(SS) 15 - 16,Cocaine-type,1.9, ,,,EUROPE,ARQ,Western and Central Europe,2013
Estonia,"(SS) 6, 8, 12 grades",Cocaine-type,0.8, ,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,(SS) 15 - 16,Cocaine-type,2, ,,,EUROPE,ARQ,Western and Central Europe,2013
Germany,(SS) 15 - 18,Cocaine-type,4,Cocaine salts.   Region Frankfurt am Main,1,,EUROPE,ARQ,Western and Central Europe,2013
Germany,(SS) 15 - 18,Cocaine-type,1,Crack.   Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 19,Cocaine-type,1.77, ,0.8,1.31,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 19,Cocaine-type,1.16,Cocaine salts,0.54,0.87,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 19,Cocaine-type,0.96,Crack,0.38,0.45,EUROPE,ARQ,Western and Central Europe,2013
Poland,(SS) 15 - 16,Cocaine-type,3.5, ,1.1,1.9,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Cocaine-type,2.4,Cocaine any (HCL and/or crack),0.8,1.9,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Cocaine-type,2,Cocaine salts,0.5,1.6,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Cocaine-type,0.9,Crack,0.5,0.8,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (Scotland),(SS) 15,Cocaine-type,2,Cocaine,1,2,EUROPE,Government,Western and Central Europe,2013
United Kingdom (Scotland),(SS) 15,Cocaine-type,1,Crack,1,1,EUROPE,Government,Western and Central Europe,2013
France,17,Cocaine-type,3.2,Cocaine salts.  Urban areas (excluding overseas departments),,1.6,EUROPE,ARQ,Western and Central Europe,2014
France,17,Cocaine-type,1.1,Crack.  Urban areas (excluding overseas departments),,0.4,EUROPE,ARQ,Western and Central Europe,2014
Germany,(SS) 15 - 18,Cocaine-type,3, Region Frankfurt am Main,1,,EUROPE,ARQ,Western and Central Europe,2014
Germany,(SS) 15 - 18,Cocaine-type,0,Crack.   Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2014
Italy,(SS) 15-17,Cocaine-type,1.9,Female,0.8,1.3,EUROPE,ARQ,Western and Central Europe,2014
Italy,(SS) 15-17,Cocaine-type,3.3,Male,1.7,2.5,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Cocaine-type,3.5, ,1.8,2.8,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Cocaine-type,2.3,Cocaine salts,1.2,1.8,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Cocaine-type,2.7,Crack,1.4,2.1,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Cocaine-type,0.5,Female,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Cocaine-type,0.9,Male,,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS) 15,Cocaine-type,2.4,Cocaine salts. Female,,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS) 15,Cocaine-type,1.2,Cocaine salts. Male,,,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),(SS)15,Cocaine-type,2.3, ,0.9,2,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),(SS)15,Cocaine-type,2.3,Cocaine salts,0.9,2,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),(SS)15,Cocaine-type,0.3,Crack,0.2,0.2,EUROPE,ARQ,Western and Central Europe,2014
Montenegro,(SS) 16,Cocaine-type,3, ,,2,EUROPE,ARQ,South-Eastern Europe,2015
Montenegro,(SS) 16,Cocaine-type,2,Crack,,1,EUROPE,ARQ,South-Eastern Europe,2015
Romania,15 -16,Cocaine-type,3.8, ,,,EUROPE,ARQ,South-Eastern Europe,2015
Romania,15 -16,Cocaine-type,3.3,Cocaine salts,,,EUROPE,ARQ,South-Eastern Europe,2015
Romania,15 -16,Cocaine-type,1.2,Crack,,,EUROPE,ARQ,South-Eastern Europe,2015
Germany,(SS) 15 - 16,Cocaine-type,1,Crack.   Region Frankfurt am Main,,0,EUROPE,ARQ,Western and Central Europe,2015
Germany,(SS) 15 - 16,Cocaine-type,4,Region Frankfurt am Main,1,0.3,EUROPE,ARQ,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Cocaine-type,2.1, ,,1.8,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15-19,Cocaine-type,3.8, ,1.5,2.5,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15-19,Cocaine-type,3.2,Cocaine salts,1.3,2.2,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15-19,Cocaine-type,1.7,Crack,0.7,1.1,EUROPE,ARQ,Western and Central Europe,2015
Latvia,(SS) 19,Cocaine-type,2.3,Cocaine salts,,2.1,EUROPE,ARQ,Western and Central Europe,2015
Latvia,(SS) 19,Cocaine-type,2.2,Crack,,,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS) 15 - 16,Cocaine-type,1.8, ,,,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS) 15 - 16,Cocaine-type,1.8,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2015
Lithuania,(SS) 15 - 16,Cocaine-type,2.2,Cocaine salts,,1.3,EUROPE,ARQ,Western and Central Europe,2015
Lithuania,(SS) 15 - 16,Cocaine-type,0.9,Crack,,0.6,EUROPE,ARQ,Western and Central Europe,2015
Portugal,(SS) 15-16,Cocaine-type,2,Cocaine salts,,,EUROPE,ARQ,Western and Central Europe,2015
Portugal,(SS) 15-16,Cocaine-type,1,Crack,,,EUROPE,ARQ,Western and Central Europe,2015
Slovakia,(SS) 15 - 16,Cocaine-type,1.9, ,,1.1,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cocaine-type,0.5,Female,,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Cocaine-type,1.2,Male,,,EUROPE,ARQ,Western and Central Europe,2015
Finland,(SS) 15 - 16,Cocaine-type,1,Cocaine salts,,,EUROPE,ARQ (ESPAD),Western and Central Europe,2015
Austria,(SS) 15 - 16,Cocaine-type,2, ,,1.5,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Austria,(SS) 15 - 16,Cocaine-type,1.8,Cocaine salts,,1.4,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Austria,(SS) 15 - 16,Cocaine-type,0.6,Crack,,0.4,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Czechia,(SS) 15 - 16,Cocaine-type,1.4,Cocaine salts,0.3,0.8,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Denmark,(SS) 15 - 16,Cocaine-type,1.8,Cocaine salts,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Cocaine-type,2.8, ,,2,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Netherlands,(SS) 12 - 16,Cocaine-type,1.3, ,0.5,0.9,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Belgium,(SS) 15 - 16,Cocaine-type,1,"Crack, Flemish par",,,EUROPE,ESPAD,Western and Central Europe,2015
Belgium,(SS) 15 - 16,Cocaine-type,3,Flemish part,,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 16,Cocaine-type,3, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Czechia,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Czechia,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Denmark,(SS) 15 - 16,Cocaine-type,2, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Estonia,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Faroe Islands,(SS) 15 - 16,Cocaine-type,0, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Faroe Islands,(SS) 15 - 16,Cocaine-type,0,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
France,(SS) 15 - 16,Cocaine-type,4, ,,,EUROPE,ESPAD,Western and Central Europe,2015
France,(SS) 15 - 16,Cocaine-type,3,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Greece,(SS) 15 - 16,Cocaine-type,1.34, ,,1.05,EUROPE,ESPAD,Western and Central Europe,2015
Greece,(SS) 15 - 16,Cocaine-type,1,Crack,,0.76,EUROPE,ESPAD,Western and Central Europe,2015
Hungary,15 - 16,Cocaine-type,3.2,Cocaine salts,,1.9,EUROPE,ESPAD,Western and Central Europe,2015
Hungary,15 - 16,Cocaine-type,1.6,Crack,,0.9,EUROPE,ESPAD,Western and Central Europe,2015
Iceland,(SS) 15 - 16,Cocaine-type,2, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Iceland,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Cocaine-type,3, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Cocaine-type,3, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Cocaine-type,1.4,Crack,,0.9,EUROPE,ESPAD,Western and Central Europe,2015
Monaco,(SS) 15 - 16,Cocaine-type,3, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Monaco,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Netherlands,(SS) 15 - 16,Cocaine-type,2, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Netherlands,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Norway,(SS) 15 - 16,Cocaine-type,1, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Norway,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,(SS) 15 - 16,Cocaine-type,4, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,(SS) 15 - 16,Cocaine-type,2,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
Slovenia,(SS) 15 - 16,Cocaine-type,2, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Slovenia,(SS) 15 - 16,Cocaine-type,1,Crack,,,EUROPE,ESPAD,Western and Central Europe,2015
United Kingdom (Scotland),15,Cocaine-type,3.9,Cocaine,1.9,3.5,EUROPE,Government,Western and Central Europe,2015
United Kingdom (Scotland),15,Cocaine-type,1.5,Crack,0.9,1.3,EUROPE,Government,Western and Central Europe,2015
Latvia,(SS) 15-16,Cocaine-type,2.3,Cocaine salts,,2.1,EUROPE,Govt.,Western and Central Europe,2015
Latvia,(ss) 15-16,Cocaine-type,2.2,Crack,,,EUROPE,Govt.,Western and Central Europe,2015
Italy,(SS) 15-19,Cocaine-type,3.56, ,1.55,2.46,EUROPE,ARQ,Western and Central Europe,2016
Italy,(SS) 15-19,Cocaine-type,3.1,Cocaine salts,1.4,2.21,EUROPE,ARQ,Western and Central Europe,2016
Poland,(SS) 15 - 16,Cocaine-type,3.4, ,1,1.6,EUROPE,ARQ,Western and Central Europe,2016
Sweden,(SS) 15 - 16,Cocaine-type,0.9, ,,,EUROPE,ARQ,Western and Central Europe,2016
Belgium,(SS) 12 - 18,Cocaine-type,2,Flemish part /Cocaine salts,,1.1,EUROPE,ARQ / ESPAD,Western and Central Europe,2016
Belgium,(SS) 15 - 16,Cocaine-type,2.2,Flemish part /Cocaine salts,,1.3,EUROPE,ARQ / ESPAD,Western and Central Europe,2016
Cyprus,(SS) 15 - 34,Cocaine-type,2.1, ,0.3,0.2,EUROPE,ARQ / ESPAD,Western and Central Europe,2016
United Kingdom (England),15,Cocaine-type,3.6,Cocaine Powder,1.3,2.9,EUROPE,Government,Western and Central Europe,2016
United Kingdom (England),15,Cocaine-type,1.3,Crack,0.2,0.7,EUROPE,Government,Western and Central Europe,2016
United Kingdom (Scotland), ,Cocaine-type,2.4,Cocaine,1.2,2.1,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2016
United Kingdom (Scotland), ,Cocaine-type,1,Crack cocaine,0.6,0.9,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2016
Italy,(SS) 15-19,Cocaine-type,1.56,Crack,0.86,1.12,EUROPE,ARQ,Western and Central Europe,2106
Luxembourg,11 - 17,Ecstasy,3.1, ,,1.7,EUROPE,ARQ,Western and Central Europe,1999
Turkey,15 - 16,Ecstasy,1.8, ,,0.8,EUROPE,ARQ,South-Eastern Europe,2003
Greenland,(SS) 15 - 16,Ecstasy,2, ,,1,EUROPE,ESPAD,Western and Central Europe,2003
Albania,14 - 19,Ecstasy,4.9, ,,,EUROPE,ARQ,South-Eastern Europe,2004
Liechtenstein,12 - 16,Ecstasy,0.7, ,,0.6,EUROPE,ARQ,Western and Central Europe,2005
Russian Federation,15 - 16,Ecstasy,3.2, ,,,EUROPE,ARQ/ ESPAD,Eastern Europe,2007
Ukraine,(SS) 15 - 16,Ecstasy,3, ,,,EUROPE,ESPAD,Eastern Europe,2007
Croatia,(SS) 16,Ecstasy,1.9, ,,0.3,EUROPE,ARQ,South-Eastern Europe,2007
Romania,(SS) 16,Ecstasy,1.2, ,,0.6,EUROPE,ESPAD,South-Eastern Europe,2007
Cyprus,(SS) 16,Ecstasy,3, ,2,3,EUROPE,ARQ,Western and Central Europe,2007
Czechia,(SS) 16,Ecstasy,4.5, ,1.2,3,EUROPE,ARQ,Western and Central Europe,2007
Denmark,(SS) 15 - 16,Ecstasy,5.2, ,,,EUROPE,ARQ,Western and Central Europe,2007
Estonia,(SS) 15 - 16,Ecstasy,5.7, ,1.6,3.9,EUROPE,ARQ,Western and Central Europe,2007
Finland,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ARQ,Western and Central Europe,2007
Germany,(SS) 15 - 16,Ecstasy,3.6, ,,2,EUROPE,ARQ,Western and Central Europe,2007
Latvia,15 - 16,Ecstasy,6.5, ,,4.1,EUROPE,ARQ,Western and Central Europe,2007
Malta,(SS) 15 - 16,Ecstasy,3.9, ,1.7,3.1,EUROPE,ARQ,Western and Central Europe,2007
Netherlands,(SS) 12 - 18,Ecstasy,2.4, ,0.8,,EUROPE,ARQ,Western and Central Europe,2007
Slovenia,(SS) 15 - 16,Ecstasy,3.3, ,1.3,2.5,EUROPE,ARQ,Western and Central Europe,2007
Czechia,(SS) 15 - 16,Ecstasy,4.6, ,,3,EUROPE,ARQ./ ESPAD,Western and Central Europe,2007
Austria,(SS) 15 - 16,Ecstasy,3.4, ,1.4,,EUROPE,ESPAD,Western and Central Europe,2007
Cyprus,(SS) 15 - 16,Ecstasy,3, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Faroe Islands,(SS) 15 - 16,Ecstasy,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
France,(SS) 15 - 16,Ecstasy,4, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Hungary,(SS) 15 - 16,Ecstasy,1.2, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Iceland,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Ireland,(SS) 15 - 16,Ecstasy,4, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Lithuania,(SS) 15 - 16,Ecstasy,3.4, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Monoco,(SS) 15 - 16,Ecstasy,4, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Netherlands,(SS) 15 - 16,Ecstasy,4, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Norway,(SS) 15 - 16,Ecstasy,1, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Portugal,(SS) 16,Ecstasy,2.2, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Portugal,13 - 18,Ecstasy,, ,,1.7,EUROPE,ESPAD,Western and Central Europe,2007
Slovenia,(SS) 16,Ecstasy,3.1, ,,2.5,EUROPE,ESPAD,Western and Central Europe,2007
Switzerland,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ESPAD,Western and Central Europe,2007
Republic of Moldova,(SS) 15 - 16,Ecstasy,1.6, ,0.8,1.3,EUROPE,ESPAD,Eastern Europe,2008
Bosnia and Herzegovina,(SS) 15 - 16,Ecstasy,, ,,3,EUROPE,ARQ,South-Eastern Europe,2008
Bulgaria,14 - 19,Ecstasy,7.1, ,2.6,4.6,EUROPE,ARQ,South-Eastern Europe,2008
Serbia,(SS) 16,Ecstasy,1.5, ,,,EUROPE,ARQ,South-Eastern Europe,2008
Montenegro,(SS) 15 - 16,Ecstasy,, ,,1,EUROPE,ESPAD,South-Eastern Europe,2008
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Ecstasy,3.1, ,1.6,2.1,EUROPE,ESPAD,South-Eastern Europe,2008
Gibraltar,12 - 18,Ecstasy,, ,,0.4,EUROPE,ARQ,Western and Central Europe,2008
Germany,12 - 25,Ecstasy,3.2, ,0.3,0.9,EUROPE,Govt.,Western and Central Europe,2008
Sweden,(SS) 15 - 16,Ecstasy,1, ,,1,EUROPE,ARQ,Western and Central Europe,2009
Belarus,15 - 16,Ecstasy,1.1, ,0.2,0.7,EUROPE,ARQ,Eastern Europe,2010
Ukraine,15 - 34,Ecstasy,2, ,0.2,1,EUROPE,ARQ,Eastern Europe,2010
Republic of Moldova,(SS) 15 - 24,Ecstasy,1.2, ,0.2,0.6,EUROPE,Govt.,Eastern Europe,2010
Belgium,(SS) 15 - 16,Ecstasy,2.82, ,,1.53,EUROPE,ARQ,Western and Central Europe,2010
Greece,(SS) 15 - 16,Ecstasy,1.2, ,,,EUROPE,ARQ,Western and Central Europe,2010
Italy,(SS) 15 - 16,Ecstasy,1.1, ,0.3,0.6,EUROPE,ARQ,Western and Central Europe,2010
Latvia,School survey,Ecstasy,4.7, ,1.7,3,EUROPE,ARQ,Western and Central Europe,2010
Luxembourg,12 - 18,Ecstasy,1, ,,0.7,EUROPE,ARQ,Western and Central Europe,2010
Netherlands,(SS) 12 - 18,Ecstasy,2.6, ,0.9,,EUROPE,ARQ,Western and Central Europe,2010
Poland,18 - 19,Ecstasy,3.5, ,0.8,1.4,EUROPE,ARQ,Western and Central Europe,2010
Slovakia,(SS) 15 - 16,Ecstasy,1.9, ,0.6,1.4,EUROPE,ARQ,Western and Central Europe,2010
Spain,14 - 18,Ecstasy,2.5, ,1,1.7,EUROPE,ARQ,Western and Central Europe,2010
United Kingdom (England),15,Ecstasy,2.6, ,0.8,2.3,EUROPE,ARQ,Western and Central Europe,2010
Republic of Moldova,(SS) 15 - 24,Ecstasy,1.2, ,0.1,0.6,EUROPE,ARQ,Eastern Europe,2011
Russian Federation,15 - 16,Ecstasy,2.6, ,0.7,1.2,EUROPE,ARQ,Eastern Europe,2011
Ukraine,15 - 17,Ecstasy,3.1, ,,,EUROPE,ARQ,Eastern Europe,2011
Bosnia and Herzegovina,(SS) 15 - 16,Ecstasy,1.4, ,0.4,0.7,EUROPE,ARQ,South-Eastern Europe,2011
Romania, 15 - 16,Ecstasy,2, ,0.6,1.4,EUROPE,ARQ,South-Eastern Europe,2011
Bulgaria,(SS) 15 - 16,Ecstasy,4.4, ,2.2,3.2,EUROPE,ESPAD,South-Eastern Europe,2011
Montenegro,(SS) 16,Ecstasy,3.3, ,1.2,2.4,EUROPE,ESPAD,South-Eastern Europe,2011
Serbia,(SS) 15 - 16,Ecstasy,1.5, ,,,EUROPE,ESPAD,South-Eastern Europe,2011
Belgium,(SS) 15 - 16,Ecstasy,2.3, ,,0.6,EUROPE,ARQ,Western and Central Europe,2011
Czechia,(SS) 15 - 16,Ecstasy,3.3, ,0.4,1.5,EUROPE,ARQ,Western and Central Europe,2011
Denmark,(SS) 15 - 16,Ecstasy,1.5, ,,,EUROPE,ARQ,Western and Central Europe,2011
Estonia,(SS) 15 - 19,Ecstasy,2.9, ,,,EUROPE,ARQ,Western and Central Europe,2011
Finland,(SS) 15 - 16,Ecstasy,1, ,,,EUROPE,ARQ,Western and Central Europe,2011
France,17,Ecstasy,1.9, ,,1.4,EUROPE,ARQ,Western and Central Europe,2011
Germany,(SS) 15 - 16,Ecstasy,3, ,,,EUROPE,ARQ,Western and Central Europe,2011
Germany,12-17,Ecstasy,, ,,0.2,EUROPE,ARQ,Western and Central Europe,2011
Ireland,(SS) 15 - 16,Ecstasy,2, ,1,2,EUROPE,ARQ,Western and Central Europe,2011
Liechtenstein,(SS) 15 - 16,Ecstasy,3, ,,,EUROPE,ARQ,Western and Central Europe,2011
Lithuania,(SS) 15 - 16,Ecstasy,2.1, ,,,EUROPE,ARQ,Western and Central Europe,2011
Netherlands,(SS) 15 - 16,Ecstasy,2.6, ,0.9,,EUROPE,ARQ,Western and Central Europe,2011
Slovenia,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ARQ,Western and Central Europe,2011
United Kingdom (England),15,Ecstasy,2.7, ,0.8,2.3,EUROPE,ARQ,Western and Central Europe,2011
Cyprus,15- 16,Ecstasy,3, ,3,3,EUROPE,ESPAD,Western and Central Europe,2011
Iceland,(SS) 15 - 16,Ecstasy,2, ,1,1,EUROPE,ESPAD,Western and Central Europe,2011
Latvia,15 - 16,Ecstasy,4.3, ,1.5,2.3,EUROPE,ESPAD,Western and Central Europe,2011
Malta,(SS) 15 - 16,Ecstasy,3, ,2,2,EUROPE,ESPAD,Western and Central Europe,2011
Norway,(SS) 15 - 16,Ecstasy,1, ,1,1,EUROPE,ESPAD,Western and Central Europe,2011
Portugal,(SS) 15 - 16,Ecstasy,3, ,1,3,EUROPE,ESPAD,Western and Central Europe,2011
Belgium,(SS) 15 - 16,Ecstasy,1.8, ,,1,EUROPE,ARQ,Western and Central Europe,2012
Cyprus,15 - 24,Ecstasy,0.8, ,0.1,0.1,EUROPE,ARQ,Western and Central Europe,2012
Italy,(SS) 15 - 19,Ecstasy,0.78, ,0.25,0.5,EUROPE,ARQ,Western and Central Europe,2012
Poland,(SS) 15 - 16,Ecstasy,3, ,1.5,2.2,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Ecstasy,3, ,1.2,2.2,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Ecstasy,3, ,1.2,2.4,EUROPE,ARQ,Western and Central Europe,2012
Bulgaria,15 - 19,Ecstasy,4.1, ,1.9,3.1,EUROPE,ARQ,South-Eastern Europe,2013
Denmark,(SS) 15 - 16,Ecstasy,1.5, ,,,EUROPE,ARQ,Western and Central Europe,2013
Estonia,"(SS) 6, 8, 12 grades",Ecstasy,0.8, ,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,15- 16,Ecstasy,2, ,,,EUROPE,ARQ,Western and Central Europe,2013
Germany,(SS) 15-18,Ecstasy,4, ,1,,EUROPE,ARQ,Western and Central Europe,2013
Italy,(SS) 15 - 19,Ecstasy,0.81, ,0.29,0.53,EUROPE,ARQ,Western and Central Europe,2013
Latvia,15 - 16,Ecstasy,2.43, ,,,EUROPE,ARQ,Western and Central Europe,2013
Poland,(SS) 15 - 16,Ecstasy,2.6, ,1,1.4,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Ecstasy,2.1, ,1.2,1.8,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (Scotland),(SS) 15,Ecstasy,2, ,1,2,EUROPE,Government,Western and Central Europe,2013
France,17,Ecstasy,3.8, ,,2.1,EUROPE,ARQ,Western and Central Europe,2014
Germany,(SS) 15 - 18,Ecstasy,5, ,1,,EUROPE,ARQ,Western and Central Europe,2014
Netherlands,(SS) 15 - 16,Ecstasy,2.6, ,0.9,,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Ecstasy,1.2, ,0.4,0.9,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Ecstasy,0.5, ,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS) 15 - 16,Ecstasy,0.7, ,,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS) 15 - 16,Ecstasy,0.9, ,,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS) 15 - 16,Ecstasy,1.9, ,,,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),(SS)15,Ecstasy,2.7, ,1.3,2.4,EUROPE,ARQ,Western and Central Europe,2014
Republic of Moldova,(SS) 15 - 16,Ecstasy,1, ,,,EUROPE,ESPAD,Eastern Europe,2015
Montenegro,(SS) 16,Ecstasy,3, ,,2,EUROPE,ARQ,South-Eastern Europe,2015
Romania,(SS) 15 - 16,Ecstasy,2.1, ,1,1.4,EUROPE,ARQ,South-Eastern Europe,2015
Albania,(SS) 15 - 16,Ecstasy,2.7, ,,2.2,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Bulgaria,(SS) 15 - 16,Ecstasy,7.1, ,,6,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Croatia,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ESPAD,South-Eastern Europe,2015
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ESPAD,South-Eastern Europe,2015
Germany,(SS) 15 - 16,Ecstasy,7,Region Frankfurt am Main,3,0.5,EUROPE,ARQ,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Ecstasy,3.1, ,,2.1,EUROPE,ARQ,Western and Central Europe,2015
Italy,(SS) 15 - 19,Ecstasy,3.3, ,1.4,2.4,EUROPE,ARQ,Western and Central Europe,2015
Latvia,(SS) 19,Ecstasy,2.7, ,,1.2,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS) 15 - 16,Ecstasy,1.8, ,,,EUROPE,ARQ,Western and Central Europe,2015
Lithuania,(SS) 15 - 16,Ecstasy,1.8, ,,0.9,EUROPE,ARQ,Western and Central Europe,2015
Portugal,(SS) 15-16,Ecstasy,2, ,0.8,1.6,EUROPE,ARQ,Western and Central Europe,2015
Slovakia,(SS) 15 - 16,Ecstasy,3.9, ,,2.2,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Ecstasy,0.4, ,,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS) 15 - 16,Ecstasy,0.9, ,,,EUROPE,ARQ,Western and Central Europe,2015
Finland,(SS)  15  - 16,Ecstasy,1, ,,,EUROPE,ARQ (ESPAD),Western and Central Europe,2015
Austria,(SS) 15 - 16,Ecstasy,2, ,,1.4,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Czechia,(SS) 15 - 16,Ecstasy,2.7, ,0.6,1.7,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Denmark,(SS) 15 - 16,Ecstasy,0.5, ,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Ecstasy,2, ,,1.5,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Netherlands,(SS) 12 - 16,Ecstasy,1.9, ,0.6,1.5,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Latvia,(SS)15-16,Ecstasy,2.7, ,,1.2,EUROPE,ARQ/Govt.,Western and Central Europe,2015
Belgium,(SS) 15 - 16,Ecstasy,3, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 16,Ecstasy,3, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Estonia,(SS) 15 - 16,Ecstasy,3, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Faroe Islands,(SS) 15 - 16,Ecstasy,0, ,,,EUROPE,ESPAD,Western and Central Europe,2015
France,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Greece,(SS) 15 - 16,Ecstasy,1.25, ,,1.11,EUROPE,ESPAD,Western and Central Europe,2015
Hungary,(SS) 15 - 16,Ecstasy,3.6, ,,2.1,EUROPE,ESPAD,Western and Central Europe,2015
Iceland,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Monaco,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Norway,(SS) 15 - 16,Ecstasy,1, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,(SS) 15 - 16,Ecstasy,3, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Slovenia,(SS) 15 - 16,Ecstasy,2, ,,,EUROPE,ESPAD,Western and Central Europe,2015
United Kingdom (Scotland),(SS) 15,Ecstasy,5, ,3,,EUROPE,Government,Western and Central Europe,2015
Cyprus,(SS) 15 - 34,Ecstasy,1.5, ,0.1,0.1,EUROPE,ARQ,Western and Central Europe,2016
Italy,(SS) 15 - 19,Ecstasy,3.04, ,1.32,2.1,EUROPE,ARQ,Western and Central Europe,2016
Poland,(SS) 15 - 16,Ecstasy,3.9, ,0.9,1.9,EUROPE,ARQ,Western and Central Europe,2016
Sweden,(SS) 15 - 16,Ecstasy,0.6, ,,,EUROPE,ARQ,Western and Central Europe,2016
United Kingdom (Scotland),(SS) 13 & 15,Ecstasy,2.1, ,1.3,2,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2016
United Kingdom (Scotland),(SS) 13 & 15,Ecstasy,3, ,1.6,2.7,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2016
Liechtenstein,12 - 19,Tranquillizers and Sedatives,1.1,Barbiturates,,1.8,EUROPE,,Western and Central Europe,2005
Austria,14 - 17,Tranquillizers and Sedatives,2.6, ,,,EUROPE,,Western and Central Europe,2007
Cyprus,16 - 16,Tranquillizers and Sedatives,7, ,,,EUROPE,,Western and Central Europe,2007
Czechia,16 - 16,Tranquillizers and Sedatives,9.1, ,,,EUROPE,,Western and Central Europe,2007
Estonia,15 - 16,Tranquillizers and Sedatives,7.1, ,,,EUROPE,,Western and Central Europe,2007
Finland,15 - 16,Tranquillizers and Sedatives,5, ,,,EUROPE,,Western and Central Europe,2007
Malta,15 - 16,Tranquillizers and Sedatives,4.7, ,,11.1,EUROPE,,Western and Central Europe,2007
Netherlands,12 - 18,Tranquillizers and Sedatives,0.6,GHB,,,EUROPE,,Western and Central Europe,2007
Slovenia,15 - 16,Tranquillizers and Sedatives,5.2, ,,,EUROPE,,Western and Central Europe,2007
Slovenia,15 - 16,Tranquillizers and Sedatives,0.6,GHB,,,EUROPE,,Western and Central Europe,2007
Germany,(SS) 15-16,Tranquillizers and Sedatives,2.2,GHB. Select regions,,,EUROPE,ESPAD,Western and Central Europe,2007
Bulgaria,14 - 19,Tranquillizers and Sedatives,15.9, ,6.4,10.5,EUROPE,,South-Eastern Europe,2008
Bulgaria,14 - 19,Tranquillizers and Sedatives,12.7,Barbiturates,5.3,8.4,EUROPE,,South-Eastern Europe,2008
Bulgaria,14 - 19,Tranquillizers and Sedatives,11.8,Benzodiazepines,4.2,7.4,EUROPE,,South-Eastern Europe,2008
Republic of Moldova,15 - 16,Tranquillizers and Sedatives,1.6, ,,,EUROPE,,Eastern Europe,2010
Greece,15 - 16,Tranquillizers and Sedatives,3, ,,,EUROPE,,Western and Central Europe,2010
Italy,15 - 16,Tranquillizers and Sedatives,4, ,1.2,2.2,EUROPE,,Western and Central Europe,2010
Netherlands,12 - 18,Tranquillizers and Sedatives,0.5,GHB,0.1,,EUROPE,,Western and Central Europe,2010
Poland,18 - 19,Tranquillizers and Sedatives,20, ,4,10,EUROPE,,Western and Central Europe,2010
Poland,18 - 19,Tranquillizers and Sedatives,11,Other sedatives and tranquillizers,1,7,EUROPE,,Western and Central Europe,2010
Slovakia,15 - 16,Tranquillizers and Sedatives,9.5,Benzodiazepines,2.7,3.7,EUROPE,,Western and Central Europe,2010
Spain,14 - 18,Tranquillizers and Sedatives,1.2,GHB,0.5,0.7,EUROPE,,Western and Central Europe,2010
Spain,14 - 18,Tranquillizers and Sedatives,10.4, ,3,5.6,EUROPE,ARQ,Western and Central Europe,2010
United Kingdom (England),15,Tranquillizers and Sedatives,0.4, ,0.1,0.2,EUROPE,ARQ,Western and Central Europe,2010
Republic of Moldova,16 - 16,Tranquillizers and Sedatives,2.4, ,,,EUROPE,ARQ,Eastern Europe,2011
Republic of Moldova,15 - 16,Tranquillizers and Sedatives,5, ,,,EUROPE,ESPAD,Eastern Europe,2011
Romania,15 - 16,Tranquillizers and Sedatives,3.1, ,,,EUROPE,,South-Eastern Europe,2011
Turkey,15-16,Tranquillizers and Sedatives,4.3, ,0.7,0.8,EUROPE,,South-Eastern Europe,2011
Bosnia and Herzegovina,15 - 16,Tranquillizers and Sedatives,4.21,Benzodiazepines,,,EUROPE,ARQ,South-Eastern Europe,2011
Romania,15 -16,Tranquillizers and Sedatives,0.9,GHB,,,EUROPE,ARQ,South-Eastern Europe,2011
Bulgaria,15 -16,Tranquillizers and Sedatives,4.2, ,,,EUROPE,ESPAD,South-Eastern Europe,2011
Montenegro,15,Tranquillizers and Sedatives,4.9,Benzodiazepines,,,EUROPE,ESPAD,South-Eastern Europe,2011
Serbia,15 - 16,Tranquillizers and Sedatives,7.5, ,,,EUROPE,ESPAD,South-Eastern Europe,2011
Latvia,15 - 16,Tranquillizers and Sedatives,2.1,GHB,,,EUROPE,,Western and Central Europe,2011
Czechia,15 - 16,Tranquillizers and Sedatives,10.1, ,,,EUROPE,ARQ,Western and Central Europe,2011
Estonia,15 - 19,Tranquillizers and Sedatives,8.1, ,,,EUROPE,ARQ,Western and Central Europe,2011
Finland,15 - 16,Tranquillizers and Sedatives,7, ,,,EUROPE,ARQ,Western and Central Europe,2011
Iceland,15 - 16,Tranquillizers and Sedatives,8, ,,,EUROPE,ARQ,Western and Central Europe,2011
Ireland,15 - 16,Tranquillizers and Sedatives,3, ,,,EUROPE,ARQ,Western and Central Europe,2011
Liechtenstein,15 - 16,Tranquillizers and Sedatives,2, ,,,EUROPE,ARQ,Western and Central Europe,2011
Lithuania,15 - 16,Tranquillizers and Sedatives,13.1, ,,,EUROPE,ARQ,Western and Central Europe,2011
Slovenia,15 - 16,Tranquillizers and Sedatives,5, ,,,EUROPE,ARQ,Western and Central Europe,2011
Slovenia,15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ARQ,Western and Central Europe,2011
United Kingdom (England),15,Tranquillizers and Sedatives,1.4, ,0.6,1.1,EUROPE,ARQ,Western and Central Europe,2011
Cyprus,15 - 16,Tranquillizers and Sedatives,10, ,,,EUROPE,ESPAD,Western and Central Europe,2011
Latvia,15 - 16,Tranquillizers and Sedatives,4.2, ,,,EUROPE,ESPAD,Western and Central Europe,2011
Malta,15 - 16,Tranquillizers and Sedatives,3, ,,,EUROPE,ESPAD,Western and Central Europe,2011
Norway,15 - 16,Tranquillizers and Sedatives,4, ,,,EUROPE,ESPAD,Western and Central Europe,2011
Portugal,15 - 16,Tranquillizers and Sedatives,7, ,,,EUROPE,ESPAD,Western and Central Europe,2011
Poland,15 - 16,Tranquillizers and Sedatives,1.2,GHB,,,EUROPE,,Western and Central Europe,2012
Cyprus,15 - 24,Tranquillizers and Sedatives,, ,0.7,1.2,EUROPE,ARQ,Western and Central Europe,2012
Germany,(SS) 15-18,Tranquillizers and Sedatives,2,GHB.  Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2012
Greece,15 - 16,Tranquillizers and Sedatives,9.3, ,,,EUROPE,ARQ,Western and Central Europe,2012
Italy,15 - 19,Tranquillizers and Sedatives,1.57, ,0.67,1.05,EUROPE,ARQ,Western and Central Europe,2012
Poland,15 - 16,Tranquillizers and Sedatives,15.5, ,,,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Tranquillizers and Sedatives,8.9, ,3.4,5.8,EUROPE,ARQ,Western and Central Europe,2012
Spain,14 - 18,Tranquillizers and Sedatives,1.3,GHB,0.7,1,EUROPE,ARQ,Western and Central Europe,2012
United Kingdom (England),15,Tranquillizers and Sedatives,0.7, ,0.3,0.6,EUROPE,ARQ,Western and Central Europe,2012
Republic of Moldova,14 - 17,Tranquillizers and Sedatives,, ,,0.35,EUROPE,ARQ,Eastern Europe,2013
Bulgaria,15 - 19,Tranquillizers and Sedatives,12.2, ,4.7,9,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,15 - 19,Tranquillizers and Sedatives,10.4,Barbiturates,3.3,7.1,EUROPE,ARQ,South-Eastern Europe,2013
Bulgaria,15 - 19,Tranquillizers and Sedatives,5.4,Benzodiazepines,2.3,4.1,EUROPE,ARQ,South-Eastern Europe,2013
Estonia,"(SS) 6, 8, 12 grades",Tranquillizers and Sedatives,1,Barbiturates,,,EUROPE,ARQ,Western and Central Europe,2013
Estonia,"(SS) 6, 8, 12 grades",Tranquillizers and Sedatives,1,Benzodiazepines,,,EUROPE,ARQ,Western and Central Europe,2013
Finland,15 - 16,Tranquillizers and Sedatives,6, ,,,EUROPE,ARQ,Western and Central Europe,2013
Italy,15 - 19,Tranquillizers and Sedatives,2.45, ,0.78,1.35,EUROPE,ARQ,Western and Central Europe,2013
Poland,15 - 16,Tranquillizers and Sedatives,19.7, ,5.1,11,EUROPE,ARQ,Western and Central Europe,2013
Poland,15 - 16,Tranquillizers and Sedatives,1.3,GHB,0.7,0.7,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (England),15,Tranquillizers and Sedatives,0.8, ,0.4,0.6,EUROPE,ARQ,Western and Central Europe,2013
United Kingdom (Scotland),(SS) 15,Tranquillizers and Sedatives,1, ,1,1,EUROPE,Govt.,Western and Central Europe,2013
Republic of Moldova,15 - 35,Tranquillizers and Sedatives,, ,,0.1,EUROPE,ARQ,Eastern Europe,2014
France,17,Tranquillizers and Sedatives,15.8,Urban areas (excluding overseas departments),,,EUROPE,ARQ,Western and Central Europe,2014
Germany,(SS) 15-18,Tranquillizers and Sedatives,1,GHB.  Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Tranquillizers and Sedatives,7.8, ,3,5.3,EUROPE,ARQ,Western and Central Europe,2014
Spain,14 - 18,Tranquillizers and Sedatives,1,GHB,0.4,0.7,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS)15-16,Tranquillizers and Sedatives,4.8,Female,1.5,3.5,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS)15-16,Tranquillizers and Sedatives,0.3,GBL. Female,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS)15-16,Tranquillizers and Sedatives,0.3,GBL. Male,,,EUROPE,ARQ,Western and Central Europe,2014
Sweden,(SS)15-16,Tranquillizers and Sedatives,3.1,Male,1.2,2.4,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS)15-16,Tranquillizers and Sedatives,2.8,Female,,,EUROPE,ARQ,Western and Central Europe,2014
Switzerland,(SS)15-16,Tranquillizers and Sedatives,2.9,MAle,,,EUROPE,ARQ,Western and Central Europe,2014
United Kingdom (England),15,Tranquillizers and Sedatives,0.5, ,0,0.4,EUROPE,ARQ,Western and Central Europe,2014
Republic of Moldova,16 -17,Tranquillizers and Sedatives,, ,,0,EUROPE,ARQ,Eastern Europe,2015
Republic of Moldova,(SS) 15 - 16,Tranquillizers and Sedatives,0,GHB,,,EUROPE,ESPAD,Eastern Europe,2015
Republic of Moldova,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Eastern Europe,2015
Montenegro,(SS) 16,Tranquillizers and Sedatives,10, ,,,EUROPE,ARQ,South-Eastern Europe,2015
Romania,(SS) 15-16,Tranquillizers and Sedatives,2, ,,,EUROPE,ARQ,South-Eastern Europe,2015
Romania,(SS) 15-16,Tranquillizers and Sedatives,1.1,GHB,,,EUROPE,ARQ,South-Eastern Europe,2015
Albania,(SS) 15 - 16,Tranquillizers and Sedatives,7.6, ,,,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Bulgaria,(SS) 15 - 16,Tranquillizers and Sedatives,5.1, ,,,EUROPE,ARQ / ESPAD,South-Eastern Europe,2015
Albania,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,South-Eastern Europe,2015
Bulgaria,(SS) 15 - 16,Tranquillizers and Sedatives,3,GHB,,,EUROPE,ESPAD,South-Eastern Europe,2015
Croatia,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,South-Eastern Europe,2015
Montenegro,(SS) 15 - 16,Tranquillizers and Sedatives,2,GHB,,,EUROPE,ESPAD,South-Eastern Europe,2015
The former Yugoslav Republic of Macedonia,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,South-Eastern Europe,2015
Finland,(SS)  15 - 16,Tranquillizers and Sedatives,6, ,,,EUROPE,ARQ,Western and Central Europe,2015
Germany,(SS) 15 - 18,Tranquillizers and Sedatives,1,GHB.  Region Frankfurt am Main,,,EUROPE,ARQ,Western and Central Europe,2015
Italy,15 - 19,Tranquillizers and Sedatives,14, ,4.2,7.2,EUROPE,ARQ,Western and Central Europe,2015
Italy,15 - 19,Tranquillizers and Sedatives,0.8,GHB,0.5,0.7,EUROPE,ARQ,Western and Central Europe,2015
Latvia,(SS) 19,Tranquillizers and Sedatives,5.1, ,,,EUROPE,ARQ,Western and Central Europe,2015
Latvia,(SS)15-16,Tranquillizers and Sedatives,1.1,GHB,,,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS)15-16,Tranquillizers and Sedatives,2.7, ,,,EUROPE,ARQ,Western and Central Europe,2015
Liechtenstein,(SS)15-16,Tranquillizers and Sedatives,2.7,Benzodiazepines,,,EUROPE,ARQ,Western and Central Europe,2015
Lithuania,(SS)15-16,Tranquillizers and Sedatives,8.9, ,,,EUROPE,ARQ,Western and Central Europe,2015
Portugal,(SS) 15-16,Tranquillizers and Sedatives,5, ,,,EUROPE,ARQ,Western and Central Europe,2015
Slovakia,(SS)15-16,Tranquillizers and Sedatives,9.7, ,,,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS)15-16,Tranquillizers and Sedatives,3.6,Female,1,2.7,EUROPE,ARQ,Western and Central Europe,2015
Sweden,(SS)15-16,Tranquillizers and Sedatives,2.4,Male,0.8,1.8,EUROPE,ARQ,Western and Central Europe,2015
Austria,(SS) 15 - 16,Tranquillizers and Sedatives,4.3,Sedatives and tranquillizers,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Hungary,(SS)15-16,Tranquillizers and Sedatives,9, ,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Hungary,(SS)15-16,Tranquillizers and Sedatives,1.1,GHB,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Tranquillizers and Sedatives,2.9, ,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Netherlands,(SS) 12 - 16,Tranquillizers and Sedatives,0.4,GHB,,0.2,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Norway,(SS) 15 - 16,Tranquillizers and Sedatives,6, ,,,EUROPE,ARQ / ESPAD,Western and Central Europe,2015
Austria,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Belgium,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS)  15 - 16,Tranquillizers and Sedatives,2,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Czechia,(SS) 15 - 16,Tranquillizers and Sedatives,0,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Denmark,(SS) 15 - 16,Tranquillizers and Sedatives,0,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Estonia,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Faroe Islands,(SS) 15 - 16,Tranquillizers and Sedatives,0,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
France,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Greece,(SS) 15 - 16,Tranquillizers and Sedatives,0,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Greece,(SS)15-16,Tranquillizers and Sedatives,4.17, ,,,EUROPE,ESPAD,Western and Central Europe,2015
Iceland,(SS) 15 - 16,Tranquillizers and Sedatives,0,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Ireland,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Liechtenstein,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Lithuania,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Malta,(SS) 15 - 16,Tranquillizers and Sedatives,0,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Monaco,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Poland,(SS) 15 - 16,Tranquillizers and Sedatives,2,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Portugal,(SS) 15 - 16,Tranquillizers and Sedatives,1,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Slovakia,(SS) 15 - 16,Tranquillizers and Sedatives,2,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Slovenia,(SS) 15 - 16,Tranquillizers and Sedatives,0,GHB,,,EUROPE,ESPAD,Western and Central Europe,2015
Cyprus,(SS) 15 - 16,Tranquillizers and Sedatives,, ,1.2,4,EUROPE,ARQ,Western and Central Europe,2016
Italy,(SS) 15 - 19,Tranquillizers and Sedatives,3.14, ,4.12,6.88,EUROPE,ARQ,Western and Central Europe,2016
Italy,(SS) 15 - 19,Tranquillizers and Sedatives,0.88,GHB,0.63,0.7,EUROPE,ARQ,Western and Central Europe,2016
Sweden,(SS) 15 - 16,Tranquillizers and Sedatives,0.4, ,,,EUROPE,ARQ,Western and Central Europe,2016
Sweden,(SS) 15 - 16,Tranquillizers and Sedatives,0.1,GHB,,,EUROPE,ARQ,Western and Central Europe,2016
United Kingdom (Scotland),(SS) 13 & 15,Tranquillizers and Sedatives,1.2, ,0.7,1,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2016
United Kingdom (Scotland),(SS) 13 & 15,Tranquillizers and Sedatives,0.9,GHB/GBL,0.6,0.7,EUROPE,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Western and Central Europe,2016
Australia,12 - 17,Amphetamines,1,Methamphetamine,,0.6,OCEANIA,ARQ,Australia and New Zealand,2007
New Zealand,13 - 17,Amphetamines,1.2,Methamphetamine,,,OCEANIA,ARQ,Australia and New Zealand,2007
Guam,(SS) Grades 9 - 12,Amphetamines,5.9,Youth Risk Behavior Survey/ methamphetamine,,,OCEANIA,Govt.,Micronesia,2007
Marshall Islands,(SS) Grades 9 - 12,Amphetamines,13.1,Youth Risk Behavior Survey/ methamphetamine,,,OCEANIA,Govt.,Micronesia,2007
Northern Mariana Islands,(SS) Grades 9 - 12,Amphetamines,4.9,Youth Risk Behavior Survey/ methamphetamine,,,OCEANIA,Govt.,Micronesia,2007
Palau,(SS) Grades 9 - 12,Amphetamines,7.1,Youth Risk Behavior Survey/ methamphetamine,,,OCEANIA,Govt.,Micronesia,2007
American Samoa,(SS) Grades 9 - 12,Amphetamines,5.7,Youth Risk Behavior Survey/ methamphetamine,,,OCEANIA,Govt.,Polynesia,2007
New Zealand,Youth 16-17,Amphetamines,2.15,Household survey,,1.4,OCEANIA,Govt.,Australia and New Zealand,2008
Australia,14 - 19,Amphetamines,2.4,Non-specified ATS,0.6,1.6,OCEANIA,ARQ,Australia and New Zealand,2010
Australia,14-19,Amphetamines,2.3,Amphetamines,0.8,2,OCEANIA,ARQ,Australia and New Zealand,2013
New Zealand,16-24,Amphetamines,,Household survey,,1.8,OCEANIA,Govt.,Australia and New Zealand,2014
New Zealand,16-24,Amphetamines,,Household survey,,1.3,OCEANIA,Govt.,Australia and New Zealand,2015
Australia,14 - 19,Amphetamines,2.3,"Meth-amphetamines / 2016 annual prevalence, 2013 lifetime and past 30 day prevalence",0.8,0.8,OCEANIA,ARQ,Australia and New Zealand,2016
Australia,12 - 17,Cocaine-type,0.8,"Cocaine, any (HCl and/ or Crack)",,0.4,OCEANIA,ARQ,Australia and New Zealand,2007
Guam,(SS) Grades 9 - 12,Cocaine-type,4.6,Youth Risk Behavior Survey,2,,OCEANIA,Govt.,Micronesia,2007
Marshall Islands,(SS) Grades 9 - 12,Cocaine-type,7.7,Youth Risk Behavior Survey,5.3,,OCEANIA,Govt.,Micronesia,2007
Northern Mariana Islands,(SS) Grades 9 - 12,Cocaine-type,4.7,Youth Risk Behavior Survey,2.9,,OCEANIA,Govt.,Micronesia,2007
Palau,(SS) Grades 9 - 12,Cocaine-type,5.9,Youth Risk Behavior Survey,3.5,,OCEANIA,Govt.,Micronesia,2007
American Samoa,(SS) Grades 9 - 12,Cocaine-type,5.4,Youth Risk Behavior Survey,3,,OCEANIA,Govt.,Polynesia,2007
New Zealand,Youth 16 - 17,Cocaine-type,0.1,Household survey,,0.1,OCEANIA,Govt.,Australia and New Zealand,2008
Australia,14 - 19,Cocaine-type,2.1, ,0.7,1.3,OCEANIA,ARQ,Australia and New Zealand,2010
Australia,14-19,Cocaine-type,2.1, ,0.3,1.1,OCEANIA,ARQ,Australia and New Zealand,2013
Australia,14 - 19,Cocaine-type,2.1,"2016 annual prevalence, 2013 lifetime and past 30 day prevalence",0.3,1,OCEANIA,ARQ,Australia and New Zealand,2016
Australia,12 - 17,Ecstasy,2.2, ,,2,OCEANIA,ARQ,Australia and New Zealand,2007
Guam,(SS) Grades 9 - 12,Ecstasy,5.8, ,,,OCEANIA,Govt.,Micronesia,2007
Marshall Islands,(SS) Grades 9 - 12,Ecstasy,13.1, ,,,OCEANIA,Govt.,Micronesia,2007
Northern Mariana Islands,(SS) Grades 9 - 12,Ecstasy,4.7, ,,,OCEANIA,Govt.,Micronesia,2007
Palau,(SS) Grades 9 - 12,Ecstasy,6.9, ,,,OCEANIA,Govt.,Micronesia,2007
American Samoa, ,Ecstasy,5, ,,,OCEANIA,Govt.,Polynesia,2007
New Zealand,Youth 16-17,Ecstasy,3.6, ,,2.35,OCEANIA,Govt.,Australia and New Zealand,2008
Australia,14 - 19,Ecstasy,4.7, ,1.2,2.8,OCEANIA,ARQ,Australia and New Zealand,2010
Australia,14-19,Ecstasy,3.9, ,,3,OCEANIA,ARQ,Australia and New Zealand,2013
Australia,14 - 19,Ecstasy,3.9,"2016 annual prevalence, 2013 lifetime",,1,OCEANIA,ARQ,Australia and New Zealand,2016
New Zealand,Youth 16-17,Tranquillizers and Sedatives,2.9, ,,1.6,Oceania,Govt. HHS,Australia and New Zealand,2008
Australia,14 - 19,Tranquillizers and Sedatives,, ,,1,Oceania,ARQ,Australia and New Zealand,2010
Australia,14 - 19,Tranquillizers and Sedatives,4.5,Other sedatives and tranquillizers,1.6,3.2,Oceania,ARQ,Australia and New Zealand,2010
